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Enterohaemorrhagic Escherichia coli (EHEC) are a recently emerged group of 
pathogens that can cause fatal infections in the young and elderly.   EHEC 
utilize a virulence factor delivery organelle called a ’Type 3 secretion system’ 
that results in the formation of characteristic  ‘pedestal structures’ on epithelial 
cells allowing colonization in the human or ruminant gastrointestinal tract. To 
achieve this, effector proteins have to be injected into host cells. The SepL-SepD 
complex has been shown to be key for controlling T3-related protein secretion in 
EHEC. Lack of either protein results in effector hypersecretion and strongly 
impaired secretion of EspADB translocon proteins. Therefore, the expression 
and function of SepL was the focus of my PhD research. The expression of SepL 
was shown to be heterogeneous and co-expressed with EspA filaments in EHEC 
O157 strains. My work revealed two transcriptional regulators (Ler and SepD) 
and two putative posttranscriptional regulators (Hfq and CsrA) of SepL 
expression. Further experiments mapped a key mRNA region required for 
heterogeneous expression of SepL.  This  sequence forms a predicted hairpin 
structure around the Shine-Dalgarno (SD) site of sepL.  A model has been 
formed  based on my data in which Hfq and CsrABCD bind to the mRNA 
potentially competing to control translation. Functionally, the C-terminus of 
SepL was found to be expendable for 1) SepD binding; 2) SepL membrane 
localization and 3) translocon export, however it was required for 1) limiting 
effector secretion via (2) a Tir interaction which might be disassociated by (3) an 
EscD interaction once host cell signals are sensed. Previously, the concept of 
two different types of T3 secretion signal were demonstrated in Yersinia spp, I 
tested this hypothesis in EHEC using both wild type and SepL/SepD deficient 
EHEC strains. SepL/SepD is required for the  N-terminal signal pathway but not 
a chaperone binding domain signal pathway. A 12aa NleA which only contained 
an N-terminal signal was shown to bind to SepD and so did the multi-functional 
T3 chaperone ― CesT. Finally, Far-Western assays demonstrated that SepL 
only interacted with Tir while SepD could bind other effector proteins indicating 
that SepL/SepD may act as a targeting hub for effector protein secretion. 
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1.1 Escherichia coli 
Escherichia coli (Escherichia coli) is a common bacterial species isolated 
from the gastrointestinal tract of humans and other mammals. It is named 
after Theodor Escherich, a German paediatrician who first isolated and 
studied the organism in 1885 (Escherich, 1885).  For a long time Escherichia 
coli was considered a harmless part of the flora present in the lower intestine 
of humans and warm-blooded animals (Conway, 1995). Escherichia coli 
strains can be benign commensals which benefit their hosts by producing 
vitamin K2 (Marley et al., 1986) or by preventing the colonisation of 
pathogenic bacteria within the intestine (Gamage et al., 2006, Leatham et al., 
2009). Escherichia coli was also adapted as a useful tool for biological 
research (Lederberg, 1996, Lederberg, 1946, Russo, 2003) and 
biotechnology (Lee, 1996). However, it was later shown that these 
‘commensal’ Escherichia coli, found within gastrointestinal tract or other 
locations (such as bloodstream, urinary tract, abdominal cavity or 
gallbladder), could be associated with disease (Johnson and Nolan, 2009, 
Dho-Moulin and Fairbrother, 1999, Dobrindt, 2005, Dobrindt and Hacker, 
2008, Johnson and Russo, 2002, Kaper et al., 2004, Russo and Johnson, 
2006, Smith et al., 2007, Vimr and Steenbergen, 2006, Sivick and Mobley, 
2010). A further issue is that many strains of Escherichia coli are resistant to 
multiple antibiotics and this may be due to their presence in complex 
polymicrobial environments like the gastrointestinal tract and their capacity 
to form biofilms; both factors facilitating the exchange of genetic 
information (Literak et al., 2009, Pallecchi et al., 2010, Skurnik et al., 2009, 
Salyers et al., 2004).  
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1.2 Pathogenic Escherichia coli  
Escherichia coli is one species within the large bacterial family, the 
Enterobacteriaceae, the enteric bacteria, which are facultative anaerobic 
Gram-negative rods that live in the intestinal tracts of animals in health and 
disease. Commensal (non-pathogenic) Escherichia coli are usually harmless 
and may actually help the host by preventing pathogen colonization 
(Gamage et al., 2006, Leatham et al., 2009). However, these commensal 
strains can be associated with opportunistic infections, for example 
peritonitis, an inflammation of the peritoneum which can occur following 
perforation of gastrointestinal tract as a result of injuries or surgery (Levine, 
1984). It is now clear that certain Escherichia coli strains are more likely to 
be associated with both intestinal and extra-intestinal infections (Bauchart et 
al., 2010, Croxen and Finlay, 2010, Johnson et al., 2010, Moriel et al., 2010, 
Sheldon et al., 2010, Wieser et al., 2010).  For example, Escherichia coli is a 
common Gram-negative bacterium isolated from septicaemia cases, 
especially from patients with compromised immune systems (Orrett and 
Changoor, 2007) and is one of the most common organisms associated with 
uncomplicated urinary tract infections (Johnson, 1991). These pathogenic 
Escherichia coli strains are generally separated from other commensal 
isolates according to the serotype.  Serotyping is important to help 
distinguish the limited number of strains that actually cause disease.  In the 
1940's Kauffmann turned his attention to the Escherichia coli group. He 
based the serotyping scheme on three types of antigen: the somatic ‘O’ 
antigen (O-specific polysaccharide side chain of lipopolysaccharide-LPS), 
the capsular ‘K’ antigen and the flagellar ‘H’ antigen. The K antigens were 
subdivided into three types depending on their heat-sensitivity. Initially there 
were 25 O, 55 K and 20 H antigens described (Kauffmann, 1944, Kauffmann, 
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1947). As new antigens were described new numbers were added to the 
scheme. Occasionally a number was removed either due to the type strain 
being reclassified as not being an Escherichia coli or the antigen being too 
similar to another to warrant being given a separate number. More recently, 
the number of O antigens had reached 173, with 103 K antigens and 56 H 
antigens (Orskov and Orskov, 1990, Orskov and Orskov, 1992).  
 
1.2.1 Extraintestinal pathogenic Escherichia coli 
(ExPEC) 
Escherichia coli acquire sets of genes by horizontal transfer, for example 
mediated by plasmids and bacteriophages.  ExPEC have been shown to share 
sets of horizontally-acquired virulence determinants as ‘pathogenicity 
islands’ (Johnson et al., 2003, Johnson et al., 2010, Johnson and Nolan, 2009, 
Smith et al., 2007, Johnson and Russo, 2005).  There are four main 
Escherichia coli groups involved in extraintestinal infections and these are 
described below:  
1. Uropathogenic Escherichia coli (UPEC): Escherichia coli is the most 
commonly isolated bacterial species associated with urinary tract infections 
(UTI) including cystitis and pyelonephritis (Watts and Hunstad, 2008, 
Dhakal et al., 2008, Mulvey et al., 2000, Seed and Hultgren, 2005, Wiles et 
al., 2008, Sivick and Mobley, 2010).  75% of clinical isolates belong to six 
O-serogroups suggesting that UPEC are a true pathogen group (Johnson, 
1991). Important virulence factors associated with UPEC strains include: 
various filamentous adhesive organelles involved in colonisation (Chen et al., 
2009, Cosar et al., 2001, Justice et al., 2006, Lane and Mobley, 2007, Lane 
et al., 2007, Ong et al., 2008, Rodriguez-Pastrana et al., 2007, Simms and 
Mobley, 2008b, Simms and Mobley, 2008a, Ulett et al., 2007); the pore-
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forming toxin alpha-hemolysin (HlyA) and cytotoxic necrotizing factor type 
1 (CNF1) which both contribute to the symptoms of cystitis caused by 
UPEC infection in humans (Wullt et al., 2000, Miyazaki et al., 2002, 
Reigstad et al., 2007, Smith et al., 2008).  
2. Neonatal meningitis associated Escherichia coli (NMEC): While a very 
rare infection, specific Escherichia coli strains can infect babies during the 
passage through the birth canal (Krohn et al., 1997) and these strains 
probably invade through the naïve gastrointesinal tract and cause 
bacteraemia.  Once in the blood, NMEC penetrate the blood brain barrier 
(BBB) causing meningitis.  It has been shown that successful crossing of the 
BBB by Escherichia coli requires a high-degree of bacteraemia both in vitro 
and in vivo (Kim, 2002, Xie et al., 2004). Meningitis associated with 
Escherichia coli can also occur in individuals with suppressed immune 
systems (Bonacorsi and Bingen, 2005, Orskov and Orskov, 1985). 
Interestingly, the majority of Escherichia coli isolates from meningitis 
infection produce the K1 capsule, contributing to survival in the bloodstream 
as a result of the antiphagocytic properties of the capsule (Wieser et al., 2010, 
Hacker et al., 1993, Vimr and Steenbergen, 2006);  
3. Avian pathogenic Escherichia coli (APEC): In most cases, these 
pathogenic Escherichia coli cause colisepticaemia in birds resulting in 
significant economic losses in the poultry industry.  The strains are 
considered to enter the respiratory tract and colonise the air sacs and then 
invade the bloodstream (Bauchart et al., 2010, Johnson et al., 2010, 
Stathopoulos et al., 1999, Dho-Moulin and Fairbrother, 1999, Dozois et al., 
2000).  Related strains are associated with a number of complex brain, lung 
and urinary tract diseases in humans and other mammals.  
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4. Mammary pathogenic Escherichia coli (MPEC) ― MPEC are a putative 
group of Escherichia coli pathogens causing mastitis in farm animals which 
has not been well characterised (Shpigel et al., 2008).  
 
1.2.2 Intestinal pathogenic Escherichia coli 
Escherichia coli normally colonize human gastrointestinal tract immediately 
(a few hours to days) after birth (Adlerberth et al., 1991, Wold and 
Adlerberth, 2000). Although most of Escherichia coli are harmless, certain 
serotypes were found responsible for causing diarrhoea in human and 
animals (Kaper et al., 2004, Hedberg et al., 1997, Hill et al., 1991, Huppertz 
et al., 1996, Koutkia et al., 1997, Levine, 1987, Levine et al., 1978, Levine 
and Edelman, 1984, Nagy and Fekete, 1999, Nataro and Kaper, 1998). Here, 
Escherichia coli are classified into 6 groups associated with diarrhoea. These 
categories are based on differences in virulence properties, adherence 
patterns and interactions with the intestinal mucosa, O & H types and 
involvement in distinct clinical syndromes. These groups are:  
1. Enteroinvasive Escherichia coli (EIEC): these strains produce dysentery 
that is clinically indistinguishable from shigellosis. It was found that 
Escherichia coli strains isolated from patients with dysentery were also able 
to cause experimental keratoconjunctivitis in guinea pigs and caused a 
Shigella-like illness in children and adults (Parsot, 2005).  
2. Enteroaggregative Escherichia coli (EAggEC): these strains are associated 
with persistent diarrhoea in young children. The distinguishing feature of 
EAggEC strains is their ability to attach to tissue culture cells in an 
aggregative manner (Navaneethan and Giannella, 2008).  
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3. Enterotoxigenic Escherichia coli (ETEC): produce diarrhoea resembling 
cholera but much milder in degree (travellers diarrhoea) (DuPont, 2009). 
Two types of toxins are produced. Two toxins with related mechanisms of 
action: (A) Heat labile toxins (LT) which are similar to choleragen. LTs raise 
adenylate cyclase activity in cells; the subsequent production of cyclic AMP 
leads to dysregulation of water and ion secretion; (B) Heat stable toxin (ST): 
these toxins activate guanylate cyclase which also leads to dysregulation of 
water and ion transport across epithelial cells leading to diarrhoea (Okoh and 
Osode, 2008, Fleckenstein et al., 2010);  
4. Diffusely adherent Escherichia coli (DAEC): this is a relatively poorly 
defined group of strains with some strains considered to contain similar 
chromosomal regions to the EPEC/EHEC groups described below. (Beinke 
et al., 1998).  
5. Enteropathogenic Escherichia coli (EPEC): these strains are often 
associated with infant diarrhoea. Clinical symptoms include fever, diarrhoea, 
vomiting and nausea usually with non-bloody stools (DuPont, 2009). EPEC 
induce a characteristic morphological (A/E) lesion with destruction of 
microvilli without invasion of the organism (Cleary et al., 2004, Marches et 
al., 2003, Gauthier et al., 2003a, DeVinney et al., 1999, Rosa et al., 1998);  
6. Enterohaemorrhagic Escherichia coli (EHEC): these strains cause a 
diarrhoeal syndrome distinct from EIEC (and Shigella) in that there is 
copious bloody discharge and no fever. Production of Verotoxin or Shiga 
toxins (also sometimes referred to as "Shiga-like") is highly associated with 
this group of organisms.  These infections can be life-threatening due to 
effects on vascular endothelium, in particular in the kidneys (haemolytic 
uremia) (Roe et al., 2003a, Marches et al., 2003, DeVinney et al., 2001, 
Stordeur et al., 2000, Frankel et al., 1998). 
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1.2.2.1 Escherichia coli and Shigella 
Shigella was originally described by Kiyoshi Shiga, a Japanese physician 
and bacteriologist, during a severe epidemic with 30% mortality rate in 1897 
(Shiga, 1898). Shigella is a group of Gram-negative bacteria which are very 
closely related to Escherichia coli. To date, Shigella strains have only been 
associated with dysentery in primates, (Ryan KJ, 2004, Ogawa et al., 2008, 
Schroeder and Hilbi, 2008). Shigella species are indistinguishable from 
Escherichia coli species at the DNA level (Brenner et al., 1969, Hartl and 
Dykhuizen, 1984). Originally Shigella was grouped as a pathogen Bacillus 
to be separated from harmless Bacillus coli (Escherichia coli) in the early 
1940’s (Lan and Reeves, 2002). Later, various pathogenic Escherichia coli 
were reported after the first pathogenic Escherichia coli ― EIEC O124 was 
described in 1944 (Lan et al., 2004). Shigella was reported to share virulence 
factors with pathogenic Escherichia coli (Parsot, 2005, Maurelli et al., 1998, 
O'Brien et al., 1982, Hartl and Dykhuizen, 1984, Levine, 1987, Jarvis et al., 
1995). It was proposed that Shigella and pathogenic Escherichia coli 
evolved from non-pathogenic commensal Escherichia coli (Levine and 
Edelman, 1984, Hartl and Dykhuizen, 1984, Kaper et al., 1997, Maurelli et 
al., 1998, Lan and Reeves, 2002, Fukiya et al., 2004, Lan et al., 2004, Parsot, 
2005). Shigella, unlike Escherichia coli, are lysine decarboxylase positive 
and do not produce gas when they ferment glucose (Sansonetti, 1999, 
Maurelli et al., 1998). In addition, Shigella strains are non-motile and 
generally do not ferment lactose whilst most Escherichia coli strains are 
motile and ferment lactose (Sansonetti, 1999, Maurelli et al., 1998).  
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1.3 Attaching and effacing Escherichia coli (AEEC) 
Moon et al. (1983) coined the term ““Attaching and effacing” (A/E) and 
linked this phenotype and EPEC infection together for the first time. This 
lesion is remarkably different from lesions caused by non-A/E lesion 
forming pathogens such as ETEC or V. cholerae. An A/E lesion is 
characterised by degeneration of microvilli on gut enterocytes, gross 
cytoskeletal reorganization of intestinal epithelial cells and intimate 
attachment between bacteria and host cells (Baldini et al., 1983a, Baldini et 
al., 1983b, Moon et al., 1983, Knutton et al., 1989a). A/E lesion forming 
bacteria can be observed embedded on epithelial cells or forming pedestal-
like structures on the cell surface (Fig.1.1) (Knutton et al., 1989a, Knutton et 
al., 1989c). Such an intimate adherence mechanism may also cause an issue 
for clinical therapy (Hill et al., 1991, Law, 1994). In order to examine A/E 
lesion formation, electron microscopy (EM) was required before Knutton et 
al. (1989a) developed the fluorescent-actin staining (FAS) test. In this test, 
Fluorescein isothiocyanate (FITC) or Rhodamine (TRITC)-labelled 
phalloidin is used to specifically bind polymerized filamentous actin (F-actin) 
accumulated at the sites of bacterial attachment (Fig.1.2). This test has 
proved a very valuable tool for the study of bacterial factors involved in A/E 
lesion formation. 
 
Both EPEC and EHEC are able to induce typical A/E lesions (Phillips and 
Frankel, 1997), and are therefore both AEEC, but they are not the only 
pathogens that can initiate A/E pathology as the mouse gastrointestinal 
pathogen, Citrobacter rodentium (CR) can also induce A/E lesions on 
infected host cells (Luperchio and Schauer, 2001).  
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Fig. 1.2. Fluorescent-actin staining (FAS) test of EPEC infection. 
EPEC strain E2348/69 was used to infect HEp-2 tissue culture cells. Actin 
(green) and EPEC bacteria (red) were detected after staining with Alexa 488 
phalloidin and rabbit anti-EPEC polyclonal anti-sera, followed by anti-rabbit 
antibody labelled with Cy3 (reproduced from Hobson et al., 2008). 
Fig. 1.1. A. Enterohaemorrhagic Escherichia coli (EHEC) (Image credit: Dennis 
Kunkel Microscopy, Inc.); B. EPEC (purple) induces the formation of pedestals 
on the host cell surface (orange) (Image reproduced from 
www.biotech.ubc.ca/faculty/finlay/); C. Gross localized perturbation of brush 
border architecture. Original magnification: ×8000. (Image reproduced from 




C. rodentium is the causative agent of transmissible murine colonic 
hyperplasia and is associated with mild diarrhoea in infected mice 
(Klapproth et al., 2005). In the 1960s, C. rodentium was isolated after two 
major outbreaks of diarrhoea in laboratory mice in the United States 
(Brennan et al., 1965) and Japan (Muto et al., 1969) which resulted in high 
morbidity and mortality. At the time the isolates were designated as an 
atypical Citrobacter freundii strain (C. freundii ANL) or Murine pathogenic 
Escherichia coli (atypical Escherichia coli Ex30) respectively. Further 
studies on subsequent disease outbreaks in mouse colonies revealed a 
genomic relatedness among all atypical C. freundii and Murine pathogenic 
Escherichia coli strains isolated from rodents (Schauer et al., 1995, 
Luperchio et al., 2000). Therefore, they were reclassified as a separated 
species, Citrobacter rodentium. As with the human pathogens EPEC and 
EHEC, C. rodentium is able to form typical A/E lesions on infected 
intestinal tissue and serves as an important model pathogen for investigating 
the mechanisms controlling attaching and effacing pathology and it provides 
an ideal in vivo model for studying interaction between host and pathogen, 
including epithelial hyperproliferation and tumour promotion in the distal 
colon of the mouse (Luperchio and Schauer, 2001, Kelly et al., 2006).  
 
EPEC is a common cause of diarrhoea in developing countries nowadays, 
and particularly dangerous for children less than 1 year old (Hill et al., 1991, 
Jarvis et al., 1995, Frankel et al., 1998). EPEC was first reported in the 
1940s when an infantile diarrhoea outbreak in UK was investigated (Bray, 
1945, Walker-Smith, 1996). However, during the following decades, there 
were doubts about the pathogenic potential of EPEC until 1978 when 
research involving human volunteers Levine et al., (1978) demonstrated its 
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pathogenicity by inducing diarrhoea in the volunteers following ingestion of 
EPEC O127:H6 strain E2348/69. For many years, EPEC was defined by 
serotype only and a consensus was reached on the basic characteristics of 
EPEC in 1995 which included the capacity to form A/E lesions and the lack 
of Shiga toxin; as another closely related AEEC, EHEC, can produce Shiga 
toxin (McDaniel et al., 1995).  
 
1.4 Enterohaemorrhagic Escherichia coli (EHEC) 
Enterohaemorrhagic Escherichia coli are associated with gastrointestinal 
infection in humans. EHEC strains are defined by a combination of factors 
including the ability to produce Shiga toxin(s), specific adherence factor(s), 
enterohaemolysin, in addition to the somatic antigens which the most 
prevalent EHEC strains express; including O111, O26 and O157. EHEC 
O157:H7 is the main EHEC serotype associated with outbreaks of 
gastrointestinal disease in North America, parts of Europe and Japan which 
are mainly developed countries. It is an important pathogen that can be life-
threatening particularly in the young and the elderly. EHEC was first 
recognized as a cause of illness in 1982 during an outbreak of severe bloody 
diarrhoea in the USA and the outbreak was traced to contaminated 
hamburgers (CDC, 1982, Frankel et al., 1998). Therefore, it was initially 
known as a “hamburger disease”.  Since then, EHEC have emerged as an 
important group of zoonotic pathogens (Table 1.1) that can cause acute 
gastroenteritis (an inflammation of the gastrointestinal tract resulting in acute 
diarrhoea) and haemorrhagic colitis (HC) (an inflammation of the large 
intestine with the loss of blood) (Noel and Boedeker, 1997, Croxen and 
Finlay, 2010, Dziva et al., 2004, Rivas et al., 1996, Roe, 2000), with the 
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potential to lead to haemolytic uremic syndrome (HUS) which is a severe 
complication characterized by hemolytic anemia (a decrease in the normal 
number of red blood cells because of the abnormal breakdown), acute renal 
failure (kidney damage) and thrombocytopenia (a low platelet count) 
(Corrigan and Boineau, 2001, Anagnou et al., 1991, Bogdanovic et al., 1988, 
Olgaard et al., 1974, Riley et al., 1983, Boyce et al., 1995).  
 
Table 1.1 Major outbreaks of EHEC infection since 1982 
Time Country Details 
 
1982 USA Restaurant, contaminated hamburgers (CDC, 1982) 
 
1982 USA The food-distribution system contaminated spinach (CDC, 1982, 
Riley et al., 1983) 
 
Sept. 1984 Nebraska, USA Nursing home; undercooked hamburger patties (Ryan et al., 
1986) 
 
Sept. 1985 Canada Nursing home; contaminated sandwiches and then a second 
wave associated with person-to-person transmission of infection 
(Carter et al., 1987) 
 
Apr. 1986 Canada Dairy farm; a field trip to a dairy farm / raw milk (Dorn and Angrick, 
1991) 
 
Nov. 1986 Washington state, USA Restaurant/nursing home; ground beef (Ostroff et al., 1990) 
 
1988 Germany Multiple cases, no clear cource; sorbitol fermenting EHEC strain 
O157:H- (Karch et al., 1993) 
 
Oct. 1988 Missouri, USA day-care center; undercooked hamburger (Skala, 1994, 
Armstrong et al., 1996) 
 
Jan. 1990 Missouri, USA >100 cases, the source of the outbreak has not been identified, 
may have been waterborne (Swerdlow et al., 1992) 
 
1990 Saitama, Japan Water supply in a nursery (Akashi et al., 1994) 
 
1991 Massachusetts. USA 23 patient drank apple cider purchased at a roadside stand 
(Besser et al., 1993) 
 
Dec. 1991 Minnesota USA Schools; meat supplied in the meals (Armstrong et al., 1996) 
 
May. 1992 Scotland UK A semi-rural area of south-east Scotland; related to a childrens’ 
paddling pool (Brewster et al., 1994) 
 
Dec. 1992 - Jan. 1993 The western USA Restaurants; 700 people ill from Escherichia coli O157:H7 in 
hamburgers (Crump et al., 2002) 
 
Jul. 1993 California, USA Home cooked hamburgers (CDC, 1994a & 1994b) 
 
Mar. - Aug. 1993 Oregon and Washington, 
USA 
4 chain Z restaurants: contaminated steak and salad (Jackson et 
al., 2000) 
 
1994 Leicestershire, UK Escherichia coli  O157:H7 isolated from nine animals on the farm 
was indistinguishable from the strain isolated from human 
samples (Shukla et al., 1995) 
 
Jul. 1994 New Jersey, USA Meat (CDC, 1995a, CDC, 1995b) 
 
1995 Wales UK Farm; contact with cattle (Milne et al., 1999) 
 
Jul. 1995 Georgia and Tennessee, 
USA 
Restaurant; hamburgers (CDC, 1996b) 
 




Jul. 1996 Sakai City, Osaka, Japan contaminated bean sprouts, >6000 cases occurred, after the 
outbreak, more than 1000 secondary infections occurred in the 
families of the patients (Yoshioka et al., 1999) 
 
Oct. 1996 North America Unpasteurized apple cider or juice (McCarthy, 1996) 
 
Oct. 1996 Morioka, Japan 198 students and seven school employees were infected with the 
O157 strain of Escherichia coli. Radish sprouts were briefly 
suspected in this outbreak (Watanabe et al., 1999, Michino et al., 
1999) 
 
Nov. 1996 Lanarkshire Scotland UK 500 people infected and at least 20 deaths. The outbreak was 
traced to a single butcher's shop and bakery which operated a 
substantial wholesale and retail trade in cooked and raw meat 
products (Dundas et al., 1999, Attenborough and Matthews, 2000) 
 
Jun. - Jul. 1997 Michigan and Virginia, 
USA 
Associated with eating alfalfa sprouts grown from the same lot of 
seed (CDC, 1997) 
 
Aug. 1997 USA The outbreak was traced to the contaminated beef processed in a 
plant in Nebraska and distributed nationally (Bender et al., 1997) 
 
Jun. 1998 Nevada and California, 
USA 
non-motile strain of Escherichia coli O157. Cases were linked to 
an alfalfa/clover sprout mixture from the same producer (Van 
Beneden et al., 1999) 
 
Jun. 1998 USA 50 people infected and cases linked to tainted cheese curds made 
at a Stanley dairy (CDC, 2000a & 2000b) 
 
Aug. 1999 Washington County, New 
York, USA 
consumption of beverages purchased from vendors supplied with 
water drawn from an unchlorinated fairground’s well was 
associated with the outbreak (CDC, 1999) 
 
May 2000 Scotland UK Water supply as possible source (Artz and Killham, 2002) 
 
Jul. - Sept. 2000 Wisconsin USA Contaminated beef at Sizzler restaurant (Yoon et al., 2009) 
 
Dec. 2000 Minnesota USA Contaminated ground beef purchased from SuperValu/Cub food 
stores (Proctor et al., 2002) 
 
2000 Pennsylvania, USA Visiting a dairy farm (Crump et al., 2002) 
 
2000 Ohio, USA The Medina County fair; the water system from which food 
vendors were supplied was the source of the Escherichia coli 
outbreak (Crump et al., 2003) 
 
Aug. 2001 British Columbia, 
Canada 
Raw goat's milk from a co-operative farm (McIntyre et al., 2002) 
 
2001 Ohio, USA An environmental and site investigation revealed Escherichia coli 
contamination on doorways, rails, bleachers, and sawdust. 
Investigators concluded that the Lorain County Fair was the 
source of the outbreak (Crump et al., 2003) 
 
Nov. 2001 northwestern England 
UK 
Contaminated meat (Rajpura et al., 2003) 
Jul. 2002 Washington UK Romaine lettuce made by ‘Spokane Produce’ (Lee et al., 2004) 
 
Aug. 2002 Lane County, Oregon 
USA 
Originated from exposure to animals in ‘the sheep and goat barn’ 
(Services, 2003) 
 
Aug. 2003 Dublin Ireland Restaurants were identified as the possible source of the outbreak 
(Carroll et al., 2005)  
 
Sept.-Oct. 2003 California USA Contaminated spinach (Jay et al., 2007)  
 
2003 Texas USA 25 people ill after attending the Fort Bend County Fair (Durso et 
al., 2005) 
 
2004 North Carolina USA Associated with a goat and sheep petting zoo (Goode et al., 2009) 
 
Mar. 2005 Orlando, Tampa, USA Associated with animal petting (CDC, 2005) 
 
Sept. 2005 South Wales UK A total of 157 cases were identified, mainly school children from 
contaminated meals (O'Brien, 2005) 
 
Dec 2005 Washington & Oregon, 
USA 
Raw milk (CDC, 2007) 
 
May 2006 Scotland UK Associated with a nursery (Pollock et al., 2010) 
 
Sept. 2006 USA Raw spinach (Wendel et al., 2009) 
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Nov. – Dec. 2006 USA 81 illness linked to Taco John's Restaurants   
 
Sept. 2007 Scotland, UK Contaminated cold meat (Webster et al., 2007) 
 
Jun, 2008 Ohio and Michigan, USA Associated with ground beef sold at Kroger stores   
 
Jun. 2009 USA  Outbreak linked to Nestle cookie dough  
 
Aug. 2009 Surry England, UK Visiting Godstone ‘petting’ farm (Wise, 2009)  
 
Nov. 2009 New York, USA Contaminated ground beef from a New York ground beef 
company (Moss, 2009)  
 
Feb. 2010 England UK Feltham Hill Nursery & Infant School, contamination source 
undefined (Teed, 2010)  
 
EHEC infection is characterized by abdominal pain and contraction, 
followed by diarrhoea (Su and Brandt, 1995). As the disease progresses, the 
diarrhoea becomes watery or even bloody. Vomiting can occur, but rarely 
fever (Ryan et al., 1986). The incubation period for the disease is normally 3 
to 9 days, although shorter and longer periods can be observed. In general, 
this sickness lasts for about a week and resolves without any further long-
term problems (Cohen and Giannella, 1992, Griffin et al., 1988). Most 
infections have been traced back to contamination from ruminant faeces 
(polluted water, fruit and vegetables) (Hashimoto et al., 1999). The other 
sources of infections include meat (ground beef), cross-contamination in 
food preparation, waterborne, person-to-person, animal-to-person and other 
foods of animal origin (Okrend et al., 1990, Padhye and Doyle, 1991, 
Chapman et al., 1993, Rangel et al., 2005, Rivas et al., 1996). A further 
factor, which is of great significance, is the size of the infectious dose (<700 
organisms): this is incredibly small in comparison with those for most other 
food-borne pathogens (Tuttle et al., 1999). Escherichia coli O157:H7 
infection can be prevented simply by thoroughly cooking ground beef, 
avoiding unpasteurized milk and cross-contamination of foods, and washing 
hands carefully (VernozyRozand and RayGueniot, 1997). Escherichia coli 
O157:H7 infections can occur as isolated cases or as part of an outbreak 
(AlJader et al., 1999, Tuttle et al., 1999). Cases are seen more frequently 
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during the summer months which might due to high prevalence of EHEC 
contaminations in farm products and/or environmental survival of the 
bacteria (Chapman et al., 1997, Heuvelink et al., 1998, Van Donkersgoed et 
al., 1999, Chapman et al., 2000). 
 
The natural reservoirs of EHEC are ruminants, such as cattle and sheep, in 
which EHEC do not seem to cause disease (Orskov et al., 1987, Elder et al., 
2000). A 2003 study on the prevalence of Escherichia coli O157:H7 in 
livestock at 29 county and 3 large state agricultural fairs in the United States 
found that Escherichia coli O157:H7 could be isolated from 13.8% of beef 
cattle, 5.9% of dairy cattle, 3.6% of pigs, 5.2% of sheep, and 2.8% of goats 
(Keen, 2003). Over seven percent of pest fly pools also tested positive for 
Escherichia coli O157:H7.  Although cattle are known to be a major 
reservoir for this pathogen, the ecology of the organism in animals is poorly 
understood. Four strains of O157:H7 were surveyed in experimentally 
infected calves by Naylor et al.. Most bacteria were found in faeces, and 
post-mortem examination revealed that the recto-anal tissues were colonised 
by Escherichia coli O157:H7 (Naylor et al., 2003). These tissues also 
express a high density of lymphoid follicles, which may govern tropism, 
possibly via intimin - the bacterial adhesion protein (Naylor et al., 2003). 
The accessibility and identification of this site of colonisation may facilitate 
simple intervention strategies.  
 
1.4.1 Shiga toxin 
A defining characteristic of EHEC is the production of Shiga toxin (Stx), the 
genes for which are introduced into strains on certain lambdoid 
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bacteriophages. While there are many factors that contribute to the 
pathogenesis of EHEC infection, Stx is a key virulence factor causing the 
most severe symptoms (O'Brien et al., 1983, Karmali et al., 1983). These 
phage-encoded toxins are comprised of a single A subunit (~32 KDa) 
associated with a pentamer of B subunits (~7.7 KDa) (Tesh and O'Brien, 
1991).  There are two groups of the Shiga toxin family which are called 
Shiga toxin 1 (Stx1) and Shiga toxin 2 (Stx2). Stx1 is basically identical to 
Shiga toxin produced by Shigella dysenteriae type 1 (O'Brien et al., 1982, 
O'Brien and LaVeck, 1983) which is also a cause of HUS. Stx2 has multiple 
subtypes (Stx2c, Stx2e, Stx2v etc.) which have different binding affinities to 
host cell molecules such as Globotriaosylceramide (Gb3) or 
Globotetraosylceramide (Gb4) (Lingwood et al., 1987, Boyd and Lingwood, 
1989, DeGrandis et al., 1989, Lingwood, 1993).  
 
It has been shown that purified Stx can cause fluid accumulation and 
histological damage in rabbit ileal loops (Keenan et al., 1986). Considering 
the Gb3 receptor binding of Stx and that the Gb3 receptor is present at 
higher levels on villus cells rather than on crypt cells in rabbits, a possible 
diarrhoeagenic mechanism in this host is the selective killing of absorptive 
villus tip intestinal epithelial cells by Stx; however the distribution of the 
Gb3 receptor is different in human cells, and so the basis to EHEC induction 
of diarrhoea in humans is unclear and maybe more likely to be associated 
with host cell responses to other virulence factors (Schuller et al., 2004, te 
Loo et al., 2000). Stx is also referred to as Verocytotoxin (VT) or Shiga-like 
toxin (SLT) (Richardson et al., 1988, O'Brien et al., 1984). As a 
consequence, EHEC are considered a subset of the Verocytoxin producing 
E.coli (VTEC) or Shiga toxin producing Escherichia coli (STEC). 
 24
1.4.2 Type 3 secretion system (T3SS) 
At least seven different bacterial secretion systems have been reported and 
have been numbered accordingly;  type 1, 2, 3, 4, 5, 6, and 7 secretion 
systems (Fig.1.3.).  The type 1 secretion system (T1SS) is able to allow 
polypeptides of up to 800 kDa across the cell envelope which depends on an 
ATP-binding cassette (ABC) transporter in the inner membrane, a membrane 
fusion protein (MFP) and outer membrane protein (Omp) (Holland et al., 
2005). Type 2 secretion systems (T2SS) utilize a two-step process in which 
proteins are delivered to the periplasm first via the general secretory system 
(Sec) or potentially the Twin-arginine translocation (Tat) pathway and then 
transported to the exterior by an outer membrane secretin (Cianciotto, 2005). 
The type 4 secretion/pilus system (T4SS/T4PS) is evolutionally-related to 
T2S which utilize a simultaneous one step Sec-independent translocation of 
substrates across both membranes which can translocate protein, DNA or 
Fig. 1.3. Schematic diagram of bacterial secretion pathways.   
It is only the basics of each secretion system that are presented here.  HM: Host membrane; 
OM: Outer membrane; IM: Inner membrane; MM: Mycomembrane, ATPase is shown in red 
and periplasmic chaperone is shown in green. 
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protein-DNA complexs (Christie et al., 2005). However, it was suggested 
that the translocation of Pertussis toxin subunits requires a Sec-dependent 
T4SS (Gauthier et al., 2003b). The type 5 secretion system (T5SS) is an 
autotransporter system in which the protein, once in the periplasm, forms a 
pore-like complex to present part of its own polypeptide sequence externall, 
this can remain attached or be cleaved for export (Henderson et al., 2004). 
The type 6 secretion system (T6SS) was discovered more recently and is not 
as well characterized yet (Filloux et al., 2008). It can translocate virulence 
factors into eukaryotic cells in an ATPase (ClpV) dependent manner (Bingle 
et al., 2008). Type 7 secretion systems have been found in Gram-positive 
and Acid fast bacteria for the secretion of the prototypic ESX proteins 
including the 6 kDa early secreted antigenic target (ESAT-6) and the 10 kDa 
culture filtrate protein (CFP-10) (Simeone et al., 2009). In addition to the 
above, the chaperone-usher pathway is employed to assemble various pili 
(Kline et al., Nuccio and Baumler, 2007). The substrate requires the sec 
system for crossing the inner membrane and then the formation of a 
chaperone-substrate complex to prevent auto-aggregation in the periplams 
and to deliver the protein to the ‘gateway’  usher in the outer membrane for 
export (Thanassi et al., 1998).  
 
T3SS is a Sec-independent delivery channel for ATP-energized effector 
protein delivery into host cells, although the same system initially exports 
the translocation needle/filament and pore forming proteins to enable this 
export. In this respect, this export is equivalent to that used to drive flagellal 
export (Thomas and Finlay, 2003, Aldridge and Hughes, 2001), and in fact 
flagella in certain species have been associated with exporting effector 
proteins into host cells, e.g. from Campylobacter spp. (Young et al., 1999, 
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Konkel et al., 2004).  The T3SS is composed of a basal apparatus spanning 
across the two bacterial double membranes and an extension structure to 
reach the host cell (Yip and Strynadka, 2006, Galan and Wolf-Watz, 2006, 
Fig. 1.4. Schematic diagram of the type three secretion system [Based on 
(Gauthier and Finlay, 2003, Gauthier et al., 2003a, Yip et al., 2005b, Crepin et al., 
2005a, Nadler et al., 2006, Ogino et al., 2006, Sekiya et al., 2001, Daniell et al., 
2001, Wilson et al., 2001, Andrade et al., 2007, O'Connell et al., 2004, Tree et al., 
2009)].  
The basal body of the T3SS is composed of the outer membrane ring EscC, the 
inner membrane proteins EscD, Q, R, S, T, U, V, and the EscJ lipoprotein, which 
connects the inner and outer membrane ring structures. The needle structure, 
EscF, provides a base for EspA polymerization to form the filament. EspB and 
EspD form the translocation pore in the host cell plasma membrane, connecting 
the bacteria with the eukaryotic cell via EspA filaments. The ATPase EscN 
provides the energy to the system by hydrolyzing ATP molecules into ADP. The 
location of SepD and SepL remains unclear (Kresse et al., 2000, O'Connell et al., 
2004).  
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Zarivach et al., 2007, Zarivach et al., 2008). In brief, T1, 3, 4 and 6 secretion 
systems can translocate substrates out of the bacterial cell in a one-step 
process; and the other systems need an intermediate step via the  periplasm.  
 
T3SS was first recognized in 1993 (Salmond and Reeves, 1993) after 
intensive work has been carried simultaneously on the Yop/Ysc secretion in 
an animal pathogen, Yersina enterocolitica, by two independent research 
groups led by Guy R. Cornelis and Hans Wolf-Watz respectively (Michiels 
et al., 1990, Michiels and Cornelis, 1991, Forsberg et al., 1991, Hakansson 
et al., 1993, Cornelis and Wolf-Watz, 1997). Very soon after that, similar 
secretion machinery was also found in plant pathogens, Erwinia amylovora 
and Pseudomonas solanacearum (Wei et al., 1992, Genin et al., 1992, 
Gough et al., 1992). The T3SSs are molecular syringes (needles) that inject 
bacterial virulence factors or effector proteins directly into host cells. These 
injected bacterial molecules subvert cellular processes and contribute to the 
disease. As with other Gram-negative pathogens, such as Yersinia spp., 
Pseudomonas spp., Shigella spp. and Salmonella spp., EHEC has a type 3 
secretion system (T3SS) (Fig. 1.4) (Table 1.2) (Urbanowski et al., 2005, 
Torruellas et al., 2005, Schroeder and Hilbi, 2008, Miki et al., 2009).  
 
EHEC T3SS consists of the structural proteins known as the basal apparatus  
(EscCDJRSTUV…) and also the translocon proteins (EspADB) which form 
a needle like filament to facilitate injection of effectors into the host cells 
(Ogino et al., 2006). The basal apparatus consists of multiple proteins 
forming a pore through the bacterial double membrane which requires the 
Sec-pathway for assembly.  The basal appratus recruits effector proteins to 
the export channel with the help of chaperone proteins (Gauthier and Finlay, 
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2003, Gauthier et al., 2003a, Thomas et al., 2005, Zarivach et al., 2007). 
With the help of the apparatus ATPase protein - EscN, effectors are unfolded 
and energized for release through the T3SS ‘tunnel’ (Akeda and Galan, 2005, 
Evans et al., 2006, Gauthier and Finlay, 2003, Gauthier et al., 2003a, 
Zarivach et al., 2007, Andrade et al., 2007). After then it was proposed 
substrate export would be driven by the proton motive force (PMF) in the 
T3SS ‘tunnel’ (Galan, 2008, Minamino and Namba, 2008, Paul et al., 2008). 
All the structural proteins are crucial for the T3SS and any damage of these 
proteins would result in a severe impairment of T3SS function (Gauthier et 
al., 2003a, Nadler et al., 2006, Ogino et al., 2006). The ATPase is required 
for T3S and this has been shown in a number of studies (Gauthier and Finlay, 
2003, Zarivach et al., 2007, Andrade et al., 2007). The PMF is known to 
drive ion, DNA and protein/solute transport in many different cases (Ohsumi 
and Anraku, 1983, Wong and Buckley, 1989, Strobel et al., 1989, Van 
Leeuwen et al., 1991, Bradbeer, 1993, Bose et al., 2002, Maier et al., 2004, 
Crosa et al., 2009) and was suggested to be involved in flagellar assembly 
back in 1977 (Bar Tana et al., 1977) and subsequent work proved this theory 
(Galperin et al., 1982, Paul et al., 2008). Recent work has suggested the 
PMF as important for T3S in Yersina but the mechanism remains to be 
elucidated (Wilharm et al., 2004). 
 
Exo-flagella are whip-like organelles emanating from the bacterial surface 
which are important for bacterial motility and pathogenesis (Karlinsey et al., 
1998, Karlinsey et al., 2000a, Eichelberg and Galan, 2000, Giron et al., 2002, 
Berg, 2003). It was demonstrated that the bacterial flagellar hook and 
filament were assembled in a manner analogous to that of the T3SS 
(Karlinsey et al., 2000a, Desvaux et al., 2006). Published work confirmed 
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that flagellar T3SS (F-T3SS) and non-flagellar T3SS (NF-T3SS) were all 
probably derived from the same ancestor (Nguyen et al., 2000, Gophna et al., 
2003, Saier, 2004). There were at least nine conserved proteins shared 
between the F-T3S and NF-T3S systems (Desvaux et al., 2006). However,  
 
Table 1.2 Non-flagellar T3SSs found in various Gram-negative 
pathogens (Urbanowski et al., 2005, Torruellas et al., 2005, Kelly et 
al., 2006, Schroeder and Hilbi, 2008, Miki et al., 2009, Wang et al., 
2009, Cornelis, 2006). 
T3SS family Taxon Organism Details 
Yersina pestis 
Yersinia pseudotuberculosis  
Human, cattle, rodent pathogen 
Y. enterocolitica Human pathogen 
Pseudomonas aeruginosa Animal, insect and human, Opportunistic  pathogen 
Vibrio parahaemolyticus Human pathogen 
Aeromonas salmonicida Fish pathogen 
γ-proteobacteria 
 
Photorhabdus luminescens mutualistic with entomophagous nematodes 
β-proteobacteria Bordetella pertussis Human pathogen 
Ysc 
δ-proteobacteria Desulfovibrio vulgaris Sulphate reducing environmental bacteria 
EPEC, EHEC Human pathogens form AE lesion 
Citrobacter rodentium Mouse pathogen form AE lesion 




Rodent and human pathogen 
γ-proteobacteria 




Emerging human pathogen (evoking meloidosis) 
Salmonella enterica Human pathogen (SPI-2 responsible for host cell invasion) 
Shigella flexneri Human pathogen 
Yersinia enterocolitica Human pathogen 
γ-proteobacteria 
Sodalis glossinidius Tse-tse fly symbiont 





Emerging human pathogen (evoking meloidosis) 
Pseudomonas syringae,  Plant pathogen 
Erwinia amylovora Plant pathogen 
Pantoea agglomerans Non-pathogen, environmental and human commensal 
Hrp1 γ-proteobacteria 
Vibrio parahaemolyticus Human pathogen 
γ-proteobacteria Xanthomonas campestris Plant pathogen 
Ralstonia solanacearum Plant pathogen 
Hrp2 
β-proteobacteria 
Burkholderia pseudomallei Human pathogen 
Chlamydia trachomatis  Obligate intracellular human pathogen Chlamydiales Chlamydiaceae  
Chlamydia pneumoniae Obligate intracellular human pathogen 
Mesorhizobium loti Plant symbiont (Nitrogen fixation) Rhizobium α-proteobacteria 
Rhizobium sp Plant symbiont (Nitrogen fixation) 
 
Table 1.3 Main components of T3SSs 
Organism Filament ATPase Needle Gatekeeper Ruler Switch C-ring 
Yersina spp. (Ysc) LcrV YscN YscF YopN-TyeA YscP YscU YscQ 
EHEC/EPEC EspA EscN EscF SepL Orf16 EscU EscQ 
Salmonella enterica (SPI-1) SipD InvC Prgl InvE InvJ SpaS SpaO 
Shigella spp. IpaD Spa47 MxiH MxiC Spa32 Spa40 Spa33 
Flagellum FliC FliI FlgE - FliK FlhB FliN 
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the F-T3SS and NF-T3SS are not the exact same system but evolutionary 
related (Table 1.3) (Nguyen et al., 2000, Gophna et al., 2003, Saier, 2004). 
Structurally, both systems have a basal complex spanning between two 
bacterial membranes with a protein export channel in the middle; they also 
have a hollow filamentous organelle extended from the basal complex (Bar 
Tana et al., 1977, Wei et al., 2001, Giron et al., 2002). Functionally, the 
flagellar filament is flexible and can rotate driven by the PMF which is 
critical for bacterial motility (Journet et al., 2005, Bar Tana et al., 1977); but 
the NF-T3SS normally has a needle like filament for effector translocation 
into host cells (Journet et al., 2005). Generally, the non-flagellar T3SS is 
characterized by a number of attributes (i) contact-dependence (Mecsas and 
Strauss, 1996); (ii) an energy requirement for protein secretion and 
translocation into host cells; (iii) secretion-regulated expression of genes 
encoding proteins secreted downstream in the pathway; and (iv) dedicated 
cytoplasmic chaperones for some secreted proteins. It differs from other 
secretion pathways in Gram-negative bacteria by the absence of (i) 
conserved sequences involved in translocation except within some species 
(Miao, 2000), (ii) a cleaved signal sequence in secreted polypeptides, and (iii) 
a periplasmic secretion intermediate (Charkowski et al., 1997). The non-
flagellar and flagellar T3SSs share all but the first characteristic and the 
ability to translocate proteins into eukaryotic cells, although translocation 
may occur through flagella in certain bacteria. Another difference is that the 
group of YopN-TyeA family gating proteins that switch substrate secretion 
in the non-flagellar T3SS are not found but not in the flagellar system 
(Pallen et al., 2005b). On the other hand, the flagella T3SS is closely 
regulated by sigma factors and chemotaxis (Paul et al., 2010, Sarkar et al., 
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2010, Dong and Schellhorn, 2009a, Aldridge et al., 2006, Desvaux et al., 
2006, Dutton et al., 2005, Tart et al., 2005). 
 
In contrast to the secretion process in other systems, T3S is triggered when a 
pathogen comes in close contact with host cells, and hence has been called 
‘contact-dependent secretion’ (Ginocchio et al., 1994, Watarai et al., 1995, 
Menard et al., 1994, Rosqvist et al., 1994). Levels of type 3 protein secretion 
are also dependent on environmental cues (Kenny et al., 1997a). 
Temperature, growth phase and salt conditions are factors known to induce 
synthesis of the secretion apparatus and effector proteins in various 
pathogens (Edwards and Schifferli, 1997, Chilcott and Hughes, 2000, 
Cambronne and Schneewind, 2002, Knodler et al., 2002, Yahr and 
Wolfgang, 2006). Because of this medium-dependent secretion proteins are 
secreted only when the bacteria are cultured in a medium with the 
appropriate stimuli; absence of this information can make the secretion 
system difficult to study. 
 
1.4.3 A pathogenicity Island (PAI) for A/E lesion 
formation 
A three-stage model of pathogenesis was proposed by Donnenberg and 
Kaper for EHEC and EPEC (Donnenberg and Kaper, 1992). In this model: 
(1) with the help of bacterial surface adhesive factors, such as flagella or 
fimbriae, bacteria initially adhere to epithelial cells; (2) adherence of bacteria 
to epithelial cells induces different signal transduction pathways via injection 
of virulence factors that alter the intracellular environment in host cells; and 
(3) intimate bacterial adherence occurs to host cells with pedestal formation.  
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The capacity to form A/E lesions is conferred by a pathogenicity island 
known as the locus of enterocyte effacement (LEE) (Fig. 1.5.).  As shown 
for EPEC O127, all the proteins needed for inducing A/E lesions can be 
encoded by this chromosomally-located PAI (McDaniel and Kaper, 1997). 
Previous research demonstrated that an Escherichia coli K12 strain can form 
A/E lesion on epithelial cells when transformed with the LEE from EPEC 
but, interestingly, not when transformed with the EHEC LEE (McDaniel and 
Kaper, 1997, Elliott et al., 1999b). The size of the LEE in EPEC/EHEC 
O157 is about 35 kb (Elliott et al., 1999b, Kaper et al., 1997, Perna et al., 
1998, Frankel et al., 1998). There are five major operons termed LEE1, 
LEE2, LEE3, LEE4 and LEE5 (including tir) in the LEE of EHEC, 
containing at least 41 open reading frames (ORFs).  
 
These genes encode different products, ① Type 3 secretion apparatus: ‘Esc’ 
- Escherichia coli secretion and ‘Sep’ - secretion of Escherichia coli proteins; 
Fig. 1.5. Gene map of EHEC LEE  
EHEC LEE has a size of about 35 Kbs and has 5 major operons with 41 genes. Those 
genes encode different components which contributed to E. coli type three secretion 
system including Basal apparatus (EscCDEIJNLQRSTUV), needle structure EscF, EspA 
filament and EspDB pore forming protein, Sep (secretion of E. coli protein) proteins, Ces 
(Chaperone of E. coli secretion) proteins, regulators, bacterial adhesion - intimin, 
traslocated effector (Map, Tir, , EspFGHZ) and other proteins with unknown function. 
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② Type 3 ‘translocators’ including Escherichia coli secreted proteins 
(Esp)A,D,B; ③ effector proteins including the mitochondria-associated 
protein (Map), EspF/G/G2/H, and the translocated intimin receptor (Tir); ④ 
the outer membrane adhesin, Intimin; ⑤ transcriptional regulators: the LEE-
encoded regulator (Ler); global regulator of LEE-activator/repressor (GrlA/R) 
and multiple point controller (Mpc); ⑥ chaperone proteins: CesT, CesAB, 
CesA2, CesD,CesD2 and CesF; ⑦ proteins of unknown function. The G+C 
content of the LEE (38.3%) is significantly lower than that of the 
Escherichia coli chromosome (50.8%) as a whole, suggesting that the LEE 
arose by horizontal gene transfer of this pathogenicity island from another 
species (Deng et al., 2001, McDaniel and Kaper, 1997, Karaolis et al., 1997).   
 
1.4.3.1 Intimin (bacterial surface adhesion) 
As mentioned above, the LEE in attaching and effacing pathogens encodes 
an important outer membrane adhesin, intimin, which binds to the bacterial 
protein Tir, as well as to host encoded proteins such as nucleolin on host cell 
membranes (Sinclair and O'Brien, 2002, Sinclair and O'Brien, 2004, Sinclair 
et al., 2006, Kenny et al., 1997b). These intimin-related interactions were 
demonstrated to play a pivotal role in inducing typical A/E lesions 
(Rosenshine et al., 1996b, Frankel et al., 1996, Kenny and Finlay, 1997, 
Kenny et al., 1997b, Hicks et al., 1998, Sinclair and O'Brien, 2002). Surface 
interactions are critical for the intimate attachment phenotype and trigger 
consequent cytoskeleton rearrangement in epithelial cells.  So far, six intimin 
derivatives (, and) have been shown to be expressed by A/E 
pathogens (Jores et al., 2003). Although the mechanism of intimin secretion 
was unknown, it was reported that intimin export required multiple 
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periplasmic chaperones and possibly a type 5 secretion system (Bodelon et 
al., 2009).  
 
1.4.3.2 T3 basal structure 
As mentioned above the T3 needle complex (NC) shares similarities with the 
bacterial flagella system. The T3 NC starts at the cytoplasm of the bacterium, 
crosses the two membranes and protrudes out of the cell. This sophisticated 
injectisome can be considered in two parts; the basal body and polymerized 
EspA needle extension. The T3 basal apparatus is embedded in the bacterial 
membrane and forms a multi-ring structure spanning from the bacterial inner 
membrane to the outer membrane. This basal complex is composed of more 
than 20 structural proteins which are encoded by genes located within the 
LEE. The assembly of T3 NC involves three steps: First, the insertion of 
inner membrane and outer membrane ring in a Sec-dependent manner 
(Gauthier et al., 2003a); and then export of the needle structural protein, 
EscF, that is integrated into the outer and inner rings as a base for the 
filament structure (Sekiya et al., 2001, Daniell et al., 2001, Wilson et al., 
2001). EspA is secreted via the T3SS and is added to the top of the EscF 
needle; polymerized EspA forms the main translocation filament (Daniell et 
al., 2001).  
 
There are many T3 basal proteins found in the EHEC inner membrane 
(Gauthier et al., 2003a). These proteins include EscD (also known as Pas - 
protein associated with secretion), EscQ, EscR, EscS, EscT, EscU, EscV and 
the membrane associated ATPase – EscN (Kresse et al., 1998, Ogino et al., 
2006, Pallen et al., 2005a, Zarivach et al., 2008, Gauthier and Finlay, 2003, 
Gauthier et al., 2003a, Andrade et al., 2007).  EscD exhibits homology to the 
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T3 apparatus protein YscD of Yersinia enterocolitica and PscD of 
Pseudomonas aeruginosa. YscD is an inner membrane component in the 
Yersinia T3SS and mediates the delivery of virulence factors through the 
bacterial double membranes (Kresse et al., 1998, Pallen et al., 2005a). As a 
homologue protein in EHEC and EPEC, EscD was shown to be an inner 
membrane component and to be required for EHEC T3 export regulation 
(Kresse et al., 1998).  In this same study, direct interactions were detected 
between secreted proteins (Tir / EspD, B) and cytoplasmic but not 
membrane-localized EscD which hints at a potential mechanism of T3SS 
regulation (Kresse et al., 1998). Further study of T3 basal apparatus 
assembly revealed that EscD could interact with EscC (outer membrane ring) 
and EscF (needle construct).  EscC was proposed as an outer membrane ring 
protein and its localization has been proven in several reports (Gauthier et al., 
2003a, Ogino et al., 2006). Using CsCl fraction analysis, EscC was found 
mainly in both the inner and outer membrane fractions (Ogino et al., 2006) 
and could bind to EscD and EscF.  Another predicted component of the basal 
apparatus, EscJ, is presumed to be exported into the periplasm in a Sec-
dependent manner and to form a bridge spanning the two membrane rings, 
although this mainly localized to the outer membrane fraction (Crepin et al., 
2005a). EscJ was also known to bind to the needle protein, EscF, in vitro 
(Ogino et al., 2006), providing a link between the translocon proteins and the 
basal apparatus (Sekiya et al., 2001, Ogino et al., 2006).   
 
1.4.3.3 EspA filament 
EspA filaments act as a bridge between the bacteria and host cells and 
effector proteins are translocated into host cells via this channel.  EspA is a 
T3 translocon protein encoded by LEE which is polymerized to form a 
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hollow conduit on the bacterial outer surface. Contact between the EspA 
filament and the host cell triggers completion of assembly of the filament tip 
during which EspD and EspB are secreted and inserted into the host cell 
membrane (Warawa et al., 1999, Ide et al., 2001). 
 
EspA is a 25KDa peptide polymerized to form a helical tube and a whole 
EspA filament extends from the T3 basal apparatus by attaching to the EscF 
needle complex with EspD and EspB pore-forming proteins on the tip of the 
filament.  The first report of a 3D structure of EspA filaments in EPEC was 
presented by Daniell et al. (2003). The structure comprises a helical tube 
which has a diameter of 120 Å with a central channel of 25 Å (diameter) 
Fig. 1.6. Schematic diagram of EspA filament. 
Comparing with the Ysc T3SS needle (Mueller et al., 2005), the length of 
EHEC/EPEC EspA filament is highly variable and longer. EHEC/EPEC T3SS 
needles length was found in a range of 32-688nm (Sekiya et al., 2001). For plant 




through which effector proteins may be transported (Knutton et al., 1998, 
Cleary et al., 2004). The subunit arrangement corresponds to a one-start 
helix with 28 subunits present in five turns of the helix and an axial rise of 
4.6 Å per subunit (Daniell et al., 2003). Unlike NF-T3SS needle extensions 
in other animal pathogens, the length of EspA filament is variable and much 
longer (Fig.1.6.) which implies its unique application in the gastrointestinal 
tract, for example for penetrating the mucus barrier and thick glycocalyx 
(Daniell et al., 2001).  Despite the similarity between EspA proteins in 
EHEC/EPEC, they show antigenic polymorphism as EspA filaments from 
different EPEC and EHEC strains show little immunological cross-reactivity 
(Neves et al., 2003b, Crepin et al., 2005b). Such polymorphisms among 
functional EspA filaments of EPEC and EHEC are likely to have important 
implications for the development of EspA-based vaccines.  
 
EspD/B both have homology to YopD/B (Yersinia) and PopD/B 
(Pseudomonas) proteins (Wachter et al., 1999, Broms et al., 2003) which are 
thought to form a pore complex in the host membrane and induce contact-
dependent haemolysis of red blood cells (RBCs) (Hakansson et al., 1993, 
Rosqvist et al., 1995, Hartland et al., 1996, Neyt and Cornelis, 1999, Broms 
et al., 2003). Previous studies have shown that EPEC induces contact-
independent haemolysis of RBCs, and Esp translocon proteins are involved 
in this activity (Warawa et al., 1999, Shaw et al., 2001, Shaw et al., 2002). 
Moreover, with EspA filaments opening a channel between the bacterium 
and host cell, a series of subsequent responses of the T3SS might be initiated 
in the pathogenic bacterium via sensing signals from the host cell (Abe et al., 
2002, Ide et al., 2003, Roe et al., 2003a).  
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1.4.3.4 T3 effector proteins 
Various substrates are translocated into the host cell via T3SS at different 
stages of colonisation/infection. These ‘effectors’ contribute to different 
aspects of the host-pathogen interaction. In general, there are three main 
themes of activities related to T3SS translocated effectors. 1. Colonisation 
and invasion: EHEC/EPEC translocate their own bacterial adhesion receptor 
(Tir) into the host cells that allows intimate contact between bacteria and 
epithelia cells (Kenny et al., 1997b). Other effectors, such as Map and 
EspG/G2 from EHEC/EPEC, EseG from Edwardsiella tarda, are involved in 
disruption of the host microtubule network which can be critical for pedestal 
formation (Dean and Kenny, 2004, Tomson et al., 2005, Xie et al.). 2. 
Cytotoxicity: Some virulence factors can also cause tissue 
damage/dysfunction which might lead to cell death. For example, ExoU 
from P. aeruginosa was shown to be responsible for destruction of 
intracellular membranes (Veesenmeyer et al., 2010). Translocated EspF 
from EHEC/EPEC can disrupt epithelial tight junction which contribute to 
diarrhoea symptoms (Crane et al., 2001). 3. Immune-response: For example, 
NF-B is a key factor activating the expression of inflammatory genes and 
T3 effectors can modulate host immune-responses by inhibiting its activation. 
SopE from Salmonella, OspG from Shigella and NleH from EPEC/EHEC 
are all involved in these activities (Friebel et al., 2001, Kim et al., 2005, 
Garcia-Angulo et al., 2008). 
 
1.4.3.4.1 LEE-encoded effector proteins 
The EspA filament provides a channel for delivering T3S related effector 
proteins into eukaryotic cells. Many virulence factors are found encoded by 
genes of the LEE pathogenicity island which include Tir (EspE), Map, EspF, 
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G, H and SepZ (EspZ). These factors are injected into host cells and 
considered then to interfere with host cell regulatory pathways and functions. 
orf19 (map) codes for the mitochondrial-associated protein (Map), which is 
transferred by the T3SS into host cells. Map plays at least two roles when it 
is injected into host cells. One is mediating Cdc42-dependent filopodia 
formation and another is targeting mitochondria to induce dysfunction 
(Czerucka et al., 2001, Kenny et al., 2002, Dean and Kenny, 2004, Dean et 
al., 2006). Gene espG (rorf2) is highly conserved and can be found in the 
LEE of all A/E pathogens. EspG is normally expressed in very small 
amounts. It is speculated that EspG may play an accessory role in virulence. 
The function of EspG is not fully understood but it has been shown that 
EspG and its homologue EspG2 (orf3) were responsible for epithelial 
paracellular permeability and microtubule disruption (Elliott et al., 2001, 
Tomson et al., 2005, Matsuzawa et al., 2005). EspH is encoded by orf18 of 
the LEE and the translocation of EspH into host cells is T3SS-dependent. It 
is reported that EspH appeared to be localized to the cell membrane in host 
cells. Overexpression of EspH repressed the formation of filopodia and 
enhanced the formation of actin pedestals (Tu et al., 2003). This fact 
indicates that EspH is a modulator of the host actin cytoskeleton structure. 
Effector protein SepZ, also known as EspZ, is hypervariable among A/E 
pathogens, with sequences sharing between 60 to 81% amino acid identity 
with SepZ of EPEC. (Kanack et al., 2005) However, its location and 
function is still unknown in the host cell.  
 
As one of the most thoroughly investigated effector proteins, Tir was the 
first EPEC effector molecule to be identified (Kenny et al., 1997b) which 
was also known as Hp90 or EspE protein in previous reports (Rosenshine et 
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al., 1992, Deibel et al., 1998). Tir is encoded by a gene in LEE5 which 
contains the bacterial adhesin (Intimin) gene ─ eaeA.  It was a key finding 
that EPEC adherence is related to the tyrosine phosphorylation of a protein 
of ~ 90 KDa (Hp90) with subsequent studies revealing that Hp90-Intimin 
interaction was essential for pedestal formation (Rosenshine et al., 1996a, 
Rosenshine et al., 1996b, Kenny and Finlay, 1997). Although comparison of 
the EHEC O157 and EPEC O127 LEE regions shows a high degree of 
identity between the genes encoding the type 3 secretion apparatus and 
protein chaperons, those genes encoding the secreted and effector proteins 
are more variable (Perna et al., 1998). Tir is the most divergent LEE-
encoded molecule, with <60% identity between EHEC O157:H7 and EPEC 
homologues and only 40% identity within the C-terminal domain (Paton et 
al., 1998, Kenny, 1999). The interaction of EPEC Tir with the outer 
membrane adhesin, intimin, triggers actin aggregation beneath the attached 
bacteria and Tir tyrosine/474 phosphorylation is essential for this event 
(Kenny, 1999). However, the EHEC O157:H7 Tir molecule is not tyrosine 
phosphorylated. Tir phosphorylation differences between 
enterohaemorrhagic and enteropathogenic Escherichia coli implied a 
different Tir-based mechanism for pedestal formation (DeVinney et al., 
2001).  
 
Following being secreted or translocated into epithelial cells by T3 
machinery, TirEPEC is integrated into the epithelial cell plasma membrane 
(Hartland et al., 1999) exposing an extracellular central domain that 
functions as an intimin receptor. Interaction with intimin initiates clustering 
of TirEPEC, activating signalling pathways by recruiting the Nck/N-
WASP/Arp2/3 complex followed by actin polymerization (Calier, 2000, 
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Campellone et al., 2002, Campellone and Leong, 2003, Schuller et al., 2007). 
As TirEHEC is not tyrosine phosphorylated, it was demonstrated to lack the 
TirEHEC/Nck interaction during pedestal formation. Later it was revealed that 
signalling activation in the host cell during EHEC infection requires 
recruitment of an EHEC T3 translocated factor ─ EspFu (TccP), an Nck-like 
protein (Campellone et al., 2004, Garmendia et al., 2004, Allen-Vercoe et al., 
2006) but binding to Tir via IRSp53/ Insulin receptor tyrosine kinase 
substrate (IRTKS) (Vingadassalom et al., 2009, Weiss et al., 2009). 
However, in certain EHEC and EPEC strains, a T3 effector TccP2 was found 
in complex with Tir to induce actin polymerization in addition of Nck 
signalling cascade (Whale et al., 2006).   
 
1.4.3.4.2 Non-LEE encoded effector proteins 
Although the LEE encoded most of the proteins required for A/E lesion 
formation, many factors encoded by genes outside of the LEE contribute to 
pathogenesis (Morabito et al., 2003). In 2003, a T3 secreted protein, Cif, was 
identified outside of the LEE in EPEC/EHEC using transposon mutagenesis 
and reporter gene studies (Marches et al., 2003, Charpentier and Oswald, 
2004). This molecule blocks cell cycle G2/M transition and induces the 
formation of stress fibres through the recruitment of focal adhesions 
(Marches et al., 2003). Later, another Non-LEE-Encoded (Nle) type 3 
translocated virulence factor, NleA (EspI), was found to be present in the 
LEE-containing Escherichia coli pathogens and C. rodentium using a 
proteomic analysis (Gruenheid et al., 2004, Mundy et al., 2004b) It was 
found absent from non-pathogenic strains of Escherichia coli and non-LEE-
containing pathogens (Mundy et al., 2004b). It was found to target to the 
Golgi in the host cell (Gruenheid et al., 2004) and to inhibit cellular protein 
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secretion by disrupting mammalian COPII function (Kim et al., 2007). Soon 
after that, multiple non-LEE encoded effectors (NleB-G) were identified in 
C. rodentium using a proteomic approach due to a T3SS-dependent 
hypersecretion phenotype exhibited by sepL or sepD mutants (Deng et al., 
2004). As most of Non-LEE-Encoded factors were discovered recently, only 
a few of them have been investigated thoroughly.   Subsequent research 
revealed that NleB is found not be secreted into the bacterial supernatant 
while it was translocated into host cells and essential for colonisation (Kelly 
et al., 2006, Roe et al., 2007). Previously those effectors were identified 
using experimental approach, such as transposon mutagenesis, proteomic 
analysis and various reporters (Deibel et al., 1998, Marches et al., 2003, 
Deng et al., 2004). In 2006, a collaboration between Toru Tobe and Mark J. 
Pallen’s groups employing both bioinformatics and experimental methods 
(Tobe et al., 2006) identified a large number of T3S effectors. There were 62 
effector genes found using homology-based searches and 39 of them were 
proven to be exported using reporter genes and proteomic analysis (Tobe et 
al., 2006). This study also discovered that most of those effector genes were 
found located in lambdoid prophages although they were scattered 
throughout the EHEC chromosome in 25 exchangeable effector loci (Tobe et 
al., 2006). 
 
1.4.3.5 T3 chaperone proteins 
Many T3 secreted proteins depend on specific chaperones for stabilization 
and/or secretion. Chaperones identified for effector proteins of A/E 
pathogens so far include: CesT (Tir, Map, NleA…) (Abe et al., 1999, Elliott 
et al., 1999a, Creasey et al., 2003a, Thomas et al., 2005) and CesF (EspF) 
(Elliott et al., 2002); and for the translocator proteins— CesD (EspB and  
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Table 1.4 Representative members of different classes of 
chaperones (Modified from Parsot et al., 2003) 
Class Orgnism Chaperone Size pI 
EPEC/EHEC CesT 156  
SycE 130 4.5 
SycH 143 4.8 
SycT 130 4.4 
Yersinia spp. 
SycN 123 5.1 
Shigella spp. IpgE 120 4.0 
SicP 116 3.9 Salmonella spp. 
SigE 113 3.9 
SpcU 137 4.4 
IA 
Pseudomonas spp. 
Orf1 116 5.0 
EPEC/EHEC CesF 127 4.2 
Shigella spp. Spa15 133 4.2 
Salmonella spp. InvB 135 4.4 
Yersinia spp. YscB 137 9.3 
 YsaK 135 4.3 
IB 
Sodalis spp. InvB 135 3.7 
CesD 151 7.4 EPEC/EHEC 
CesD2 135 5.3 
SycB 168 4.5 Yersinia spp. 
SycD 169 4.5 
Shigella spp. IpgC 155 4.4 
SicA 165 4.6 Salmonella spp. 
SscA 157 8.0 
II 
Pseudomonas spp. PcrH 168 4.4 
FlgN 140 5.3 
FliS 122 4.9 
Salmonella spp. 
FliT 135 4.7 
CesAB 107 Alkaline 
III 
EPEC/EHEC 
CesA2 92 5.5 
 
EspD) (Wainwright and Kaper, 1998), CesD2 (EspD) (Neves et al., 2003a), 
CesAB (EspA and EspB) (Creasey et al., 2003c) and CesA2 (EspA) (Su et 
al., 2008).  
 
Although these chaperone proteins involved in T3S are responsible for 
different substrates, they can be classified into 3 groups: Class I (effector 
proteins), Class II (the translocation pore) and Class III (The extracellular, 
helical components) (Table 1.4). Genes encoding T3 chaperones are 
normally carried by the pathogenicity island that also contains the genes 
encoding the other T3SS components. Although these chaperones share little 
sequence homology they are well conserved in protein structure (Fig. 1.7.) 
and have several widely known characteristics, such as a small size, an 
acidic pI (4-5) (Table 1.4), and a predicted amphiphilic  helix in the 
carboxy-terminal region. Class I chaperones bind their cognate effector 
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within their first 100 amino acids downstream of the N-terminal secretion 
signals and have two sub-categories which are chaperones associated with 
only one (class IB) or multiple (class IA) secreted virulence factors. 
Apparently, in EHEC, CesF which interacts with EspF only belongs to class 
IB and CesT which binds several effectors belongs to class IA. 
Crystallographic structures of the chaperones SicP and SigE from 
Salmonella enterica, SycE from Yersinia pseudotuberculosis, and CesT from  
Fig. 1.7. A. Ribbon diagrams of SycE, SigE, SicP and CesT dimers; monomers are 
shown in blue and red. In the CesT dimer, the amino- and carboxy-terminal regions of 
each monomer (in magenta and cyan) are donated from adjacent molecules in the 
crystal. B. Ribbon diagrams of SicP–SptP35–139 and SycE–YopE17–85 complexes; 
both SptP35–139 and YopE17–85 are shown in green. One view is the same 
orientation as in (A), and the other has been rotated by 90° around the horizontal axis. 
Wild-type SptP and YopE have 543 and 219 residues, respectively. (Reproduced from 




EPEC/EHEC/CR confirmed that class IA chaperones function as dimers 
(Birtalan and Ghosh, 2001, Luo et al., 2001, Stebbins and Galan, 2001) (Fig.  
1.7.).   
 
 
As described in previous reports, CesT was known to interact with at least 
four T3 effector proteins (Tir, Map, EspF and NleA) in EHEC/EPEC/CR 
(Thomas et al., 2005, Creasey et al., 2003a, Abe et al., 1999, Elliott et al., 
1999a, Creasey et al., 2003b). Moreover, a very recent study demonstrated 
that this multi-effector T3 chaperone protein has five other binding partners 
(EspG, EspZ, NleG, NleH, and NleH2) (Thomas et al., 2007) which were all 
discovered using a sepD deletion genetic background. CesT has been proven 
to be multi-functional (Elliott et al., 1999a), therefore it is the most 
important and interesting chaperone protein among AE pathogens. 
Functionally, CesT is important for Tir expression as well as the secretion of 
multiple effector proteins (Thomas et al., 2007, Li et al., 2006, Thomas et al., 
2005, Creasey et al., 2003a).  
 
As it was first identified as a Tir chaperone protein, the interaction between 
CesT and Tir has been investigated in detail. Gel filtration studies showed 
that Tir-CesT forms a large multimeric complex (Elliott et al., 1999a). It was 
revealed that CesT is not just responsible for Tir secretion or translocation 
via T3SS, but was also required for stabilizing Tir in the EHEC/EPEC 
cytoplasm (Abe et al., 1999, Elliott et al., 1999a). Further studies revealed 
that the amphipathic alpha-helical region of the C-terminal CesT was able to 
bind Tir, whereas the N-terminal residue of CesT was required for CesT 
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dimerization and translocation of Tir (Delahay et al., 2002, Thomas et al., 
2005). Also the interaction between Tir-CesT complex and T3SS ATPase 
EscN was detected (Gauthier and Finlay, 2003) and EscN is required for T3 
basal apparatus targeting (Inner membrane) of both Tir and CesT (Thomas et 
al., 2005).  
 
EspB and EspD translocators form a pore in the host membrane which is 
important for T3 virulence factor delivery. In order to open a channel 
between bacterium and host cell, there were specific chaperone proteins 
(Class II) involved in stabilising pore forming translocators in the bacterial 
cytoplasm and targeting translocon proteins for secretion. In EHEC/EPEC 
T3SS, it was known that CesD is critical for EspB and EspD secretion and a 
second chaperone protein CesD2 is also required for EspD export. 
(Wainwright and Kaper, 1998, Neves et al., 2003a). Class II chaperones 
were proposed to be structurally different from the class I chaperones 
CesT/SigE (Pallen et al., 2003). Pallen et al. detected tetratricopeptide-like 
repeats in the class II CesD/SycD/LcrH chaperone family but not in the class 
I CesT/SigE chaperone family that implied the functional diversity of two 
chaperone groups (Pallen et al., 2003). 
 
The class III chaperones were originally known as flagellar chaperones. 
Flagellar system used cytoplasmic chaperones for hook, cap or flagellin 
protein export (Aldridge et al., 2003, Parsot et al., 2003). Normally the 
chaperone binds to the C-terminal part of the substrate subunit and prevents 
subunit self-aggregation/interaction (Auvray et al., 2001, Fraser et al., 1999). 
In A/E lesion forming pathogens, EHEC/EPEC/CR, there were two 
chaperones (CesAB and CesA2) reported for EspA filament export (Creasey 
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et al., 2003c, Su et al., 2008). CesAB and CesA2 are required for stabilising 
EspA protein in bacterium cell, while CesAB is only found critical for EspB 
secretion but not for the stability of intracellular EspB (Creasey et al., 2003c, 
Su et al., 2008). Also CesAB was found purified with the EspA monomer 
which suggested CesAB-EspA interactions prevent EspA aggregation 
(Creasey et al., 2003c). Although CesAB shares several characteristics such 
as small molecular weight and -helical structure, it has an alkaline pI which 
is uncommon (Creasey et al., 2003c, Jackson et al., 1998)  
 
Chaperone-substrate interactions have been studied with different 
approaches (Wattiau et al., 1994, Schesser et al., 1996, Day and Plano, 1998, 
Hueck, 1998, Elliott et al., 1999a, Neyt and Cornelis, 1999, Cheng and 
Schneewind, 1999, Aldridge and Hughes, 2001, Birtalan and Ghosh, 2001, 
Luo et al., 2001, Stebbins and Galan, 2001). Although some of them still 
need further investigations, current observations suggest that these 
interactions prevented aggregation, limit toxic effects of misallocation of 
substrate and keep the substrate soluble within the bacterium before it is 
exported by the T3SS (Edqvist et al., 2006, Letzelter et al., 2006, Wilharm et 
al., 2007, Johnson et al., 2007, Paul et al., 2008, Buttner et al., 2008, Miki et 
al., 2009, Hu et al., 2009, Spaeth et al., 2009, Cornelis, 2006). These 
chaperone escorting activities seemed very important in T3SS and chaperone 
recycling might also be happening in a very efficient way (Lee and Galan, 
2004, Thomas et al., 2005, Yip et al., 2005a, Gonzalez-Pedrajo et al., 2006, 
Johnson et al., 2007, Thomas et al., 2004, Evans et al., 2006). In brief, 
chaperone proteins were required not only for facilitating T3 substrate 
secretion but also for substrate targeting selection/hierarchy in T3SS. 
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1.4.3.6 Substrate switching components of T3SS 
Although the filamentous extension of the T3SS shows variation in length 
(Daniell et al., 2001), the length of T3SS needle seems to be well controlled 
(Sekiya et al., 2001). A similar regulation was also observed for flagellar 
secretion with the flagellar hook being normally 55nm and the length of FliC 
flaments being variable (Karlinsey et al., 2000b, Minamino and Macnab, 
2000). YscP is a key regulator for T3SS needle length in Yersinia spp. and 
FliK is responsible for hook length in the flagellar T3SS (Wagner et al., 
2009, Shibata et al., 2007). There were different models presented which 
might explain how the needle length is controlled. It was hypothesised that 
YscP can act as an internal molecular ruler to measure needle length (Journet 
et al., 2003). The loss of YscP resulted in various lengths of needle structure 
in Yersina and the length of the T3SS needle is dependent on the length of an 
extended YscP (Journet et al., 2003). This theory was tested by swapping 
two different size YscP proteins.; when cross-complementary experiments 
were performed in Yersinia spp., the shorter YscP (Y. pestis) also produced 
shorter YscF needles which suggested the YscF needle was controlled by the 
actual size of YscP (Journet et al., 2003). Another ‘cap model’ was proposed 
in which flagellar hook length is determined by the amount of subunit 
protein secreted by the flagellar apparatus (Makishima et al., 2001). 
However the exact mechanism underlying this model is not clear and two 
recent studies suggested that FliK can also act as an internal ruler, as 
discussed for YscP, which favours the ruler model of needle/hook length 
control (Shibata et al., 2007, Erhardt et al., 2010). In addition, a molecular 
clock model has been suggested which implies that the timing is critical for 
the needle length as well as a FliK ruler (Moriya et al., 2006).  In both 
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Salmonella and Shigella, a mechanism has been proposed in which the 
completion of the inner rod determines the needle length and substrate 
switching (Marlovits et al., 2004). Ruler proteins, YscP and FliK, have a 
reserved C-terminus responsible for substrate switching and has been termed 
the ‘T3S4’ domain, standing for Type 3 secretion substrate specificity 
switching (Agrain et al., 2005, Minamino and Macnab, 2000, Minamino et 
al., 2004). This T3S4 domain switches substrate specificity to effector 
secretion and the ruler is then released. There was another proposed key 
molecule for substrate switching, YscU (Yersinia T3SS) or FlhB (Flagellar 
T3SS). YscU, as well as FlhB, was known as a self-cleavable protein (a 30-
kDa N-terminal and a 10-kDa C-terminal part) required for translocator 
export (Lavander et al., 2002, Sorg et al., 2007). YscP export was reduced in 
a non-cleavable YscU mutant and therefore result in longer YscF needle 
produced and no translocator exported (Sorg et al., 2007). So it suggested 
that self –cleavage of YscU is required for translocator recognition and YscP 
export which controls YscF needle length (Lavander et al., 2002, Sorg et al., 
2007, Riordan and Schneewind, 2008). In the flagellar system, FlhB was 
shown to interact with FliK to work as a sensor and pass a signal relating to 
hook completion to self-cleavable FlhB for substrate switching (Minamino et 
al., 2004, Ferris et al., 2005).  This is very similar to what is proposed to 
happen in the regulation of Yersinia T3SS. In EPEC/EHEC, EscU and EscP 
were proposed to control this key step as homologues of YscU and YscP 
respectively (Zarivach et al., 2008, Pallen et al., 2005a) and further 





1.4.3.7 The locus of enterocyte effacement encoded 
regulator (Ler) 
 
As with other complex biological systems, T3SS is controlled by many 
regulators in A/E pathogens. T3SS expression is regulated by various factors 
encoded both within and outside the LEE (Bustamante et al., 2001, Sanchez-
SanMartin et al., 2001, Schauder et al., 2001, Goldberg et al., 2001, 
Umanski et al., 2002, Sperandio et al., 2002, Haack et al., 2003, Lio and Syu, 
2004, Sharma and Zuerner, 2004, Iyoda and Watanabe, 2004, Tsai et al., 
2006, Dong and Schellhorn, 2009b, Shakhnovich et al., 2009, Hansen and 
Kaper, 2009, Bhatt et al., 2009). H-NS (histone-like nucleoid-structuring 
protein) is a global DNA-binding transcriptional dual regulator which 
directly or indirectly alters the expression of 5% of all genes and 69% of the 
temperature regulated genes in Escherichia coli strain K12 (White-Ziegler 
and Davis, 2009, Bertin et al., 2001, Hommais et al., 2001). In A/E lesion 
forming pathogens, H-NS is a repressor of LEE expression in a temperature-
dependent manner by directly binding to their promoters or the regions 
nearby (Umanski et al., 2002). However, The locus of enterocyte effacement 
encoded regulator (Ler) (Fig.1.8), acting as an anti-repressor, can antagonize 
the H-NS-dependent inhibition of LEE expression (Bustamante et al., 2001) 
by interfering with H-NS binding. On the other hand, it has been suggested 
that Ler acts as a LEE5 activator in an H-NS-independent manner (Umanski 
et al., 2002). It is not just important for LEE expression, but also proved 
crucial for expression of certain non-LEE T3S-associated factors (Elliott et 
al., 2000, Roe et al., 2007).  Ler is therefore an important and general 
regulator/activator of T3S in A/E pathogens. Although other signalling 
pathways have been found to be Ler-independent that regulate T3SS in A/E 
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Escherichia coli, the majority of regulatory mechanisms were demonstrated 
to be mediated via Ler.  
 
Ler is encoded by the first gene of LEE1 operon and the expression of Ler is 
controlled by many factors by binding to its promoter or upstream regions. 
For example, GrlA, a LEE-encoded activator, was shown to stimulate Ler 
Fig. 1.8. Regulation of the LEE PAI in EPEC (A) and EHEC (B). Virulence gene 
regulation in the EAF plasmid of EPEC (C) and the EHEC pO157 plasmid (D). Thin 
arrows represent positive regulatory signals, and thin blunt arrows represent negative 
signals. Solid arrows indicate expression of regulatory proteins. Horizontally acquired 
regulatory proteins appear in ovals with a black background, and regulatory proteins 
endogenous to E. coli are within ovals with a white background. (Modified from Mellies 





expression via direct binding to the promoter region of the LEE1 operon 
(Huang and Syu, 2008). However, GrlR, a LEE repressor, negatively 
regulates the expression of LEE via sequestering GrlA (Barba et al., 2005, 
Jobichen et al., 2007, Huang and Syu, 2008). PerC (plasmid-encoded 
regulator C) was found important for LEE expression via a Ler-dependent 
manner in EPEC (Mellies et al., 1999). However, the PerC regulator is not 
present in EHEC but has several chromosomal homologues instead (Iyoda 
and Watanabe, 2004). These Pch proteins activate LEE1 transcription and 
bind to its promoter region directly (Abe et al., 2008). Quorum sensing (QS) 
in EHEC was also demonstrated to activate LEE expression with QseA, a 
key QS factor, up-regulating the transcription of LEE1 via directly binding 
upstream of the LEE1 promoter region (Sharp and Sperandio, 2007). Ler 
itself, could act as an autoregulator and at high levels can repress LEE1 
expression by binding to its own promoter region (Berdichevsky et al., 2005). 
Besides the regulation pathways via Ler expression, another kind of pathway 
is also implied by other studies in A/E pathogens. A newly identified 
regulator Mpc (multiple point controller) was known to interact with Ler and 
suppresses the expression of the LEE proteins (Tsai et al., 2006). Another 
very recent publication indicates that Mcp might be a chaperone protein for 
SepL, therefore suggesting it be renamed as CesL. However the function of 
Mpc/CesL requires more intensive investigation in future experiments 
(Younis et al.). 
 
1.5 Previous work leading to this project 
LEE4 encodes the secreted proteins EspA,D,B as well as other factors, such 
as SepL and EscF.  EspA,D,B have been shown to be necessary for A/E 
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lesion formation and signalling within host cells as translocator proteins. 
Formation of this EspA filament structure is transient and disappears once 
attachment is strengthened by intimate attachment (Ebel et al., 1998, 
Knutton et al., 1998). So, the expression and secretion of EspA and EspB 
potentially happens early during infection and are enhanced when bacteria 
are grown at 37°C in tissue culture medium and by the presence of 
micronutrients or signals produced by eukaryotic cells (Ebel et al., 1996, 
Jarvis and Kaper, 1996). Although sepL and espADB genes all locate within 
the same LEE4 operon, the transcription levels of these genes are different 
Fig. 1.9. (A). Genes located within LEE4 Operon; (B) Nucleotide sequence of the 
DNA fragment containing the sepL promoter and part of its open reading frame 
(ORF). The start of transcription (+1), the 10 and 35 consensus sequences, the 
Shine-Dalgarno (SD) sequence and sepL ORF are shaded as described in 





(Beltrametti et al., 1999, Roe et al., 2003b). At least two putative promoters 
for espADB were revealed by previous work by primer extension 
(Beltrametti et al., 1999, Mellies et al., 1999). However the theory of two 
promoters is debatable. The work in our laboratory showed no evidence of 
any expression from a promoter in front of espA, with expression only 
detectable from sepL (Roe et al., 2003b). An analysis of LEE4 mRNA levels 
and EspD levels in whole cells confirmed that the abundant transcript was 
not being translated to give an intracellular pool of Esps in low-secretor 
strains (Roe et al., 2003b), indicating significant translational control of the 
transcript. Further data from our laboratory supported posttranscriptional 
control of translocator expression, although the mechanism still remains to 
be identified. Previous work demonstrated that SepL is a key protein 
controlling T3 secretion and no further information on SepL expression was 
available (Kresse et al., 2000, O'Connell et al., 2004, Deng et al., 2005, 
Deng et al., 2004). Therefore, it would be valuable to investigate the 
expression regulation of SepL for understanding T3SS in EHEC O157. 
 
sepL is the first gene on the LEE4 operon which is about 5.6kb and followed 
by espADB genes (Beltrametti et al., 1999) (Fig.1.9E). The most well known 
regulator of EHEC T3SS is Ler which was shown activating espADB genes 
transcription (Sharma and Zuerner, 2004). It was known that sepL and 
espADB were co-transcribed and therefore Ler might also have an impact on 
sepL transcript. From previous studies, it was suggested that the espADB 
transcript is processed in a post transcriptional manner (Roe et al., 2003b). 
Its expression was sigma S dependent and controlled by multiple factors 
which included temperature, cell contact and ion concentration (Beltrametti 
et al., 1999, Creasey et al., 2003c, Ide et al., 2003, Roe et al., 2003b, Deng 
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et al., 2005).  The SepL protein has been demonstrated to be important for 
controlling the secretion of both translocon and effector proteins (Deng et al., 
2005, Deng et al., 2004, Kresse et al., 2000, O'Connell et al., 2004). Pallen 
et al. revealed the N-terminal sequence (267 aa) of SepL is homologous to 
YopN and the C-terminal sequence (83 aa) is homologous to TyeA (Pallen et 
al., 2005a). The YopN-TyeA family includes YopN-TyeA (Yersinia spp.), 
SepL (EHEC/EPEC/CR), SsaL, InvE (Salmonella spp.), MxiC (Shigella spp.) 
and PopN (Pseudomonas aeruginosa) (Pallen et al., 2005a). It was reported 
that YopN, MxiC and PopN can be secreted via T3SS while no evidence 
suggested SepL, SsaL and InvE can be exported so far (Yang et al., 2007, 
Botteaux et al., 2009, Kubori and Galan, 2002, Forsberg et al., 1991, Yu et 
al., 2010, Kresse et al., 2000). YopN was suggested acting as a key protein 
to switch on effector secretion in Yersinia spp. and a similar role for PopN in 
Pseudomonas aeruginosa (Cornelis and Wolf-Watz, 1997, Yang et al., 
2007).  MxiC was recently shown to be required for effector secretion 
(Botteaux et al., 2009). InvE, as well as SsaL, was proposed controlling the 
secretion of translocators but not effector proteins export (Kubori and Galan, 
2002, Coombes et al., 2004). Although SepL has been shown important for 
translocator export, a SepL deficent EHEC/EPEC also exhibits 
hypersecretion of effector proteins (Kresse et al., 2000, O'Connell et al., 
2004, Deng et al., 2005). So far, all the published work has mainly focused 
on the functional importance of SepL. In this thesis I have also concentrated 
on SepL expression and the link to the post transcriptional regulation of 
LEE4.   
 
So far, SepL and its homologues have demonstrated strong impact on T3 
secretion. As a binding partner of SepL, SepD was also investigated 
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previously and a sepD strain exhibited a similar phenotype as a sepL 
mutant (Deng et al., 2004, Deng et al., 2005). This evidence suggests that 
SepL and SepD may play a role as a molecular switch controlling secretion 
of translocators and effectors. SepL and SepD are demonstrated interacting 
with each other and both proteins are shown bacterial membrane associated 
in EHEC (Deng et al., 2005). However, the precise mechanism of SepL-
SepD controlling the secretion switch between translocons and effectors was 
unknown. In my study, SepL was investigated functionally according to 
several properties of this protein. 
 
1.6 Aims of the work 
1.6.1 An analysis of SepL expression and localization 
The first key aim of the research is to localise SepL and SepD in comparison 
with the T3S apparatus and EspA filaments in single bacterial cells. SepL 
will be fused to fluorescence protein reporters and visualized by 
fluorescence microscopy.  SepL and SepD fusions to GFP will be localized 
by Western blotting of bacterial fractions. Environmental and genetic factors 
that alter the localisation will be studied including mutations of defined T3S 
proteins.   
 
1.6.2 Translation and processing of the sepL mRNA 
transcript 
The second key aim of the research is to determine if SepL production is 
heterogeneous and how the LEE4 transcript is processed and translation 
regulated to generate heterogeneity. From previous data, there is evidence 
that the expression of SepL is controlled at a post-transcriptional level. The 
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aim is to verify then understand this post-transcriptional regulation.  sepL 
and LEE4 sequences important for this post-transcriptional regulation will be 
determined by mutational analysis.  
 
1.6.3 The interaction and function of SepL and SepD 
The third aim of the research is to attempt to identify binding partners of 
SepL and SepD associated with the EHEC T3SS. SepL and SepD are crucial 
for the secretion of EspADB but not effector proteins.  The mechanism has 
not been elucidated so far. Here, the aim is to define functional regions of 
the SepL protein. The research aims to determine if SepL/SepD proteins can 
bind to other T3 related targets. In particular, SepD and SepL will be over-











SepL has been shown to be critical for the control of T3S, in particular the 
switch between translocator protein (EspADB) and effector protein secretion 
(Deng et al., 2004, O'Connell et al., 2004, Deng et al., 2005). The balance of 
this secretion is also controlled by environmental conditions.  From previous 
studies, it is established EspADB cannot be secreted in a sepL mutant and 
therefore no EspA filaments are formed on the bacterial surface (Kresse et 
al., 2000). Several published works have also shown that EspADB secretion 
is required for effector translocation (Knutton et al., 1998).  For example, Tir 
translocation is completely blocked by deleting espA and this can be 
complemented by bringing back espA in trans.  
 
There have been three studies examining sepL mutants published by Kresse 
et al, Deng et al and O’Connell et al. These mutants were generated by 
inserting or deleting a partial fragment in the middle of sepL which takes 
sepL out of frame and all of these mutations could be complemented by sepL 
provided in trans.  Work within our own group has indicated that EspA 
filament expression is under post transcriptional control and that production 
of EspA filaments within a population is heterogeneous (Roe et al., 2003b, 
Roe et al., 2004).  Certain strains have a relatively high proportion of the 
population producing EspA filaments under conditions known to induce T3S, 
whereas the majority of strains examined only had a minor subset of the 
population expressing EspA filaments. As sepL is the first gene in the LEE4 
operon that also contains espADB, I wanted to know more about the 
regulation of sepL and whether it is subject to post-transcriptional control.  
As SepL is essential for EspA filamentation, it was hypothesized that the key 
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checkpoint in translocon expression that is responsible for the heterogeneity 
will be the transcription and translation of SepL.  In this study, therefore, 
several sepL mutants and fusions were constructed and analysed to examine 
SepL expression. 
 
It has been shown that T3SS expression is controlled at a post transcriptional 
level (Chilcott and Hughes, 2000, Roe et al., 2003b). Hfq (host factor 
required for phage Q RNA replication), which also know as HF-I (host 
factor I), was originally identified in Escherichia coli as an essential 
bacterial protein for RNA replication of bacteriophage Q in 1968 (Franze 
de Fernandez et al., 1968, Shapiro et al., 1968). It was found to be present in 
both Gram-positive and Gram-negative bacteria using phylogenetic analyses 
(Sun et al., 2002). Escherichia coli Hfq is a very abundant small protein 
which normally forms hexamers and previous studies indicated a homology 
link between Hfq and spliceosomal Sm proteins (Sauter et al., 2003). Many 
reports have suggested that Hfq can act as a post-transcriptional regulator via 
its ability to bind to RNA (Valentin-Hansen et al., 2004, Nogueira and 
Springer, 2000, Urban and Vogel, 2007, Urban and Vogel, 2008, Papenfort 
et al., 2009, Shakhnovich et al., 2009). Hfq acts as a sRNA chaperone which 
can bind  to non-encoding small RNA (sRNA) and protect it from 
degradation (Lease and Belfort, 2000, Moll et al., 2003b, Storz et al., 2004). 
Specific sRNAs can bind to specific mRNA transcripts and control gene 
expression (Vogel and Sharma, 2005, Vogel and Wagner, 2007). For 
example, an sRNA-mRNA complex is able to alter a structure normally 
inhibiting translation and therefore enable ribosome access to the SD 
sequence and AUG start codon (Moll et al., 2003b). In other cases, an 
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sRNA/mRNA interaction can block ribosome access to target mRNA (Moll 
et al., 2003b). Further studies suggested that Hfq binding is critical for 
stabilisation of sRNA – mRNA complex by changing its secondary structure 
(Moll et al., 2003b).  Therefore this Hfq/sRNA binding to mRNA can result 
in altered structures/presentation of target mRNAs. For some sRNA, such as 
DsrA, Hfq appears not to change its secondary structure and it is more likely 
to increase the concentration of the sRNA-mRNA complex by stabilizing the 
interaction (Brescia et al., 2003). By either mechanism, Hfq can modulate 
sRNA–mRNA complexes and regulate target gene expression post-
transcriptionally. From previous studies, it was known that Hfq has two 
RNA binding sites: the proximal site binds to sRNA and AU rich regions of 
mRNA (Sonnleitner et al., 2004); another distal site binds to poly (A) tails 
(Folichon et al., 2003). Apart from those RNA interactions, Hfq interacts 
with PAP I, PNPase and RnaseE which are involved in RNA degradation 
(Viegas et al., 2007, Mohanty et al., 2004). Taken together, this information 
implies that Hfq is a key protein involved in post-transcriptional regulation.  
 
Although Hfq was originally identified as an RNA regulator, it was shown to 
have an important role in modulating virulence expression together with 
certain sRNAs in bacterial pathogens (Chao and Vogel, 2010 Muffler et al., 
1996, Nogueira and Springer, 2000, Sledjeski et al., 2001). More and more 
evidence shows that small non-coding RNAs are involved with virulence-
related expression in pathogens with T3SSs (Vogel and Papenfort, 2006, 
Vogel and Wagner, 2007). The key component of the carbon storage 
regulator (Csr) and its homologous repressor of secondary metabolites (Rsm) 
systems is an RNA binding protein (CsrA or RsmA) that regulates gene 
expression post-transcriptionally by changing target mRNA stability and/or 
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interfering with ribosome binding (Romeo, 1996, Romeo, 1998, Majdalani et 
al., 2005). The Csr system participates in global regulation affecting central 
carbon flux, motility, biofilm formation, quorum sensing and extracellular 
factor production (Romeo, 1998, Nogueira and Springer, 2000, Jackson et al., 
2002, Majdalani et al., 2005, Viegas et al., 2007, Vogel, 2009). For example, 
CsrA acts as an activator of FlhDC expression (Wei et al., 2001, Jackson et 
al., 2002). It was also reported that the Csr system was found essential for 
bacterial pathogenesis and successful infection in the animal host probably 
by controlling the different physiological stages of pathogen infection 
(Lucchetti-Miganeh et al., 2008).  CsrA activity was known to be 
sequestrated via binding to its small non-coding RNA antagonists, CsrB and 
CsrC (Babitzke and Romeo, 2007). Previous studies suggested that CsrA 
bound to a “CAGGXXG” sequence with higher affinity and CsrB and CsrC 
both have multiple conserved CsrA binding motifs (Babitzke and Romeo, 
2007, Majdalani et al., 2005). A recent study revealed that CsrB and CsrC 
degradation is linked to the RNaseE degradosome (Suzuki et al., 2006).   
Since Hfq also interacts with RNaseE and PNPase, two key components of 
the RNA degradsome, it implies that Hfq can also mediate the Csr system 
via CsrBC RNA degradation (Basineni et al., 2009, Mohanty et al., 2004).   
According to this information, hfq and csrA were logical targets to delete and 
investigate their impact on the post-transcriptional control of LEE4. 
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2.2 Results 
2.2.1 Characterization of SepL and SepD mutants 
SepL has several predicted functional domains (Kresse et al., 2000) but the 
functions of these domains are still unknown. In order to further investigate 
both the action and expression of SepL in EHEC O157:H7, various sepL 
mutants were constructed using allelic exchange with a temperature-
sensitive plasmid─pIB307 as described in Materials and Methods.  There 
were 5 different sepL mutants generated using the same allelic exchange 
strategy (Fig. 2.1A)  Western blotting to examine the impact of the sepL 
mutations on T3 translocon expression and secretion was carried out using 
an EspD antibody in Western blotting assays. At the time of this work, a 
total deletion of the sepL open reading frame has not been published so it is 
interesting to test the impact of a total sepL deletion on T3SS in EHEC. As 
will become clear through this chapter, differences in sepL mutants are likely 
to be relevant as they will result in different final LEE4 mRNA transcripts 
and so both the impact on SepL production and the sepL-espADB mRNA 
need to be considered.  In this study, a sepL total knockout mutant 
(ZAP1143) shows a typical sepL/sepD deletion phenotype when cultured in 
MEM-Hepes medium. It has been established across a number of studies that 
this medium promotes T3S by EHEC O157 strains.  It was noted that the 
complete sepL deletion also impairs EspD production as less EspD was 
detected in the whole cell fraction. Interestingly, this phenotype was not 
complemented by plasmid-based sepL expression (Fig. 2.1B; left and middle 
panel). As stated, this irreversible phenotype might be due to a change in the 
LEE4 mRNA structure caused by deleting sepL.  In order to make the 
complete deletion, the sepL gene is replaced by a sacB-kanaR cassette.  For 
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this strain, EspD expression is totally blocked and it cannot be restored by 
sepL in trans. This insertion is very likely to prevent downstream espADB 
expression from LEE4 operon.  A third construct produced was a 
chromosomally integrated sepL-gfp strain (ZAP928) to examine SepL 
localization. Unexpectedly, this replacement also caused a reduction in EspD 
expression. This could be a result of impaired SepL function as fused to GFP, 
but it may also be a result of polar effects on the espADB transcript as above 
in which deleting sepL prevented other LEE4 genes being transcribed.  To 
test the significance of the mRNA structure on EspD production, another 
Fig. 2.1. Characterization of sepL and sepD mutants.  
Different strains (A) were cultured in MEM-Hepes and supernatant (SN) and whole cell 
(WC) samples were prepared as described in Materials and Methods. EspD was 




sepL mutant (ZAP1211) was constructed which has a minimal impact on the 
LEE4 mRNA. In ZAP1211, the sepL CDS was taken out of frame by 
insertion of an additional base at nucleotide position 345 of sepL. When this 
mutated strain was examined for T3S capacity, it also shows a typical 
sepL/sepD deletion phenotype and could be fully complemented by plasmid 
based sepL expression (Fig. 2.1B; right panel) unlike the other sepL 
constructs described above.  
 
2.2.2 Heterogeneous expression of SepL-GFP  
Previously research had indicated that the espADB transcript was subject to 
post-transcriptional control leading to heterogeneous surface expression of 
EspA filaments in EHEC O157 strains (Roe et al., 2003b). sepL is the first 
gene on the LEE4 operon followed by the espADB genes and a sepL mutant 
failed to secrete EspADB translocon proteins into the culture supernatant 
(Kresse et al., 2000). From previous studies, it is evident that sepL is initially 
expressed as part of a sepL-espADB transcript that is subsequently processed 
(Roe et al., 2003a, Roe et al., 2003b).  For this research, I wanted to 
determine if SepL is also regulated by the same mechanism and determine 
whether it also exhibits heterogeneous expression. To examine the 
expression of SepL in individual bacteria, the whole sepL ORF was 
amplified from EHEC O157, including its own promoter region, and fused to 
gfp in frame. This fusion was transformed into EHEC O157 strain ZAP193 
(a high secretor strain) and ZAP108 (a low secretor strain) and SepL-GFP 
expression examined by fluorescence microscopy as described in Materials 
and Methods.  
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Fig. 2.2. Heterogeneous expression of SepL-GFP and correlation with EspA expression at 
the single cell level. (A) E. coli O157 (ZAP193) was transformed with pDW6 containing full 
length sepL fused to gfp expressed from the sepL promoter. Bacteria were cultured in 
MEM-Hepes to an OD600 of ~0.8 and the culture fixed for fluorescence microscopy. A 
subset of the bacteria express the fusion at a high and detectable level, examples are 
indicated by arrows, under the exposure conditions used (Chapter 5). (B) A low secretor 
strain, E. coli O157 ZAP108 (Roe et al., 2003b) was also transformed with pDW6 and 
examined under the same conditions. In this field only one bacterium (highlighted by an 
arrow) expressed a high and detectable level of the SepL-GFP fusion. (C) By comparison, 
transformation of ZAP193 with an rpsm-gfp fusion results in expression of detectable GFP 
fluorescence in the majority of bacteria (>99%). (D) Correlation between SepL-GFP 
expression and EspA filament production on the bacterial cell surface. ZAP193 containing 
pDW6 was cultured and fixed as above with appropriate steps using primary and 
secondary antibodies to detect EspA filaments as described in Materials and Methods. A 
subset of bacteria did not express GFP fluorescence and these same bacteria (examples 
indicated by arrows) do not express EspA filaments on the surface. (E) To confirm the 
plasmid-based studies of sepL-gfp expression, the same construct was exchanged onto 
the chromosome to replace native sepL. This construct has a significantly altered sepL-
espADB mRNA as a result of the introduction of gfp but still produced EspA filaments on a 
subset of cells and this correlated with GFP expression (indicated by the arrow). 
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The expression of SepL-GFP was only found in a subset of bacteria (Fig. 
2.2.A-B). Under the same culture conditions, all bacteria expressed an rpsM-
gfp fusion (Fig. 2.2.C) confirming that the proportional expression was not 
due to cell viability or issues specific to GFP. As our previous work has 
demonstrated that production of EspA filaments is also heterogeneous in 
EHEC O157, I used indirect immuno-fluorescence to detect EspA filaments 
on the strain containing the full length SepL-GFP fusion.  Of those bacteria 
expressing EspA filaments, 91% had SepL-GFP expression level higher than 
22.5 relative fluorescence units (rfu) (Fig. 2.2A), whereas only 9% of EspA-
filamented bacteria had expression levels less than 22.5 rfu.  Conversely, 
82% of bacteria with no detectable surface EspA filaments had undetectable 
or low (<22.5 rfu) SepL-GFP expression.  This data demonstrates a positive 
association between SepL-GFP translation and EspA filamentation as is 
evident in Fig. 2.2D.   To rule out issues with copy number for the plasmid-
based sepL-gfp construct, the same translational fusion was used to replace 
sepL on the chromosome (ZAP928). This strain still produced EspA 
filaments but at a reduced level compared to the parent strain. In this 
background SepL-GFP expression also correlated with EspA filamentation 
(Fig. 2.2E).  It is therefore evident that SepL expression is also 
heterogeneous and may account for the checkpoint in EspADB translocon 
production as SepL is required for EspADB secretion.  
 
2.2.3 Expression of SepL-GFP in different LEE genetic 
backgrounds 
I next wanted to determine what factors control the expression of SepL.  The 
expression of the full length SepL-GFP fusion (pDW6) was measured in 
different genetic backgrounds (Fig. 2.3 and 2.4).  The first genetic 
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background tested was a sepL deletion strain. Total fluorescence 
measurement was carried out as described in Materials and Methods. There 
was no obvious difference in fluorescence level observed between the EHEC 
wild type and sepL backgrounds (Fig. 2.3). From this it is implied that the 
chromosomal integrated sepL gene doesn’t have an effect on the expression 
of SepL-GFP from the plasmid. 
 
Expression of the fusion was reduced 12.5 fold (OD600nm = 0.6) in a ler 
deletion background demonstrating that in addition to controlling 
LEE1/2/3/5 expression (Fig.2.4A). Ler also has a significant impact on 
sepL/LEE4 regulation.  In a background in which escRSTU was deleted, 
preventing the assembly of the normal basal apparatus of the 
Fig. 2.3. SepL-GFP expression in EHEC O157 sepL genetic backgrounds. SepL-
GFP expression was determined in strains transformed with the sepL-gfp fusion 
(pDW6) cultured in MEM-Hepes. Fluorescence expression was carried out as 
described in Materials and Methods. (■) Wild type EHEC O157 ZAP193 (pDW6); 
(▲) sepL ZAP1211 (pDW6); (◆) EHEC O157 ZAP 193 (control, no gfp plasmid). 
Each expression experiment was carried out on at least three occasions and one 
replicate is shown. Data cannot be combined from different experiments as the 
sampling optical density points are different each time 
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Fig. 2.4. SepL-GFP expression in different EHEC O157 genetic backgrounds. (A) 
SepL-GFP expression was determined in strains transformed with the sepL-gfp 
fusion (pDW6) cultured in MEM-Hepes. Fluorescence expression was carried out as 
described in Materials and Methods. (●) Wild type EHEC O157 ZAP193 (pDW6); (■) 
escRSTU ZAP1140 (pDW6); (▲) LEE4 ZAP984 (pDW6); ( ) sepD ZAP1144 
(pDW6); (× ) ler ZAP1004 (pDW6) (◆ ) EHEC O157 ZAP 193 (control, no gfp 
plasmid). Each expression experiment was carried out on at least three occasions 
and one replicate is shown. Data cannot be combined from different experiments as 
the sampling optical density points are different each time. (B) SepL-GFP 
heterogenous expression in individual cells were examined under fluorescence 
microscope, no significant change of SepL-GFP heterogenous expression was 




T3SS, SepL expression at OD600nm = 0.6 was reduced by 50%. A 55% 
reduction of SepL-GFP expression was detected in a LEE4 deletion 
background (Fig.2.4A).  However, expression of SepL-GFP was reduced 6.7 
fold (OD600nm = 0.6) in a sepD deletion. The expression of SepL-GFP was 
then examined in the individual bacteria in the same backgrounds.  As 
indicated by the low level of expression in those genetic backgrounds 
especially in a ler background, SepL-GFP was difficult to detect (Fig.2.4B). 
However, in my study, no evidence suggested that SepL heterogeneity was 
changed significantly in these mutants. 
 
2.2.4 Tir expression is not affected by sepL/sepD 
deletion 
In this study, SepL expression was demonstrated to be reduced in a sepD 
deletion background as shown in Fig. 2.4A. Previous work in our laboratory 
has already shown that there is co-ordinated single cell expression between 
LEE4 (espA) and LEE5 (tir) in EHEC O157:H7 strains. When EHEC O157 
(ZAP193) was cultured in a T3S permissive condition, it was found that 
LEE4 and LEE5 expression was detected in the same subset of bacterial 
cells (Roe et al., 2004). To test whether Tir expression was also regulated by 
SepL or SepD, a full length Tir-GFP translational fusion was made (pDW-tir) 
and transformed into different genetic backgrounds. Total fluorescence was 
measured as described in Materials and Methods. Although SepL expression 
was repressed in a sepD mutant, Tir expression was not altered in this 
background (Fig. 2.5). Similarly, Tir expression was not affected by deletion 
of sepL (Fig. 2.5). These results suggest that both SepL and SepD are not 
specifically involved in the co-ordinated heterogenous expression of LEE4 
and LEE5 in EHEC O157.   
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2.2.5 SepD activates sepL/LEE4 transcription 
It was observed that SepL expression was decreased in a sepD mutant strain. 
It raises the question as to whether SepD controls SepL expression at the 
transcriptional or post- transcriptional level.  To answer this, transcription of 
sepL was investigated using a gfp fusion (pAJR74, Roe et al., 2003b). This 
transcriptional fusion was transformed into different backgrounds and 
cultured in MEM-Hepes. The transcription of sepL (pAJR74) was reduced to 
the same extent as the full length SepL-GFP translational fusion (pDW6) 
(Fig. 2.6), indicating that SepD controls sepL expression at the 
transcriptional level.  
Fig. 2.5. Tir-GFP expression in different EHEC O157 genetic backgrounds. (A) Tir-
GFP expression was determined in strains transformed with the tir-gfp fusion (pDW-
tir) cultured in MEM-Hepes. Fluorescence expression was carried out as described 
in Materials and Methods. (■) Wild type EHEC O157 ZAP193 (pDW-tir); (▲) sepL 
ZAP1211 (pDW-tir); (×) sepD ZAP1144 (pDW6); (◆) EHEC O157 ZAP 193 (control, 
no gfp plasmid). Each expression experiment was carried out on at least three 
occasions and one replicate is shown. Data cannot be combined from different 
experiments as the sampling optical density points are different each time 
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2.2.6 sepL cleavage mutation doesn’t change sepL 
expression level  
Previous work in our laboratory had indicated post-transcriptional regulation 
of the LEE4 transcript, including cleavage of the transcript at the 3’ end of 
sepL to release a distinct espADB transcript.  This ‘cleavage point’ was 
previously mapped using primer extension analysis (Beltrametti et al., 1999) 
and our laboratory (Dr. A. Roe, personal communication). Published 
research interpreted this cleavage site as a transcriptional start site for 
espADB, but subsequent research has shown that there is no promoter 
activity detectable adjacent to the espADB transcript and therefore this 
transcript is most likely to be generated by cleavage of a larger LEE4 
transcript. Published research during my research has shown this to be the 
Fig. 2.6. SepD activates sepL/LEE4 transcription. (A) SepL-GFP expression was 
determined in strains transformed with the sepL-gfp fusion (pDW6) cultured in MEM-
Hepes. Fluorescence expression was carried out as described in Materials and 
Methods. (●) (pAJR74); (─) sepD ZAP1144 (pDW6); (╋) Wild type EHEC O157 
ZAP193 (pDW6); (×) Wild type EHEC O157 ZAP193 (pAJR74); (◆) EHEC O157 
ZAP 193 (control, no gfp plasmid); (▲) sepD ZAP1144 (control, no gfp plasmid). 
Each expression experiment was carried out on at least three occasions and one 
replicate is shown. Data cannot be combined from different experiments as the 
sampling optical density points are different each time 
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Fig. 2.7. Cleavage site mutation doesn’t alter SepL-GFP expression  
(A) Full length sepL and sepL cleavage site mutant all containing the sepL promoter region 
were translationally-fused to gfp and transformed into the high secretor strain E. coli O157 
ZAP193. (B-C) Modelling of RNA folding was carried out for the different sepL-gfp RNAs 
using RNADraw. After introducing a synonymous mutation at the cleavage site within sepL 
ORF, the secondary structure was changed around the end of sepL transcript. (D) The total 
fluorescence values were examined for the effect of this synonymous mutation as described 
in Materials and Methods. Data cannot be combined from different experiments as the 
sampling optical density points are different each time. There are no differences in SepL-GFP 
expression between the original construct and the mutated construct (E). This result suggests 






case with the cleavage dependent on RNaseE activity (Lodato and Kaper, 
2009).  This processing might be vital to LEE4 post transcriptional control. 
There are numerous reports which indicate that mRNA structure is crucial 
for transcript cleavage.  To examine this a synonymous mutation was 
introduced on pDW6 (full length SepL-GFP) to generate pDW6m-35 by 
site-directed mutagenesis around this cleavage site within sepL (Fig.  2.7A). 
Although pDW6m-35 still encodes the same SepL-GFP product, its mRNA 
structure around the cleavage site was changed to form a different predicted 
structure compared with the wild type fusion (Fig. 2.7B-C). However, it 
remains unknown whether this mutation would affect sepL mRNA 
processing. This altered full length SepL-GFP construct was transferred into 
EHEC ZAP193 and expressed under T3S permissive conditions. Total 
fluorescence was then measured as described in Materials and Methods. 
Compared with pDW6, the population expression level of pDW6m-35 
remained unchanged under the conditions tested (Fig. 2.7D). As the 
construct did not show any difference in expression and as a result of time 
limitations, post-transcriptional processing of this mutated sepL-gfp mRNA 
was not examined by northern analysis. When checked by fluorescence 
microscopy, this mutant demonstrated a similar phenotype to pDW6 and no 
effect was observed on heterogeneous SepL-GFP expression (Fig2.7E).  
 
2.2.7 Mutagenesis of the first base of the sepL 
transcript  doesn’t affect SepL expression  
In order to study sepL sequence variation between different EHEC strains, 
previous work in our laboratory had sequenced a variant that gave elevated 
expression levels (>100 fold) of a SepL-LacZ fusion.  This contained 3 
mutations in the sequence preceding sepL when compared with sepL from 
 75
Fig. 2.8. +1 site mutation of sepL transcription doesn’t alter SepL-GFP expression 
Modelling of RNA folding was carried out for sepL-gfp wild type (A) and +1 mutant (B) 
RNAs using RNADraw. After introducing a T→C mutation at the +1 site of sepL 
transcript, the mRNA secondary structure remains unchanged (B). The total 
fluorescence values were examined for the effect of this synonymous mutation as 
described in Materials And Methods (C). Data cannot be combined from different 
experiments as the sampling optical density points are different each time. There are 
no difference in SepL-GFP expression between the original construct and the mutated 







EDL933. Two altered nucleotides (A→T at -69 and -115) were located 
upstream of the sepL transcript and one at the first base of sepL transcript. It 
has been shown that the +1 site is important in binding the RNA polymerase 
during transcription initiation. So, the T→C change at the +1 site of sepL 
mRNA could have a significant impact on SepL expression. To further 
characterise this mutant, the translational fusion plasmid (pDW6m+1) was 
constructed in which a C was introduced to replace T at the +1 site of the 
sepL transcript using site-directed mutagenesis (Fig. 2.8A-B). pDW6m+1 
was then transformed into EHEC ZAP193 and SepL-GFP expression 
analysed. However, this +1 mutation also did not show any effect on SepL-
GFP expression (Fig. 2.8C-D). This result suggests that the two changes 
adjacent to the sepL transcript could be having an important impact on sepL 
promoter activity or regulation.  This remains to be investigated. 
 
2.2.8 Mapping the area sufficient for SepL 
heterogeneous expression 
To map the sequence which is crucial for the heterogeneous expression of 
sepL, full length sepL, the first 573, 210 and 51 base pairs of sepL were 
amplified with their own promoter and fused to gfp in frame (Fig. 2.9A). 
These constructs can therefore be used to examine the heterogeneous 
expression of sepL truncates. It was shown above that SepL was expressed at 
a very low proportion in EDL933. In order to double check the 
heterogeneous expression of sepL in another low secretor strain, the full 
length fusion was expressed in ZAP108, previously demonstrated to express 
a low proportion of EspA filaments under a T3 permissive condition (Roe et 
al., 2003b). In this strain, only a low proportion of bacteria (<1%) were 
observed by fluorescence microscopy that expressed SepL-GFP (Fig. 2.9B). 
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Fig. 2.9. Mapping the region of sepL required for post-transcriptional control 
(A) Full length sepL and sepL carboxy terminal truncates all containing the sepL 
promoter region were translationally-fused to gfp and (B) transformed into the low 
secretor strain E. coli O157 ZAP108 (Table 1). Fluorescence in the bacterial 
population was imaged; heterogeneous expression was evident for the constructs 
containing full length sepL and the 573 bp and 210 bp truncates, with fluorescence 
detectable in only a small percentage of cells (<1%). By contrast, fluorescence was 
detectable in every bacterium containing 1 the 51 bp sepL-gfp fusion. (C-D) 
Modelling of RNA folding was carried out for the different sepL-gfp RNAs using 
RNADraw. The AUG start codon for sepL is sequestered between two hairpin loops 
for the full length, 573 and 210 bp constructs as indicated in the full length model 
shown in (C) with insets to indicate the AUG start codon that is circled. (D) The start 
codon is then exposed in constructs with less sepL coding sequence, such as the 51 
bp construct indicated. 













81bp sepL-gfp 84bp sepL-gfp E 
Fig. 2.9. Mapping the region of sepL required for post-transcriptional control
(E) Based on the RNA folding predictions, the structure transition indicated in (C-
D) occurs when 81 bp of sepL are included in the modeling (G). To test this and 
define the minimum region of sepL required for heterogeneous regulation, the 
sepL promoter region and either 81 bp (E.G) or 84 bp (E,F) of the sepL open 
reading frame were fused to gfp and fluorescence examined in the low secretor 
strain ZAP108. As supported by population fluorescence measurements (H), the 
construct containing 81 bp of sepL was sufficient to restrict translation to a subset 
of the population as predicted (E). Of note is that the 84 bp sepL fusion was not 
restricted, with expression in every cell and increased levels at the population 
level (E-F). The marked difference between the translation of the 81 and 84 bp 
fusions indicates that this is the approximate transition point for the RNA structure 
to switch between the restrictive and non restrictive. Data cannot be combined 
from different experiments as the sampling optical density points are different 
each time. 
GF 
10 m 10 m 
10 m 10 m 
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Our data also showed that all SepL-GFP truncates which had 70aa or more 
of SepL could only be detected in a subset of bacterial cells (1%) (Fig. 
2.9B). A construct with the first 17aa of SepL (51bpsepL-gfp) fused to GFP 
was, by contrast, expressed in almost every individual bacterium (>99%) 
(Fig. 2.9B). These results suggest that the first 51 base pairs of sepL do not 
contain sufficient information to result in heterogeneous expression of SepL 
by comparison with the other truncates.  
 
As previous research has revealed that the structure of target mRNA is very 
important for a small RNA regulation of transcripts and since the expression 
of the different length sepL constructs varied, I used RNA modelling 
software (RNAdraw v1.1) to predict the mRNA structure of these truncates 
(all fused to gfp).  These models suggest that there is a significant change 
around the sepL AUG intiation codon when the 51 base pair construct is 
compared with the longer sepL sequences (Fig. 2.9C, D). Therefore 
combining these two observations, it indicates that a change in sepL mRNA 
structure may be playing an important role in controlling the heterogeneous 
expression of SepL.  
 
In order to define the minimum sequence required for this post-
transcriptional control, further RNA structural modelling of different length 
sepL fusions was carried out. According to this, the mRNA structure reverts 
back to the full length folding pattern once 84bp of sepL are included in the 
model (Fig.2.9F-G). As a consequence, I made 81bp and 84bp sepL-gfp 
constructs to test this prediction. It was demonstrated under the fluorescence 
microscope that 84bp sepL-gfp construct was expressed in every bacterium 
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as with the 51bp sepL-gfp construct (Fig. 2.9E). However, the 81bp sepL-gfp 
construct was only expressed in a subset of cells as with the full length sepL-
gfp construct (Fig. 2.9E). Population-based fluorescence readings also 
supported different translational patterns in these two constructs (Fig. 2.9H). 
It is clear as shown in Fig. 2.9E-H that such a slight change has a dramatic 
impact on expression/regulation.   
 
 
2.2.9 Analysis of short SepL-GFP fusions 
In addition to the truncates described above, different length sepL leading 
sequences were fused to gfp spanning from the first codon to 48bp of sepL. 
These 16 short sepL-gfp fusions were then transformed into EHEC strain 
ZAP193 and cultured in MEM-Hepes. Samples were taken at different time 
point, and the OD600nm / total fluorescence readings were measured as 
described in Materials and Methods. When the OD600 of these cultures 
reached 0.6, the sample was fixed with 4% PFA and fixed to slides. As 
shown before, GFP production was observed in every bacterium when the 
first 51bp sepL was fused to gfp. Unexpectedly, it was found out that the 
shortest sepL::gfp fusion (pDWsepL3) only showed background GFP 
production although the other 15 fusions (pDWsepL6, pDWsepL9, 
pDWsepL12, pDWsepL15, pDWsepL18, pDWsepL21, pDWsepL24, 
pDWsepL27, pDWsepL30, pDWsepL33, pDWsepL36, pDWsepL39, 
pDWsepL42, pDWsepL45 and pDWsepL48) can give a high GFP 
production in EHEC (Fig. 2.10B). The same result was also evident when 
the different constructs were examined by fluorescence microscopy. 
Fluorescence was detected in the majority of bacterial cells for all the 16 
fusions except the shortest. pDWsepL3 and pDWsepL6 both have the sepL 
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native promoter and 5’ UTR (Fig. 1.9 and 2.10A). pDWsepL3 only contains 
the first 3 base pairs (ATG start codon) of the sepL gene but pDWsepL6 
contains the first 6 base pairs. Although there is only a difference of 3 base 
pairs between pDWsepL3 and pDWsepL6, when expressed in EHEC O157, 
A 
Fig. 2.10. Analysis of short SepL-GFP fusions (A) sepL carboxy terminal truncates 
all containing the sepL promoter region were translationally-fused to gfp and (B) 
transformed into the high secretor strain E. coli O157 ZAP193 (Table 1). Unlike the 
shortest sepL (pDWsepL3) (■) fusions, other sepL fusions (pDWsepL6, pDWsepL9, 
pDWsepL12) were expressed at high levels (▲,╳, ) compared to ZAP193 
without the fusion construct (◆).Data cannot be combined from different 
experiments as the sampling optical density points are different each time. 
B 
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they provided two totally different expression patterns. This result suggests 
that the area around ATG start codon plays a vital role in sepL expression 
regulation.  
 
2.2.10 Replacement of the sepL 5’UTR impaired SepL 
expression 
As demonstrated above, although the expression of full length SepL-GFP 
can only be observed in certain cells, a short sepL region (the first 51 base 
pair of sepL ORF) including its 298 base pair promoter sequence when fused 
to the gfp reporter gene was expressed in every cell as determined by 
fluorescence microscopy (Fig. 2.9B).  It indicates that this short sepL fusion 
no longer contains the required sequence for SepL heterogeneous expression. 
Therefore, the leading mRNA sequence of sepL is not being post-
transcriptionally regulated in the same way as the full length sepL mRNA 
sequence. Post-transcriptional regulation of virulence determinants is 
common and may involve regulatory factors binding to the mRNA sequence. 
Although the extra factors can mediate the regulation by binding to the 5’ 
sequence of the gene coding area, they usually bind upstream of the gene 
coding sequence, the 5’ untranslated region (UTR) in most cases. For this 
work, I tested whether the specific 5’ UTR used is crucial for SepL 
expression. 
 
A hybrid construct was made to investigate the importance of this region. 
The full length sepL coding sequence including the ATG start codon was 
amplified from EHEC O157 strain ZAP193 and cloned into pAJR70 to 
generate an in frame fusion to gfp (pDW6m). A sepL upstream sequence 




Fig. 2.11. Replacement of sepL 5’UTR impaired SepL expression (A) A full length 
sepL-gfp plasmid in which sepL 5’UTR was replaced by an artificial sequence from 
expression vector pGEX4T2 was transformed into the high secretor strain E. coli O157 
ZAP193 genetic background (◆) . (B-C) Unlike another full length sepL-gfp fusion 
(pDW6) (■), this fusion was expressed at extremely low level (▲).Data cannot be 




strain ZAP193 and inserted in front of sepL in pDW6m to generate 
pDW6m0. As the final step, an artificial 5’ UTR including a ribosome 
binding site was then amplified from a well known expression vector ─ 
pGEX4T2 and restricted into pDW6m0 between the sepL promoter and 
coding sequence to generate pDW6m1. In summary, the final construct 
(pDW6m1) keeps almost all the DNA features of the full length sepL-gfp 
construct (pDW6) except it contains a replaced 5’ UTR region (Fig. 2.11A). 
pGEX 4T2 is a commercial vector normally used to express GST-fused 
proteins. It has an IPTG-inducible promoter and an optimised ribosome 
binding site for GST-fusion protein expression. In this study, the sequence 
containing this optimised ribosome binding site (RBS) for GST replaces the 
original sepL 5’ RBS. This hybrid construct-pDW6m1 was put into the same 
host strain-ZAP193, which was used for studying sepL expression in the 
previous experiments and cultured in MEM-Hepes (T3S pemissive 
condition). At different time points, samples were taken from the culture to 
measure the optical density at 600nm and then total fluorescence of each 
sample was measured. Fluorescence measurement was carried out as 
described in the Materials and Methods section. By comparison with pDW6, 
this chimeric fusion produced extremely low fluorescence levels. At 
OD600=0.8, the GFP expression level of pDW6m1 was reduced by a 100 fold 
compared with pDW6 (Fig. 2.11B-C). This interesting observation is more 
likely considered as a logical consequence of the sequence difference 
between those two constructs. Therefore, the replacement of sepL upstream 
sequence, primarily the RBS, more or less negates expression of this fusion.   
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2.2.11 LEE4 transcript under a post transcriptional 
regulation 
It has been reported that different sized LEE4 transcripts can be detected 
using a LEE4 (sepL) probe (Roe et al., 2003a, Beltrametti et al., 1999).  As 
shown above, the leading sequence of sepL might be important for SepL 
production. Therefore, a sepL partial deletion strain ─ M10 was made to test 
this hypothesis using allelic exchange. The first 10 base pairs of sepL ORF 
were replaced by a 6 bp BamH I restriction site. This deletion results in a 
reading frame change of sepL but otherwise leaves the rest of the LEE4 
DNA sequence unchanged. The sequencing result showed that there were 
three unexpected changes (Listed in Table 5.2) within the C-terminus of 
espA gene in this construct. However, those changes are unlikely to change 
the manner of LEE4 mRNA regulation as LEE4 expression was not changed 
in a espA strain (Deng et al., 2004). Unlike other sepL mutants, M10 shows 
a polar effect and cannot be complemented by sepL expressed from a 
plasmid. In this study, total mRNA was extracted from the different strains 
cultured in MEM-Hepes and equal amounts of total mRNA loaded onto a gel. 
A Northern analysis was carried out using a sepL probe as described in 
Materials and Methods. This Northern blotting of the EHEC wild type strain 
gave a result consistent with previous reports. There are two major bands 
detected using a sepL probe. The large transcript is about 4 Kb and the small 
transcript is about 1.1 kb (Fig.  2.12, panel 1).  For a sepD mutant in which 
the whole sepD ORF was removed from EHEC chromosome, these two 
bands were detected and the ratio of two transcripts remained similar. The 
only obvious change in the sepD mutant is that the overall density of 
detectable sepL transcripts is much weaker compared to the wild type. It also 
provides further evidence that sepD affects sepL expression at a 
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transcriptional level and not post-transcriptionally as indicated by analysis of 
the GFP fusions (Fig. 2.6). Moreover, the M10 RNA sample gave a totally 
different pattern when blotted with the same sepL probe. For M10, only the 
1.1kb band was detected (Fig. 2.12, panel 1). This result suggested that the 
LEE4 transcript was regulated differently in the M10 mutant compared to 
the wild type strain.  The SepL-GFP construct was also analysed by 
Northern blotting using total mRNA extracted from bacteria cultured in the 
same way as above and a gfp probe.  This revealed 2 major bands (Fig. 2.12, 
panel 2). These two detected bands were in a ratio comparable to those 
shown for the wild type sepL transcript. This result suggests that sepL-gfp 
transcript is also cleaved the same way as the LEE4 transcript and therefore 
 
1 2 
Fig. 2.12. Northern analyses of LEE4 operon expression. Detection of transcript 
mRNA with a sepL probe (1) in different strains and culture conditions: A. M10 
(MEM-Hepes); B. LEE4; C, sepD (MEM-Hepes); D, ZAP193 (MEM-Hepes); 
E, ZAP193 (LB).  
Panel 2 shows: pDW6 was transferred into WT EHEC (ZAP193, MEM-Hepes). 
And mRNA transcript was detected with gfp probe (F). 
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the fusion is a good indicator of WT sepL transcript expression and 
processing. 
  
2.2.12 Hfq regulation of SepL translation 
From the results above, it is evident that sepL mRNA folding and processing 
are critical for SepL heterogeneous expression.  One strong possibility is the 
involvement of a small regulatory RNA. Recent published work suggests 
that RNaseE is required for LEE4 transcript processing. Hfq, a small RNA 
chaperone is a global regulator of gene expression, and can be involved in 
RNaseE-related mRNA degradation. It is known that EDL933 hfq mutant 
has an enhanced pedestal formation phenotype, equivalent to an EDL933 
dam mutant (Prof. Martin Marinus, personal communication). Given this 
information, it was interesting to test SepL expression in an hfq mutant. 
Therefore, the full length SepL-GFP fusion was transformed into the wild 
type, hfq and hfq complemented strains which were then imaged by 
fluorescence microscopy (Fig. 2.13A). In the hfq deletion background, 
expression of the SepL-GFP fusion is clear in the majority of bacteria (>99%) 
compared to only approx. 1% in the wild type EDL933 strain. The 
proportion of bacteria expressing the fusion in hfq was then reduced 
following complementation with Hfq. This result is in agreement with 
population level measurements of SepL, including Western blotting 
(unpublished data, Xu and Gally) and culture fluorescence levels (Fig. 2.13B) 
which were elevated 100 fold in an hfq mutant. By contrast, expression from 
the 51 bp sepL-gfp fusion was increased modestly (less than 1.5 fold) 
demonstrating the importance of the extended sepL region for hfq regulation 
(Fig. 2.13C).  
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EDL933 EDL933 hfq EDL933 hfq+Hfq 
A 
Fig. 2.13 Hfq controls 
heterogeneous expression of 
SepL. (A) EDL933 and its hfq 
derivative were transformed with 
pDW6 containing full length 
sepL fused to gfp expressed 
from the native sepL promoter. 
In EDL933, less than 1% of 
bacteria express SepL-GFP. 
Deletion of hfq results in 
expression of SepL-GFP in 
>99% of cells. Complementation 
by hfq cloned into pWSK29 
restores the wild-type 
phenotype. Bacteria were 
cultured in MEM-Hepes to an 
OD600 of 0.8 and the culture 
fixed for fluorescence 
microscopy. (B) Whole cell 
population fluorescence 
measurements confirm the 
fluorescence microscopy 
observations. SepL-GFP 
expression levels in EDL933 (■) 
are equivalent to the strain 
alone not containing the plasmid 
(◆), but was raised over 100 
fold in the hfq deletion 
background (▲). This elevated 
level is returned to the wild type 
level on complementation with 
hfq ( ). (C) EDL933 and hfq 
were transformed with pDW26 
containing the first 51bp of sepL 
fused to gfp expressed from the 
sepL promoter. Unlike the full 
length sepL fusion, this 
construct was expressed at high 
levels (■) compared to EDL933 
without the fusion construct (◆) 
and this level of expression was 
increased only slightly (<1.5 
fold) in the absence of hfq (▲). 
10 m 10 m 10 m 
10 m 10 m 10 m 
B 
C 
Data in B and C cannot be combined from different 
experiments as the sampling optical density points are 
different each time 
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2.2.13 CsrA regulation of SepL translation 
CsrA is known as a post-transcriptional regulator which mediates the 
binding between sRNA csrBCD and its chaperone protein, Hfq. It has been 
revealed that CsrA plays a key role in the adaptation of bacterial pathogens 
to different stages of infection in animals (Lucchetti-Miganeh et al., 2008). 
Fig. 2.14. CsrA controls heterogeneous expression of SepL. (A) ZAP193 and its csrA 
derivative were transformed with pDW6 containing full length sepL fused to gfp 
expressed from the native sepL promoter. In ZAP193, >80% of bacteria express SepL-
GFP. Deletion of csrA results in expression of SepL-GFP in less than 1%of cells. 
Complementation by csrA cloned into pWSK29 restores the wild-type phenotype. 
Bacteria were cultured in MEM-Hepes to an OD600 of 0.8 and the culture fixed for 
fluorescence microscopy. (B) Whole cell population fluorescence measurements 
confirm the fluorescence microscopy observations. SepL-GFP expression levels in 
ZAP193 (■) are equivalent to the strain alone not containing the plasmid (◆), but was 
decreased by 10 fold in the csrA deletion background (▲). This elevated level is 
returned to the wild type level on complementation with csrA ( ).Data cannot be 
combined from different experiments as the sampling optical density points are 
different each time.
B 








An EHEC O157 csrA mutant was generated by allelic exchange and tested 
for heterogeneous SepL expression. The expression of SepL was decreased 
dramatically in this mutant at the population level. Comparing expression 
with the parental EHEC ZAP193 wild type strain, the expression of SepL-
GFP is reduced more than 20 fold in a csrA deletion mutant (Fig. 2.14B). 
When the heterogeneity of SepL expression was examined by fluorescence 
microscopy, it was evident that less than 1% of csrA bacterial cells 
expressed SepL-GFP (Fig. 2.14A). While for the high secretor parent strain 
(ZAP193), SepL-GFP expression was observed in more than 80% of cells 
(Fig. 2.14A). This data demonstrates that CsrA, directly or indirectly, is 
involved in the regulation of SepL expression. 
 
2.3 Discussion 
As suggested by previous work in our laboratory, T3S is important for the 
colonization of EHEC at the terminal rectum of cattle and the expression 
levels of T3S proteins EspD, EspA and Tir are variable between different 
EHEC strains (McNally et al., 2001, Roe et al., 2003b, Naylor et al., 2003, 
Naylor et al., 2005). This difference is exemplified by imaging the secretion 
of T3 translocon proteins, especially EspA filaments, on the bacterial surface. 
This variability has been suggested to potentially affect shedding levels from 
cattle and therefore the likelihood of subsequent human infection (Chase-
Topping et al., 2008). So far, it has been shown that T3 secretion is regulated 
by different multiple inputs which can act at transcriptional, post-
transcriptional and post-translational levels. This variation between strains is 
likely to be a total sum of various inputs from these three levels.  
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Different factors were reported to activate or repress T3SS of EHEC/EPEC. 
Some factors, such as Ler and H-NS, regulate T3S by directly activating or 
repressing LEE transcription. H-NS has been shown to repress LEE 
expression of EPEC (Umanski et al., 2002). Therefore, as an H-NS 
homologue, Ler is acting as an anti H-NS factor to activate LEE expression 
(Bustamante et al., 2001). Moreover, Ler has been shown to be important for 
switching on expression of the non-LEE encoded T3 effector NleA (Elliott et 
al., 2000). On the other hand, many factors, such as GrlA, Hha and RpoS, 
were found to regulate T3S indirectly via Ler (Juarez et al., 2000, Sharma 
and Zuerner, 2004, Barba et al., 2005, Laaberki et al., 2006, Dong and 
Schellhorn, 2009b).  In the past, Ler has been shown to have an impact on 
controlling expression from LEE1, 2, 3, 5 and also the esp genes (Sperandio 
et al., 2000, Sanchez-SanMartin et al., 2001, Haack et al., 2003, Sharma and 
Zuerner, 2004). The effect of Ler on sepL expression has not been 
mentioned since esp genes were thought to be transcribed from their own 
promoters instead of processed from a larger LEE4 transcript (Beltrametti et 
al., 1999). However, later work in our group and other groups suggested that 
two different size espADB transcripts result from post transcriptional 
cleavage of this transcript (Roe et al., 2003b, Roe et al., 2004, Lodato and 
Kaper, 2009). From my research, the expression level of SepL-GFP was 
reduced more than 10 fold in a ler deletion background and this implies that 
Ler has a major impact on LEE4/SepL expression. SepD deletion also results 
in a reduction of sepL transcription in EHEC. It has been demonstrated that 
the LEE4 operon is controlled post-transcriptionally and that the proportion 
of bacteria within a population that are engaged in T3S correlates well with 
high and low secreting phenotypes (Roe et al., 2003b, Roe et al., 2004, 
Lodato and Kaper, 2009). It is likely that the T3S phenotype is regulated not 
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only transcriptionally but also post transcriptionally in different EHEC 
isolates.  
 
PerC, which is encoded by the perABC operon on the pEAF plasmid of 
EPEC, is a positive regulator of EPEC T3SS which modulates LEE 
expression through the LEE1/ler promoter and perABC operon was only 
found in EPEC (Gomez-Duarte and Kaper, 1995).  PchA,B,C, three PerC-
homologs which are encoded within cryptic prophages, were shown to act as 
positive regulators of LEE1 in EHEC (Porter et al., 2005).  Recent work has 
shown that there are variable regions adjacent to certain pch loci and Pch 
expression can therefore differ between strains leading to altered levels of 
LEE1 expression (Yang et al., 2009).  Although LEE1 expression has a 
considerable impact on T3S expression, it is unlikely that Pch variation 
controls LEE4 heterogeneous (post transcriptional) expression since LEE4 
heterogeneous expression was not changed in a ler mutant as investigated in 
this study.  However, it remains a possibility that the Pch level could impact 
on LEE4 translation by altering expression of other regulatory factor(s).  
 
In my study, it was confirmed that EspA filament expression is 
heterogeneous and this correlated with T3S levels in various EHEC strains 
as reported (Roe et al., 2003b, Roe et al., 2004). SepL is essential for 
translocon secretion and switching from translocon to effector protein export 
(Kresse et al., 2000, O'Connell et al., 2004, Deng et al., 2005, Wang et al., 
2008).  As the first gene on the LEE4 operon, SepL expression was only 
found in the subset of cells that had EspA filaments on the surface.  Results 
of Northern analyses suggested that the sepL transcript was also being post-
transcriptionally processed as shown above (Fig. 2.12).  
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My experiments further revealed that the first part of the sepL reading frame  
(51bpsepL-gfp, Fig. 2.9B) is modulated in a different way compared with 
full length sepL transcript. By modelling the RNA structure, it was evident 
that the sequences present the AUG initiation codon differently.  I propose 
that the sequestration of the initiation codon in the full length transcript, is 
linked to the restricted heterogeneous expression and this does not occur 
with the more open access to the codon provided in the shorter construct. 
Further modelling proposed the transition for this change change would be 
around 81-84 bp of sepL sequence. In order to test this theory, two SepL-
GFP fusions (81bp sepL-gfp and 84bp sepL-gfp) were made based on the 
RNA modelling and expressed under a T3S permissive condition. A clear 
difference was found in the expression pattern between 81bp and 84bp sepL 
constructs. The heterogeneity of SepL expression was not apparent with the 
84bp sepL-gfp construct but was still heterogeneous with the 81bp sepL-gfp 
construct (Fig. 2.9E). The fact that 3 extra bases can modulate SepL 
expression pattern dramatically supports my hypothesis.  
 
Hfq is a global regulator which is recruited by sRNA factors involved in 
post-transcriptional regulation (Nogueira and Springer, 2000, Sittka et al., 
2008, Sittka et al., 2009). It was demonstrated that Hfq repressed EHEC T3S 
in my study and the heterogeneity of SepL expression was also changed in 
the absence of Hfq (Fig. 2.13). According to this data, I propose an Hfq-
dependent regulation of T3S in EHEC which is also supported by two very 
recent publications (Shakhnovich et al., 2009, Hansen and Kaper, 2009). The 
impact of Hfq on LEE1 (Ler regulation) was examined in detail in these two 
studies and it was found Ler was over-expressed in an hfq mutant.  However, 
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it was not mentioned in their studies that Hfq is important for LEE4 
heterogeneous expression. From my data, Hfq is also considered as a 
regulator of the LEE4 transcript independently of Ler.  However, a co-factor 
might be required for Hfq to regulate LEE4 expression as Hfq were known 
associated to other factors (RNA or protein) (Vytvytska et al., 1998, 
Sledjeski et al., 2001, Moll et al., 2003a, Sukhodolets and Garges, 2003, 
Folichon et al., 2003, Moll et al., 2003b). A posttranscriptional regulator, 
CsrA, was then examined for LEE4 heterogeneous expression regulation in 
my study. It was found that CsrA acts as an activator of EHEC T3S (Fig. 
2.14). A similar observation is also reported by another group recently (Bhatt 
et al., 2009) showing that CsrA binds to the ‘leading sequence’ of the sepL 
transcript.  My results discovered that the 5’ UTR and 5’ sepL sequence also 
has a significant impact on SepL expression (Fig. 2.10 and 2.11) and it was 
interesting that the two proposed CsrA binding sites are included in this 
region (Bhatt et al., 2009). Collecting all the information, it seems that CsrA 
binding could sequentially switch on LEE4 expression and Hfq would 
interfere with this binding directly or indirectly.  Although it is still not fully 
understood how exactly LEE4 is post-transcriptionally regulated in EHEC, it 
is likely that Csr-sRNA regulators control LEE4 expression by direct 
binding requiring Hfq and a rough model is proposed in Fig. 2.15.  
 
Hfq, which is normally associated with the bacterial RNA degradosome 
(Viegas et al., 2007), might not be just acting as an sRNA chaperone protein 
in LEE4 expression repression. It is potentially involved in LEE4 transcript 
turnover as well. As suggested by previous research, two main factors of the 
RNA degradosome, PnPase and RNaseE were both critical for T3SS-
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enhancing activity in Yersinia (Rosenzweig et al., 2007, Rosenzweig and 
Schesser, 2007, Yang et al., 2008) and it was proposed that the cleavage of 
LEE4 transcript is regulated by RNaseE as well (Lodato and Kaper, 2009). 
So RNA degradosome components probably coordinate LEE4 expression 
with sRNA regulators. Current ongoing work in the laboratory is mapping 
all nucleic acid sequences interacting with Hfq/CsrA to further understand 
LEE4 expression regulation.   
Fig.2.15. A simple model was proposed to elucidate the regulation of LEE4 
heterogeneous expression. LEE4 translation is activated when CsrA binds to the 
LEE4 transcript and/or inhibits Hfq-mediated CsrB sequestration via CsrA/CsrB 
binding (‘ON’). The large LEE4 (sepL-espADB) mRNA is cleaved by RNaseE after 
SepL is translated and then EspADB translation is initiated. LEE4 expression is 
repressed when CsrB binds to LEE4 transcript with its chaperone Hfq (‘OFF’). The 













Studies to investigate the function of SepL: 
including interactions between SepL/SepD 





3.1 Introduction  
T3SS is required for the formation of typical attaching and effacing lesions 
following EHEC, EPEC and CR infection of eukaryotic cells. This 
phenotype is mainly associated with bacterial attachment and pedestal 
formation on epithelial cells. It requires that the EspBD translocon proteins 
form a pore in the host cell membrane and open up an EspA conduit between 
the bacterium and host cell. After that, the translocated intimin receptor (Tir) 
is delivered into the enterocyte (Kenny et al., 1997a, Deibel et al., 1998) by 
the T3SS and Tir, together with other effector proteins, co-ordinates 
rearrangements of the cytoskeleton. The whole infection procedure includes 
1. T3SS activation, i.e. expression of the T3SS; 2. EspA filament 
assembly/elongation that requires translocon export and assembly on the 
bacterial surface; 3. EspDB pore formation that opens up a T3SS conduit; 4. 
A switch from translocon protein to effector protein secretion, potentially 
following detection of a signal indicating that a conduit has been opened. 
The T3S system is evident as a needle-like projection on the surface of the 
bacterium (Tamano et al., 2000, Sekiya et al., 2001, Daniell et al., 2001). Its 
proposed model has the basal apparatus proteins: EscD (Pas), R, S, T, U and 
V in the inner membrane and an outer membrane ring of EscC (Sekiya et al., 
2001, Ogino et al., 2006).  EscF may form a needle-like structure at the base 
of the EspA filament (Daniell et al., 2001, Yip et al., 2005b, Ogino et al., 
2006). The export of Tir and other effector proteins occurs through the 
hollow filament, with the timing and regulation of translocation potentially 
driven by chaperone proteins (Wainwright and Kaper, 1998, Elliott et al., 
1999a, Neves et al., 2003a). Therefore, translocation of effector proteins into 
the host cell relies on the expression and assembly of EspADB. The LEE 
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pathogenicity island contains at least 41 genes in five main operons and all 
the T3SS structural proteins are encoded by genes on the LEE. The espADB 
genes are included within the LEE4 operon adjacent to the first gene of this 
operon, sepL. sepL encodes a protein composed of 351 amino acids (aa) with 
a predicted molecular weight of 39.95 kDa (Kresse et al., 2000). Like many 
genes in the LEE it is highly conserved between EHEC and 
enteropathogenic Escherichia coli (EPEC) strains (93.7–94.3% identity). 
Original research in EHEC (Kresse et al., 2000) indicated that SepL was a 
T3S regulator associated with the bacterial membrane and predominately 
detected in the outer membrane fraction. Further research indicated that 
EPEC SepL is either in the cytoplasm (O'Connell et al., 2004) or in both the 
cytoplasm and the bacterial membrane (Deng et al., 2005). As shown by 
several studies, SepL is crucial for the export of EspADB but also essential 
for controlling T3S effector secretion (Kresse et al., 2000, O'Connell et al., 
2004, Deng et al., 2004, Deng et al., 2005). How SepL works to govern this 
switch is not known. Recent research by Deng et al., (2004) revealed that 
another protein, SepD, might be part of this SepL switch as well. It has been 
demonstrated by several research groups that deleting sepD results in a 
similar phenotype to knocking out sepL (Deng et al., 2004). It was shown 
that SepD is a binding partner of SepL with protein interactions investigated 
using both yeast two-hybrid and standard in vitro approaches (Creasey et al., 
2003b, O'Connell et al., 2004). Deletion of either sepL or sepD leads to an 
increase in the levels of secreted Tir and other effector proteins and this 
increased effector protein secretion is not considered to be controlled at the 
transcriptional level (Deng et al., 2004, Deng et al., 2005). However, it is 
unclear how SepL/SepD controls effector secretion although a recent report 
showed that wild type EHEC/EPEC/CR can also display a sepL or sepD-
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like phenotype when cultured under conditions of low calcium (Deng et al., 
2005). Therefore, SepL and SepD were proposed to act as a gate to allow 
translocator export and this gate dissociates or changes to allow effectors to 
be exported in response to a drop in calcium levels following the opening of 
a conduit to the host cell (Deng et al., 2005). However, there is no evidence 
that SepL or SepD interacts directly with the translocon proteins EspA, D or 
B.  It was suggested in the original SepL study that SepL had DNA and/or 
RNA binding capacities as a putative nucleotide-binding domain was 
detected in the SepL protein sequence (Kresse et al., 2000). However, no 
binding was detected between SepL and the espADB sequence (Kresse et al., 
2000).  
 
As a YopN/TyeA family protein, SepL homologues are present in many 
T3SS pathogens (SsaL in Salmonella; YopN/TyeA in Yersinia; MxiC in 
Shigella; HrpJ in Erwinia and PopN in Psudomonas) and all of them have 
been shown to be important for T3 secretion control, although the 
phenotypes and controlling mechanisms were varied (Ferracci et al., 2005, 
Coombes et al., 2004, Botteaux et al., 2009, Nissinen et al., 2007, Yang et al., 
2007). As TyeA controls the secretion of specific effector proteins in Yersinia 
spp. (Cheng and Schneewind, 2000b, Day et al., 2003, Sundberg and 
Forsberg, 2003). it was decided to investigate full-length and carboxy-
terminal truncates (TyeA homologue) of SepL in terms of the known 
activities of SepL including localization, SepD binding, translocon export 
and Tir secretion control.  
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3.2 Results 
SepL is homologous to a combination of YopN and TyeA from Yersinia spp. 
(Pallen et al., 2005a) (Fig. 3.1A). The carboxy terminus of SepL (final 83 aa) 
is homologous with TyeA and so carboxy-terminal truncates of SepL fused 
to GFP were tested to determine if these deletions can separate the different 
functions of SepL. The functions analysed were the capacity to: (i) localize 
to the bacterial membrane, (ii) bind to SepD, (iii) restore EspD secretion in 
sepL mutants and (iv) reduce Tir secretion in sepL mutants. Five truncated 
proteins were initially constructed as illustrated in Fig. 3.1A.  
 
3.2.1 Localisation of SepL 
Previous research has demonstrated that SepL in EHEC O157 can be 
detected in both membrane and cytoplasmic fractions but is not secreted into 
growth media. It was also found SepL has a binding partner-SepD which in a 
sepD deletion strain results in a sepL like hypersecretion phenotype 
(Kresse et al., 2000, O'Connell et al., 2004, Creasey et al., 2003b). The 
truncated fusion constructs (Fig. 3.1A) were examined for their presence in 
bacterial membrane-containing fractions. The full-length SepL–GFP 
construct was detected in a membrane-enriched fraction of bacteria prepared 
from T3S-permissive conditions while this was not the case for GFP alone, 
which was only detectable in the cytoplasmic fraction (Fig. 3.1B). Two other 
SepL fusions (N-terminal 340 aa and 290 aa SepL proteins fused to GFP) 
were detected in the membrane-enriched fractions, although this distribution 
was prevented by any further truncation of SepL with smaller fusions only 
being detectable in the cytoplasmic fraction. Membrane protein-OmpA and 
cytoplasmic protein-GroEL were used as controls in this study. The 
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Fig. 3.1. Analysis of SepL–GFP localization. 
A. Figure of the SepL truncates fused to GFP that were used in the study. The full-
length, 340 aa, 290 aa and 267 aa SepL regions were also generated as carboxy-
terminal 6x His-tagged constructs. 
B. Membrane localization of SepL truncates fused to GFP. Western blotting was used to 
detect GFP as described in Materials and Methods. Integrity of the fractions was 
confirmed with anti-GroEL and anti-OmpA antibodies. 
C. Fluorescence and phase contrast image overlays demonstrating localization of GFP 
and SepL–GFP in a single bacterium. Fluorescence levels were measured along a 
transect drawn through individual cells. The examples shown demonstrate the peripheral 







distributions of OmpA and GroEL in the same samples were as expected 
(OmpA > 90% in the membrane-enriched fraction; GroEL > 99% in the 
cytoplasmic fraction) (Fig. 3.1B). SepL-GFP was also observed by 
fluorescence microscopy and imaging of individual bacteria containing the 
full-length SepL–GFP clearly showed a higher concentration of fluorescence 
localized to the periphery of the bacteria (Fig. 3.1C). This was not the case 
for bacteria expressing just GFP (Fig. 3.1C). The Western blots and single 
cell images both indicated that SepL localizes to the bacterial membrane and 
this association does not require the carboxy-terminal 61 aa of SepL.  
 
As reported before, SepD is a binding partner of SepL.  A logical question 
was what effect would sepD deletion have on the localization of SepL. sepD 
was deleted by allelic exchange and the construct confirmed by 
complementation with sepD on a plasmid (pDW20) (Fig. 3.2). Localization 
of SepL–GFP was detected using a combination of protein immunoblotting 
and fluorescence microscopy (Figs 3.3A and B and 3.1C). In the membrane-
containing fraction, the proportion of the full-length SepL–GFP hybrid 
protein was much reduced in a sepD background (Fig. 3.3A). In addition, in 
this background, the localization of SepL–GFP was clearly different in the 
bacteria. The distribution now appeared asymmetric (Fig. 3.3B), unlike the 
even distribution of GFP alone, indicating that in the absence of SepD, SepL 
may associate with another cellular protein that exhibits this asymmetric 
distribution. The different length SepL-GFP fusions were then examined for 
their capacity to bind to purified GST–SepD attached to a glutathione-
sepharose 4B column. 
Full-length SepL as well as the 340 aa and 290 aa fusions bound to SepD but 
SepD interaction with further truncation from the carboxy terminus was not 
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detected (Fig. 3.4).  The data indicates that the SepL truncates that localized 
to the membrane are the same as those that bound to SepD. Given that 
deletion of sepD also reduced membrane association of SepL and altered its 
cellular distribution, it is evident that SepD is responsible for membrane 




Fig. 3.3. SepL–GFP localization in different EHEC O157 genetic backgrounds. 
A. Western blot detection of GFP in membrane and cytoplasmic fractions of the 
described EHEC O157 strains expressing SepL–GFP (pDW6). Western blotting was 
carried out as described in Materials and Methods. 
B. Localization of SepL–eGFP in a sepD mutant. Fluorescence intensities across a 
representative bacterium expressing the SepL–GFP fusion are shown. The 
asymmetric distribution of the SepL–GFP fusion in a sepD mutant background 
(ZAP1144) is apparent when compared with the distribution in the wild-type 
background (Fig. 3.1C). 
Fig. 3.2.Secretion profiles of EHEC wild type 
strain, sepL, sepD and sepD complimented 
with a SepD plasmid (pDW20). The secretion of 
proteins into the bacterial culture supernatant 
was prepared as described in M&M. Protein 
samples were separated by SDS-PAGE and 





3.2.2 Co-localization of SepL and EspA filaments 
The surface production of EspA filaments has been previously investigated 
by our research group. From the results it was evident that only a subset 
bacterial cells had EspA filaments on their surface (Roe et al., 2003b).  It 
was therefore interesting that when bacteria containing the full length SepL-
GFP fusion were examined by fluorescence microscopy, GFP expression was 
only observed in a subset of bacteria when cultured under the T3S 
stimulating conditions used. Co-staining of EspA filaments with SepL-GFP 
expression showed that there was a positive correlation between SepL-GFP 
expression and EspA production (Chapter 2: Fig. 2.2). From the fluorescent 
image, only the bacterial cell with highly expressed SepL-GFP could 
produce EspA filaments on the surface. This result also supports that SepL 
protein is crucial for translocon proteins export. 
 
Although it was very interesting why SepL-GFP expression can only be 
observed in certain cells which produced EspA filaments, I was investigating 
where SepL was located inside bacterial cells. It was reported that SepL 
Fig. 3.4. Capacity of SepL truncates to bind to SepD. Each of the SepL–GFP 
constructs was tested for the capacity to bind to immobilized GST–SepD. Following 
elution, the SepL–GFP truncates were detected by Western blotting as described in 
Materials and Methods. 
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Fig. 3.5. Localisation of SepL-GFP in EHEC O157 and association with EspA filaments.   
(A-B) Images of SepL-GFP fluorescence and EspA filament expression (detected following 
immuno-staining) overlaid onto the relevant phase contrast image. EspA filamentation was 
localised by Alexa Fluor 594 emission (617 nm) from the secondary antibody (Invitrogen) 
following immuno-staining.  Best fit ellipses were drawn around the bacterial cells that 
dissected the main fluorescence foci and levels were determined along this line in the 
direction of the arrows starting from the white line indicated. This process was repeated for 
smaller best fit ellipses that dissected the main GFP fluorescent foci (510nm).  The 
fluorescence emission values were plotted over the length of the ellipses between 0 (start) 
and 1 (end) and the main fluorescence foci were indicated by arrows (Green: SepL-GFP; 
Red: EspA). The graphs demonstrate an association between the position of EspA filaments 
and membrane-associated foci of SepL-GFP fluorescence with each of the apparent EspA 
filaments registering with a SepL-GFP focal point to within 100 nm. (C-E) Fluorescent foci 
were more evident when EHEC O157 expressing the SepL-GFP (pDW6) was co-incubated 
with EBL (embryonic bovine lung) cells. (C) Foci, indicated by the arrows, were apparent 2 hr 
following infection and were more marked at 4 hr (D).  At six hours larger foci were detected 
at the poles of the bacteria (E). (F-K) The corresponding localization of EspA (Red) and 
SepL-GFP (Green) is also very clear in EHEC when bacteria were incubated with EBL cells. 
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protein of EPEC only existed in the bacterial cytoplasm by O'Connell et al. 
2004, while other groups suggested that SepL protein was not only present in 
the bacterial cytoplasm but also associated with the bacterial membrane. In 
order to investigate these contradictory results for SepL localization, both 
biochemical methods and fluorescence microscopy were employed to 
localize SepL protein in EHEC O157:H7.  As shown above, it is clear that 
SepL is not only detected in the bacterial cytoplasm but also in membrane-
containing fractions. Further examination of individual cells revealed 
fluorescence foci at the periphery of the bacterium.  Immuno-fluorescence 
staining of EspA filaments indicated that the position of SepL-GFP foci 
corresponded with the position of extracellular EspA filaments.  To confirm 
this, GFP (SepL) and Alexifluor 594 (immuno-staining of EspA) 
fluorescence levels around bacterial cells was determined.  Example plots 
are shown in Fig. 3.5A-B.  This type of analysis indicates that SepL-GFP is 
present at higher concentrations inside the cell at sites engaged in EspA 
secretion, presumably representing the membrane spanning type 3 secretion 
apparatus.  As expected, precise co-localization was not observed as EspA 
filaments are a surface structure and SepL is a membrane-associated protein 
only detectable inside the bacterial cell. In order to examine the localisation 
of SepL-GFP during A/E lesion formation on eukaryotic cells, fluorescence 
microscopy was carried out on bacterial cells expressing the SepL-GFP 
following addition to embryonic bovine lung (EBL) cells (Fig. 3.5 C-K).  At 
two hours following infection, SepL-GFP expression was detected and weak 
foci imaged (Fig. 3.5C), these foci are clearly distributed around the edge of 
the bacteria at four hours following infection (Fig. 3.5D). After six hours, 
some of the fluorescent foci become distributed to the bacterial poles (Fig. 
3.5E).   
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Fig. 3.6. Co-localization of SepL, SepD and EspA
Localisation of SepD-RFP in EHEC O157 and association with EspA filaments (A & B). 
Overlay images of SepD-RFP (583 nm emission peak, coloured red) and immuno-
stained EspA filaments (FITC-conjugated secondary antibody, 518 nm emission peak, 
coloured green) on a phase contrast background.  The two fluorescence signals were 
measured along best fit ellipses hand drawn around and within individual bacterial 
cells as described for Fig. 3.5 and the main fluorescence foci on the plots were 
indicated by arrows (Green: EspA; Red: SepD-RFP) . The graphs demonstrate that 
the position of EspA filaments register with the SepD-RFP foci to within 100 nm. (C) 
Co-localization of SepL-GFP (green), SepD-RFP (Red) and EspA (Blue) was 
visualized as described in Chapter 5. Although the overlap of SepL/SepD is obvious 
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3.2.3 Localisation of SepD and association with SepL 
Previous work has demonstrated an in vitro interaction between SepL and 
SepD and our localisation studies above demonstrate that SepD is required 
for SepL localisation and expression.  To characterise this interaction further 
in the individual bacteria a fusion of SepD to red fluorescent protein (RFP: 
Sorensen et al., 2003) was constructed.  The localisation of this fusion was 
determined in bacteria immuno-stained for EspA filaments.  SepD-RFP 
localised to internal foci corresponding to the external position of EspA 
filaments (Fig. 3.6A-B). Compared with SepL the majority of the fusion 
protein was present in foci rather than distributed generally in the bacterial 
membrane.  Localisation of SepL, SepD and EspA filaments in single cells 
was attempted by integrating a single copy of the SepL-GFP fusion into the 
bacterial chromosome and use of the SepD-RFP construct with Alexa-fluor 
405 blue immuno-staining of EspA filaments. As expected, there was a close 
association exhibited among SepL-GFP, SepD-RFP and EspA filament 
location (Fig. 3.6C). Due to different vision angles, co-localization of SepL-
GFP/SepD-RFP was presented as mixed proteins (Fig. 3.6C2) or proteins 
located next to each other (Fig. 3.6C1)when imaged under fluorescence 
microscope. Although the overlap of SepL/SepD locations was observed 
clearly (Fig. 3.6C2), it is also noticed that SepD is more likely to be 
membrane associated as suggested by fluorescence images (Fig. 3.6C1-2).  
 
3.2.4 Complementation of translocon (EspD) export in 
a sepL mutant  
Translocon (EspADB) export was stopped in a sepL mutant and it can be 
complemented by supplying sepL in trans (Kresse et al., 2000). In this study, 
full-length SepL was fused to 6x histidine or GFP and both fusions could 
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complement a complete sepL deletion for EspD secretion to a similar extent 
as complementation with untagged SepL (Fig. 3.7A and C). A sepL deletion 
strain, ZAP1143, was used in our study and complementation of this never 
A B 
C D 
Fig. 3.7. Analysis of protein secretion in E. coli O157 (sepL) expressing different 
SepL truncates. 
A. The first two panels show EspD levels in the supernatant (SN) and whole-cell 
fractions (WC) when the different SepL–GFP constructs were used to complement a 
sepL mutant (ZAP1143). B. The panel shows detection of secreted Tir by Western 
blotting from the samples labeled in (A). C. Analysis of bacterial supernatants from a 
sepL mutant complemented with the His-tagged SepL constructs described in the 
Fig. 2.1 and the text. The wild-type (ZAP193) supernatant profile is also shown for 
comparison. These experiments confirm the results obtained with the SepL–GFP 
constructs in (A) and (B) and demonstrate that the carboxy-terminal 11 aa of SepL 
are required to limit the secretion of effector proteins in addition to Tir. D. Colloidal 
blue staining of secreted proteins from E. coli O157 engineered to contain a 
frameshift mutation in sepL (ZAP1211) and then complemented with full-length 
SepL (pDW48) and the C-terminal 11 aa deletion of SepL (pDW47). Western 
blotting for EspD and Tir for these strains is also shown. Preparation of protein 
samples and detection of Tir and EspD by Western blotting were as described in 
Materials and Methods. 
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achieved the EspD secretion levels of the wild-type strain and this was also 
the case for complementation with sepL alone, pDW24 (Fig. 3.7 A, C and D). 
Analysis of the SepL truncates in the sepL deletion strain indicated that only 
the full length protein and the 11 aa carboxy-terminal deletion (-11) were 
able to export EspD. Deletion of 11 aa from SepL partially complemented 
the sepL deletion for EspD secretion (Fig. 3.7A). It was interesting to note 
that a deletion of 61 aa (leaving a 290 aa SepL derivative) failed to export 
EspD despite membrane localization and SepD binding activity. It is 
suggested that the failure to completely complement a full sepL deletion is 
due to changes in the LEE4 transcript as discussed in chapter 2. To verify the 
phenotypes of the SepL truncates in a sepL-mutated background, a 
frameshift mutation was constructed in sepL (ZAP1211) that will have less 
impact on the structure of the LEE4 transcript by inserting a single base into 
the sepL ORF. In this background, EspD secretion could be complemented 
completely by sepL in trans (Fig. 3.7D). The 11 aa carboxy-terminal deletion 
in this background was still able to secrete EspD protein into liquid culture 
media but at reduced levels compared with the full-length complement (Fig. 
3.7D). 
 
3.2.5 Regulation of effector protein secretion 
A sepL mutant is characterized by high levels of Tir secretion (Kresse et al., 
2000)(Fig. 3.7B) and of other effector proteins including NleA (Deng et al., 
2004). To investigate the function of the different SepL truncates, the levels 
of Tir secreted were determined by Western blotting in the sepL mutants 
transformed with the different SepL fusions. Of note was that only the full-
length SepL construct was able to lower Tir secretion levels to those 
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demonstrated for the wild-type strain (Fig. 3.7B). To confirm this result and 
to rule out any impact of GFP on the phenotypes, four similar SepL truncates 
(His-tagged) were made and also tested. These were: (i) full-length SepL, (ii) 
a protein with the first 340 aa of SepL but deleted for the carboxy-terminal 
11 aa, (iii) the first 290 aa of SepL but deleted for the carboxy-terminal 61 aa 
and (iv) the first 267 aa of SepL but deleted for the carboxy-terminal 84 aa. 
These variants had exactly the same phenotypes as the respective GFP 
fusions in the sepL deletion background. For example, analysis of the 
general secretion profiles indicated that the 11 aa carboxy-terminal SepL 
truncate failed to control secretion of Tir, whereas complementation with 
full-length SepL could (Fig. 3.7B-C). Moreover, it was apparent that this 
regulation also applied to other T3S effectors with sizes equivalent to those 
of NleA and EspZ as shown by SDS-PAGE (Fig. 3.7C). This result was also 
confirmed in the sepL frameshift mutant (ZAP1211) background (Fig. 3.7D). 
 
3.2.6 Tir binds to the carboxy terminus of SepL 
As effector protein secretion is limited by full length SepL in EHEC O157 
strain, an assay was carried out to examine the direct interaction between 
SepL and effector proteins. The over-secreted effector proteins from a sepL 
mutant were separated by SDS-PAGE and Far-Western immunoblotting 
carried out to examine their interaction with 6x His-tagged SepL. As shown 
in the blot (Fig 3.8A), SepL only interacted clearly with one protein in the 
bacterial supernatant and this protein was of a molecular weight equivalent 
to Tir. This interaction was confirmed using a GST pull down experiment. 
Immobilized GST–SepL was incubated with 6x His-tagged Tir and Tir-His 
was found to be eluted with GST-SepL (Fig. 3.8B). As a control, His-tagged 
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Fig. 3.8. SepL binds to Tir. A. Detection of supernatant proteins that bind to SepL. 
Supernatant proteins from a sepL mutant (ZAP1143) were separated by SDS-PAGE, 
transferred to a nitrocellulose membrane and then incubated with SepL-His (+) 
prepared from E. coli BL21. As a control (-), the incubation with SepL-His was omitted. 
The Far-Western was developed following incubation with an anti-penta-His antibody 
as described in Materials and Methods. B. Detection of Tir binding by immobilized 
SepL. His-tagged Tir was prepared in E. coli BL21 and incubated with immobilized 
GST–SepL, GST–CesT and GST alone. Following elution, Tir-His was detected by 
Western blotting. C. NleA was expressed either with a C-terminus 6 x histidine tag or 
an N terminus 6 x histidine tag. Both were expressed and detectable in E. coli BL21 
lysates (first two lanes). The lysates were run through columns containing immobilised 
GST or GST-SepL. The columns were then washed three times with PBS and then 
eluted with GST elution buffer. The fusion proteins were detected as described in 
Materials and Methods. There was no evidence of an interaction between SepL and 
NleA in contrast to the binding of Tir by SepL (B). 
D. The C-terminus of SepL is required for Tir binding. 6x His-tagged Tir was purified 
on nickel-NTA columns and E. coli K-12 (AAEC185) lysates, containing the different 
indicated truncates of SepL fused to GFP, were run through the columns. Following 
washes, proteins were eluted and separated by PAGE. SepL constructs were then 
detected by Western blotting using an anti-GFP antibody. E. The carboxy terminus of 
SepL is sufficient to bind to Tir. The C-terminal 48 aa of SepL was fused to GST and 
immobilized onto a column. 6x His-tagged Tir bound to the 48 aa C-terminal SepL 






Tir bound to GST–CesT (+ve control) and GST–SepL but not to GST (-ve 
control) alone.  As the -11 SepL truncate failed to limit Tir secretion, it was 
anticipated that the SepL interaction with Tir requires the final 11aa carboxy 
terminus of SepL. This was confirmed as 6xHis-tagged Tir was shown to 
bind to full-length SepL–GFP but not to any of the SepL truncates (Fig. 
3.8C). Therefore, the next question was if the carboxy terminus of SepL 
alone could interact with Tir. A comparative domain analysis with 
YopN/TyeA (Fig. 3.12) was carried out to select a region of SepL for testing 
its capacity of Tir binding.  The carboxyl-terminus (48aa) was fused to GST 
and immobilized on a Glutathione-Sepharose 4B column. Tir-His was able 
to bind to this hybrid protein but not to GST alone (Fig. 3.8E). The Far-
Western analysis indicated that Tir was the only protein detected interacting 
with SepL from the different over-secreted effector proteins. However, this 
may be a result of misfolded effector proteins which do not expose an 
interaction domain after being transferred onto the nitrocellulose membrane. 
To determine if SepL could interact with another secreted effector protein, 
NleA was tagged with either an amino- or carboxy-terminal 6x histidine and 
used to examine a possible interaction. Neither fusion was found to bind to 
SepL using a GST-pull down assay (Fig. 3.8C). Therefore, in this study only 
Tir is pulled out as a SepL binding target among all the hypersecreted 
proteins although SepL could restrict the secretion of other effectors. A Tir 
binding domain was mapped to the carboxyl-end of SepL. The final 48 aa of 
SepL are sufficient to interact with Tir.  
 
3.2.7 Analysis of Tir domains that interact with SepL 
and CesT 
In the cytoplasm, Tir is stabilized by its chaperone-CesT that is also required 
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for efficient secretion of Tir via a functional T3SS (Abe et al., 1999, Elliott 
et al., 1999a). It is known that CesT is also an essential chaperone for the 
secretion of many other hyper-secreted effector proteins (Thomas et al., 
2005). Tir secretion may be limited via SepL binding to Tir but as a multi-
function chaperone, the role of CesT in this interaction is unknown. To 
determine SepL and CesT binding domains in Tir, different Tir truncates 
were labeled by 6x histidine and binding capacities to immobilized GST–
SepL, GST–CesT and GST alone were tested (Fig. 3.9). It has been reported 
that CesT was able to bind to the first 233 aa of Tir (Abe et al., 1999, Elliott 
et al., 1999a). My results demonstrated that not only did the N-terminal 200 
aa of Tir bind to CesT but another CesT binding domain was mapped in the 
carboxyl-terminus of Tir (Fig. 3.9). As suggested by the results described 
Fig. 3.9. SepL and CesT binding domains of Tir.  
Different 6x His-tagged truncates of Tir were incubated with immobilized GST–CesT, 
GST–SepL and GST alone. Following elution, 6x His-tagged Tir constructs were 
detected as described in Materials and Methods. 100aaTir-His and 200aaTir-His are 
His-tagged constructs containing the first 100 and 200 aa of Tir respectively. The first 
200 aa of Tir is known to contain a CesT binding region (Abe et al., 1999; Elliott et al., 
1999). -200aaTir-His and -382aaTir-His are His-tagged constructs containing Tir 
without the first 200 and 382 aa respectively. 
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above, deletion of the first 200 and 382 aa of Tir still produced a polypeptide 
that could bind to CesT. By contrast, the first 200 aa of Tir did not interact 
with SepL but the remainder of the protein did bind to SepL as did the 382 
amino-terminal truncate. The data indicate that there are at least two regions 
in Tir that can interact with CesT and that one of these might compete with 
SepL–Tir binding. Further mapping of these interactions would be required 
to confirm this. 
  
3.2.8 The interaction of Tir with SepL controls the 
timing of secretion 
As an 11 aa deletion of SepL retains the capacity to export translocon 
proteins but is unable to limit effector protein secretion, it raised the 
possibility that effector protein export was now occurring at the same time as 
translocon export as the capacity of SepL to bind Tir potentially sequesters 
Tir export and somehow limits the secretion of other effector proteins during 
translocon assembly. To test this, the timing of EspD and Tir secretion was 
analyzed in the wild-type strain and a sepL mutant complemented with either 
full-length sepL or the 11 aa carboxy-terminal deletion (-11). T3S activation 
in different EHEC strains was synchronized using a medium shift for which 
bacteria were cultured initially in a medium (LB) that is not permissive for 
T3S and then transferred to a medium (MEM-Hepes) that induces T3S. 
Following the transition, samples were taken at regular intervals and the 
levels of secreted Tir and EspD determined as described in Materials and 
Methods. For the full-length SepL complement in the sepL deletion, EspD 
secretion was detectable but not Tir at early time points (Fig. 3.10A). This 
pattern was similar in the wild-type strain (Fig. 3.10A) By contrast, in the 
sepL mutant complemented with the C-terminal 11 aa deletion of SepL, Tir 
 116
secretion was detectable along with EspD secretion at early time points (Fig. 
3.10A) following the induction of T3S. While it is appreciated that Tir 
secretion levels are higher in the truncate-complemented background it is 
clear from analysis of the EspD/Tir secretion ratios (Fig. 3.10B) that Tir 
secretion is no longer delayed in the sepL mutant complemented with the 11 
aa truncate by comparison with full-length sepL complementation or the 
wild type. Consequently, secretion hierarchy is disrupted when the capacity 
of SepL to bind Tir is removed. 
Fig. 3.10. Secretion timing is altered by deletion of the carboxy terminus of SepL. 
A. E. coli O157:H7 (ZAP193) (top panel) and the sepL deletion (ZAP1143) (second 
panel) complemented by either full-length SepL (pDW6) or SepL with a deletion of 
the final 11 aa (pDW30) were cultured in LB that represses T3S and then 
transferred into MEM-HEPES that induces T3S. 
B. Samples were taken at defined optical densities and the levels of secreted EspD 
and Tir determined as described in Materials and Methods. The cultures were 
repeated in triplicate and the blots shown represent the secretion patterns from one 
set from which the ratio of secreted Tir to EspD is also shown. Wild type, ZAP193 
(▲); sepL, ZAP1143 complemented with full-length SepL ( ), or with the C-





3.2.9 Tir and SepL interact with EscD 
As Tir export is restricted by SepL binding there needs to be a mechanism to 
release Tir from SepL once translocon assembly is completed. Previous 
research has demonstrated that a component of the T3S basal apparatus, 
EscD (Pas), is able to bind to Tir (Kresse et al., 1998) and when escD is 
expressed from a plasmid Tir is secreted at higher levels (Ogino et al., 2006).  
However, no mechanism was proposed for this regulation.  I hypothesised 
Fig. 3.11. SepL binds to EscD 
A. 6 x Histidine-tagged EscD was pulled down by GST-SepL (left hand side) and 6 x 
Histidine-tagged SepL was pulled down by GST-EscD (right hand side); B. The C-
terminus of SepL is required for EscD binding. GST-tagged EscD was purified on 
Glutathione Sepharose 4B columns and E. coli K-12 (AAEC185) lysates, containing 
the different indicated truncates of SepL fused to GFP, were run through the 
columns. Following washes, proteins were eluted and separated by PAGE. SepL 
constructs were then detected by Western blotting using an anti-GFP antibody. C. 
Competitive interactions between SepL, EscD and Tir. GST-SepL was bound to G-
Sepharose 4B beads, and then incubated with a lysate containing 6x Histidine-
tagged Tir. Following washes with PBS, 6x Histidine-tagged Tir was eluted with 
GST-SepL. The amount of SepL bound to Tir was reduced when EscD was added 




that if SepL was also able to bind to EscD and if this required the same SepL 
domain as for Tir binding then the over-expression of EscD could release Tir 
sequestered by SepL leading to elevated levels of secreted Tir.  To test this 
interaction GST-SepL was constructed and retained on a glutathione column 
and shown to bind to 6 x Histidine-tagged EscD (Fig. 3.11A). This was 
confirmed using reciprocally-labelled EscD and SepL (Fig. 3.11A).  
Moreover, only the full length SepL-GFP construct bound to GST-EscD (Fig. 
3.11B).  This demonstrated that full length SepL does bind to EscD and this 
interaction, as with the interaction with Tir, requires the carboxy terminal 11 
amino acids of SepL.  Competitive binding between the three proteins was 
then demonstrated, for example with EscD being able to inhibit the Tir-SepL 
interaction (Fig. 3.11C). A function of this interaction could be to release Tir 
from SepL following translocon assembly.  
 
3.3 Discussion 
SepL and SepD are known as important switches governing the T3S 
hierarchy in EHEC/EPEC/CR. From the current study, I propose that SepL 
switches T3S between the translocon and effector protein substrates by 
binding to Tir and through this sequestration prevent the secretion of Tir and 
other effector proteins while the translocon components are being exported 
and assembled. This activity requires the carboxy terminus of SepL and can 
be separated from other SepL phenotypes, including its membrane 
localization, SepD binding and translocon export.  
 
The C-terminus of SepL shares some homology with TyeA and the N-
terminus of SepL some homology with YopN, both from Yersinia spp. 
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Fig. 3.12. Protein sequence and predicted structural comparisons between SepL and 
YopN / TyeA. 
A. Amino acid alignment of SepL (gb|AAG58821) with YopN (gb|AAS58563) and TyeA 
(gb|AAS58564) of Yersinia pestis. Align X software (Invitrogen) was used to align the 
first 268 aa of SepL with YopN (294 aa) and the remaining 84 aa of SepL with TyeA 
(93 aa). Identical aa are shown by red text on a yellow background; blocks of similar 
amino acids are highlighted in green. (Red bars represent regions with helix structure 
and black bars represent regions with strand structure) 
B. Structure of the YopN76-293–TyeA complex overlaid with SepL (red). YopN and 
TyeA are depicted in green and cyan respectively. The alignment and mapping was 
performed using Swissmodel using the 1XL3 file from Schubot et al. (2005) as a 
model. PyMol (http://pymol.sourceforge.net/) was used to generate the figure. (Image 




(Pallen et al., 2005a)(Fig. 3.12). TyeA is involved in the export control of 
specific effector proteins so it was logical to investigate C-terminus deletions 
of SepL to see if these can separate the known activities of SepL and this did 
prove to be the case. Membrane localization was studied by both imaging 
and biochemical analysis of SepL–GFP fusions. While some cleavage of 
GFP was detected from these heterologous proteins it was evident that only 
the full-length SepL and SepL constructs with deletions of either 11 aa or 61 
aa from the C-terminus were able to localize to membrane containing 
fractions. The same three SepL constructs were also able to interact with 
SepD in vitro. Also, the level of SepL–GFP membrane localization was 
reduced in a sepD mutant and deletion of sepD resulted in an asymmetric 
distribution of SepL-GFP in the bacterial cell. SepD is expressed from LEE2 
along with other T3S proteins. The LEE2 operon encodes several T3S basal 
apparatus proteins (EscC, EscJ, EscI), an effector protein (SepZ/EspZ) and a 
chaperone protein (CesD) besides SepD. sepD ORF is located between escC 
and escJ which both encode T3S basal protein. It is likely that the SepD is 
part of T3 basal structure and SepL/SepD binding is responsible for the 
membrane localization of SepL, possibly to the T3S apparatus, although 
further investigation is required to verify this. This work confirms previous 
research that indicated that SepL can be membrane-associated (Kresse et al., 
2000, Deng et al., 2005), although it was reported for EPEC that SepL is 
only present in the cytoplasm (O'Connell et al., 2004). O’Connell et al. also 
concluded that effector proteins were not hyper-secreted in a sepL mutant, 
although this does not agree with this study and other published research 
(Kresse et al., 2000, Deng et al., 2005, Deng et al., 2004). In our work, the 
SepL–GFP fusion is present in the cytoplasm as well being localized at the 
bacterial membrane. The work reveals that SepL is unlikely to be a 
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membrane-inserted protein but is probably associated with the membrane via 
interaction with SepD and this localization would require the 
activation/maturation of the T3SS in EHEC. It is supported by the 
observation that the ratio of membrane localised SepL-GFP in the different 
genetic backgrounds were variable (Fig 3.3A). In a sepD deletion 
background, much less SepL-GFP was detected in the membrane fraction 
which suggested the importance of SepD in SepL localization. Ler is an 
activator of EHEC T3SS which initiates the expression of T3 basal apparatus 
proteins. Also, in my study, impaired SepL-GFP membrane localization was 
observed in a ler knockout strain. It implied that the expression or 
maturation of T3 basal proteins is essential for SepL membrane localization. 
Possibly a T3 basal apparatus related platform or binding site is required for 
SepL localization.  
 
Translocon protein export was stopped by deleting the 61 aa C-terminus of 
SepL, even though this SepL truncate still binds SepD and localizes to the 
membrane as does full length SepL. As demonstrated in my study, only the 
full-length SepL protein was able to restore normal levels of EspADB 
translocator and effector protein secretion in a sepL mutant. However, the 11 
aa deletion of SepL still functioned to some extent to export translocon 
proteins but had lost effector protein secretion control. Therefore the 
possible interaction of any of these hyper-secreted proteins with SepL was 
investigated. Tir was shown to interact with SepL and this interaction 
required the carboxy-terminal 11 aa of SepL which implied the final 11 aa of 
SepL were essential for controlling effector protein secretion by directly 
interacting with Tir. In addition, when fused to a GST tag, the C-terminal 48 
aa of SepL was capable of forming a molecule which bound Tir (Fig. 3.8E). 
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When the structure of the YopN76-293–TyeA complex (Schubot et al., 2005) 
is overlaid with SepL, it is evident that the final 48 aa of SepL map to the 
final two alpha helices of TyeA and this domain is sufficient to interact with 
Tir. The sequence divergence at the C-terminal 12 aa between TyeA and 
SepL may suggest a difference in protein recognition between the two 
pathogens. It has been reported that TyeA is required for Yersinia outer 
protein (Yop) secretion and YopN polarization to the bacterial membrane. 
However, TyeA is only required for the secretion of some Yops (YopE and 
YopH) but not all of them (Iriarte et al., 1998). As with Yersinia spp., not all 
the effectors were regulated by the SepL/SepD switch module in EHEC. 
While several effector proteins are hypersecreted in a sepL or sepD mutant, 
such as Tir and NleA (Deng et al., 2005), other research has shown that a 
group of effectors (EspF and EspG) are not over-secreted in EHEC by 
deleting sepL or sepD (O'Connell et al., 2004). Therefore, in AE forming 
Escherichia coli, secreted effector proteins might be divided into two groups 
which are: 1.) SepL/SepD regulated (hypersecreted in a sepL or sepD mutant) 
and 2.) not SepL/SepD regulated effectors (secreted normally in a sepL or 
sepD mutant). However, among the SepL/SepD regulated effectors, Tir was 
the only one which was detected to bind SepL directly. There was no 
evidence from our work that any of the other secreted effector proteins could 
interact with SepL directly although they have not all been tested 
individually. The Far-Western analysis only indicated one binding partner, 
Tir. While another effector -NleA is known to be over-secreted as well in a 
sepL mutant, it did not bind to SepL in vitro using similar approaches that 
were successful with Tir. Therefore, it appears likely that the Tir–SepL 
interaction is critical in limiting the secretion of effector proteins in general. 
This finding fits well with recently published research (Thomas et al., 2007) 
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that demonstrated that Tir is required for hyper-secretion of other effector 
proteins in a sepD mutant background.  
 
Our previous work has demonstrated that LEE4 and LEE5 are coordinately 
expressed, indicating that Tir will be produced in individual bacteria while 
the translocon is being assembled (Roe et al., 2004). Therefore, we 
investigated the hypothesis that the binding of Tir by SepL actually 
sequesters it and prevents its early release while the translocon is being 
assembled. The timing of release of Tir and the translocon protein EspD 
were investigated using a shift in culture conditions from a non-permissive 
to a permissive medium for T3S. Under these conditions, Tir secretion was 
demonstrated to be delayed in the wild type and a sepL deletion strain 
complemented by full-length SepL. However, Tir secretion occurred at the 
same time as EspD secretion when sepL was complemented with SepL 
deleted for the C-terminal 11 aa. The data support the proposition that the 
timing of Tir and effector protein secretion is directly controlled by SepL 
binding to Tir.  It also explained the effector hypersecretion phenotype of 
sepL mutants. The altered timing of EHEC T3SS probably results in an 
accumulation of SepL regulated effectors in the culture medium as these can 
be exported over a longer period by each cell. However, as the deletion of 
the C-terminus of SepL will have other effects on SepL function, we cannot 
rule out that another mechanism may be responsible for limiting effector 
protein export.  
 
How Tir binding to SepL could prevent secretion of other effector proteins is 
not understood but it must presumably stall a series of T3S apparatus 
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interactions with effector proteins prior to EscN/ATPase-driven export. 
Another key question is how such a mechanism is then switched from 
translocon substrate export to effector substrate export. It has been suggested 
that opening a conduit to the host cell via the translocon could induce a 
change in local ion concentrations in particular calcium, which may change 
the SepL/SepD complex interaction (Deng et al., 2005). My work has 
indicated that the SepL–Tir interaction could also be a target for the 
alteration of calcium concentration. Alternatively, SepL and/or SepD may 
have limited stability so their activity is only for a defined period. Although 
it has been proposed by Pallen et al., 2005 that SepL, like YopN, may be 
secreted into bacterial supernatant to initiate effector secretion via T3SS 
(Pallen et al., 2005a), no evidence was obtained to support this hypothesis in 
my study using 6x Histidine tagged SepL truncate. I tested whether His-
tagged fusions to SepL or the SepL region homologous to YopN (the first 
267 aa of SepL) are exported into the bacterial supernatant. They were not 
detectable in cultured media though both were expressed inside the bacterial 
cell (unpublished data, Dai Wang and David L. Gally) which agreed with 
other research (Younis et al.). An indication of a potential mechanism to 
release Tir from SepL comes from previous research that has shown a direct 
interaction between Tir and EscD (Pas) (Kresse et al., 1998). EscD, formerly 
known as Pas, is an inner membrane component of the T3 basal apparatus 
which is required for both translocon and effector secretion (Kresse et al., 
1998, Ogino et al., 2006). However, plasmid complementation of escD led to 
high levels of Tir secretion (Ogino et al., 2006), indicating that 
overexpression of EscD results in loss of Tir secretion control. A number of 
domains have been identified in EscD, apart from two transmembrane 
domains, two other conserved domains have been identified potentially 
 125
providing insight into its function in the T3 basal apparatus (Kresse et al., 
1998, Pallen et al., 2005a).  Pallen et al. revealed a putative phospholipid-
binding domain (also known as a BON domain) in the periplasmic part of 
EscD and a forkhead-associated (FHA) domain in its cytoplasmic part 
(Pallen et al., 2005a). The BON domain of EscD was presumed involving in 
membrane binding activity (Pallen et al., 2005a, Yeats and Bateman, 2003). 
The FHA domain was originally discovered in transcription factors and has 
been reported involved in protein-protein interaction and signalling events 
(Hofmann and Bucher, 1995). In bacterial T3SS, this FHA domain of EscD 
might also mediate signaling within bacterium possibly via reversible protein 
phosphorylation of its binding partner (Pallen et al., 2002, Durocher et al., 
2000, Durocher and Jackson, 2002). However, it is still unknown which of 
EscD partner proteins might be involved in 
phosphorylation/dephosphorylation of serine or threonine residues. From my 
work, full length SepL binds directly to EscD (Fig. 3.11) and this binding 
requires the same final 11 aa of SepL that are required for SepL –Tir 
interaction. In fact, the SepL-Tir interaction can be disassociated by adding 
extra EscD in vitro (Fig. 3.11). It is also hinted at in previous research that 
only the cytoplasmic EscD binds to Tir, not EscD in a membrane containing 
fraction. This contradiction implies that EscD is able to bind to Tir, but this 
interaction would be interrupted by another membrane associated protein, 
probably SepL. Therefore, one hypothesis is that native expressed EscD (low 
level) would not bind to Tir until SepL/SepD complex is not membrane 
associated any more or degraded following sensing the outer signals, but 
over-expressed EscD (high level) would be able to interact with Tir by 
competing with SepL/SepD which might result in Tir over-secretion when 
bringing back a plasmid based EscD; Alternatively, there could be two 
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folding patterns of EscD and only the cytoplasmic version can interact with 
Tir but not the membrane one. Environmental signals received by T3SS 
could somehow alter the configuration of membrane localized EscD to a 
cytoplasmic version, allowing it to bind to Tir by competing with SepL. This 
hypothesis is supported by the size difference between cytoplasm and 
membrane localized EscD molecules. The latter mechanism might also be 
applicable to the folding of the SepL–SepD complex which is required to 
permit translocator and effector protein export with different binding 
partners at the C-terminus of SepL.  
 
Another important factor, CesT, was previously shown to be required as a 
chaperone protein for efficient secretion and translocation of Tir. The CesT-
Tir complex is able to interact with the ATPase, EscN, which then energizes 
the export of Tir (Gauthier and Finlay, 2003). CesT is known as a multi-
functional protein which binds many other effector proteins, especially those 
known to be hypersecreted in a sepL mutant (Thomas et al., 2005). As 
shown by different research groups, CesT could bind to Tir and this binding 
is required to stabilize Tir inside of bacterial cells for Tir export (Abe et al., 
1999). Further studies revealed an N-terminal chaperone binding domain in 
Tir (Elliott et al., 1999a). My GST pull down data indicated at least two 
CesT binding domains in Tir including identification of a novel C-terminal 
binding site. However, multiple chaperone binding sites for Tir have been 
suggested by others (Elliott et al., 1999a). It remains possible that a C-
terminal domain is required for Tir secretion while an N-terminal domain is 
necessary for its stability. In the context of the current work, SepL and CesT 
were shown to bind in the same C-terminal half of Tir and our preliminary 
data support a hypothesis of competitive interactions between SepL and 
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CesT for Tir binding. Previous work in our laboratory demonstrated that 
LEE4 (SepL) and LEE5 (Tir) are co-ordinately expressed (Roe et al., 2004). 
cesT is also located on the LEE5 operon as adjacent to tir. Therefore these 
three proteins (SepL, Tir and CesT) would be expressed simultaneously 
when EHEC T3SS is activated. Consequently, Tir stabilized by CesT will be 
present in the cell and ready to be exported while EspA filaments are 
assembled. However, at this time, I propose that Tir secretion is prevented by 
the SepD-SepL ‘filter’ by a Tir-SepL interaction and this interaction becomes 
the stalling point for effector protein secretion. Once Tir export is triggered 
by disassociation of this interaction, other effectors can then be exported but 
these also have to pass through the SepD–SepL ’filter’, perhaps requiring an 
interaction of with CesT and/or effectors with SepD. 
 
Overall, hierarchical secretion of T3 secreted proteins would generate a more 
efficient delivery system providing a selective advantage during infection. In 
EHEC O157, secretion of Tir and effector proteins would be restricted until 
the translocon is assembled so they can be secreted directly into the host cell 
and it would avoid unnecessary secretion. On the other hand, if Tir is 
secreted prior to this it may interfere with translocon assembly and therefore 
prolong the time scale of T3SS filament maturation and further delay 
injecting effector proteins into host cells. More importantly, pre-matured Tir 
export may bind to the bacterial surface component-intimin and therefore 
block the subsequent interaction of intimin with host membrane-inserted Tir. 
A/E Escherichia coli along with Citrobacter rodentium are unique in having 
SepL and SepD proteins and are the only bacterial pathogens to date known 
to inject their own receptor. This may not be a coincidence as tight control 












Two secretion signal pathways: 




The T3SS is a complex organelle that promotes the secretion of translocon 
and effector proteins without disrupting the integrity of the bacterium. T3SS 
assembly can simplistically be described in three steps: the first step, the 
expression and engagement of the basal apparatus proteins (Chilcott and 
Hughes, 2000, Tamano et al., 2000); the second step, the expression and 
assembly of translocon proteins on the bacterial surface surface (Menard et 
al., 1994, Delahay et al., 1999); the third step, EspADB conduit completion 
and the switch to effector protein translocation into the host cell (Knutton et 
al., 1998, Ide et al., 2001, Daniell et al., 2001, Thomas et al., 2007) .  
 
Multiple virulence factors were found to be exported into the bacterial 
supernatant via the T3SS by an EHEC wild type strain (Elliott et al., 2000). 
Moreover, other putative T3 secreted effectors, exported in a CesT-
dependent manner, were discovered when either sepL or sepD were deleted 
(Deng et al., 2004, Li et al., 2006, Thomas et al., 2005, Tobe et al., 2006). In 
sepL or sepD backgrounds, Tir and Nle proteins were all identified as being 
over-secreted.  Tir is a receptor for intimin which is crucial for bacteria-
epithelial cell intimate attachment (Kenny et al., 1997b, Liu et al., 1999) and 
its secretion is required for effector hypersecretion (Thomas et al., 2007). 
Nle proteins are less understood although some of them, such as NleA and 
NleB, have been shown to be translocated into host cells and important for 
EHEC colonization (Gruenheid et al., 2004, Thanabalasuriar et al., 2010, 
Kelly et al., 2006); ongoing research is defining the functions of these 
additional effectors.(Tobe et al., 2006) Obviously, SepL/SepD complex is 
controlling the secretion level of effector proteins and this control is 
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potentially critical on cells and in vivo due to different aspects of effectors’ 
function (Gruenheid et al., 2004, Mundy et al., 2004a, Kelly et al., 2006, 
Deng et al., 2004).  
 
T3S effectors need be targeted to the system before being secreted as they 
are present in the cytoplasm together with thousands of other proteins. Two 
secretion related domains (the N-terminal secretion signal - NSS and the 
chaperone binding domain - CBD) were demonstrated for YopE and 
therefore two independent secretion pathways have been proposed in Yersina 
spp. (Cheng et al., 1997). The first (NSS) pathway was able to initiate 
effector protein secretion via a short peptide recognized by the needle 
complex which normally appears at the N-terminal of the protein and many 
effectors have been shown to have what may be the ‘original’ secretion 
signal (Wattiau et al., 1994, Sory et al., 1995, Crawford and Kaper, 2002, 
Lloyd et al., 2002, Charpentier and Oswald, 2004). However, effectors with 
their NSS but lacking their chaperones were observed being secreted via T3 
flagella instead of the T3SS injectisome which implied that chaperone 
binding delivery mediated by the interaction between chaperone and the 
CBD of the effector confers effector targeting/secretion specificity 
(Ramamurthi and Schneewind, 2003a, Lee and Galan, 2004, Badea et al., 
2009). In my study, to further understand the secretion controlling 
mechanism of the SepL-SepD protein complex, these two secretion 
pathways were tested in EHEC.  Work in this chapter was not completed due 
to the time limitation of my PhD. However, it still provided some interesting 




4.2.1 Two independent secretion pathways of EHEC 
T3SS 
The first 15 amino acids of Tir were shown to be sufficient to signal T3 
secretion and translocation into host cells without CesT (Crawford and 
Kaper, 2002). To my knowledge the concept of two secretion signals has not 
been investigated in EHEC/EPEC/CR. I wanted to test whether there are two 
secretion pathways for EHEC effectors and how the signals work in EHEC 
T3SS. Various fusions were made and tested in different genetic 
backgrounds to try and answer these questions. In this study, the N-terminal 
12 aa section of NleA was fused to -lactamase (bla) to investigate its N-
terminal secretion signal while Tir without its 20aa N-terminal peptide was 
fused to 6x Histidine to test the CBD secretion pathway. The bla gene 
reporter system has been used by several groups to measure the delivery of 
T3S substrates (Charpentier and Oswald, 2004, Karavolos et al., 2005). The 
-lactamase protein alone is not able to be secreted without a secretion 
signal as its Sec-dependent N terminal secretion signal has been deleted 
(Karavolos et al., 2005). For investigating 12aa NleA secretion, a full length 
NleA-Bla fusion was used as a secretion positive control while NleB-Bla 
was used as a secretion negative control in my experiment since it was not 
found exported in a previous study (Roe et al., 2007). In my experiment, 
NleB-Bla was not expressed in an EHEC wild type strain and therefore it is 
not a suitable secretion negative control. All the fusions were constructed as 
shown in Fig. 4.1A, and transformed into EHEC wild type strain ZAP 193, 
an escN mutant, a sepL mutant and a sepD mutant separately. All the strains 
were cultured in a T3S permissive condition (MEM-Hepes) and protein 
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samples were prepared as described in Materials and Methods. Using a -
lactamase or a penta-Histidine antibody, it was demonstrated that the 12aa 
Fig. 4.1. Two independent secretion pathways in EHEC
The first 12 amino acids of NleA (NSS) were fused to -lactamase and Tir truncate 
missing the first 20 amino acids was fused to 6x Histidine as shown in (A). These 
fusions were tested in different EHEC genetic backgrounds (WT, escN, sepL and 
sepD) (B and C). Supernatant (SN) and whole cell (WC) fractions were prepared as 
described in Materials and Methods. Samples were separated by 15% SDS PAGE 
and western blots were carried out using a -lactamase antibody or a pentax 
Histidine antibody as described in Materials and Methods. 12aa NleA was exported 
by wild type EHEC but not by others (B). -20aa Tir secretion was detected in both 
sepL and sepD but neither EHEC wild type strain nor an escN mutant (C). 
Therefore, NSS pathway is SepL-SepD dependent but CBD pathway is inhibited by 







NleA-Bla fusion was only detected in the supernatant of ZAP193 but not in 
the supernatant of sepL, sepD or escN (Fig. 4.1B). However, -20aa Tir, 
which has lost its N-terminal signal, was detected in the supernatant of 
sepL and sepD, but not in the supernatant of the wild type EHEC and 
escN mutant (Fig. 4.1C). In brief, this short N-terminal secretion signal (12aa) 
of NleA was able to be exported via a functional EHEC T3SS but required 
SepL-SepD complex whereas an effector (Tir) lacking its NSS (-20aa Tir) 
was only exported in the absence of SepL-SepD complex via a functional 
EHEC T3SS. These results both imply that the SepL-SepD complex plays an 
important role in controlling effector secretion. 
  
4.2.2 Interaction between SepD and other T3 
components 
My work in Chapter 3 on SepL function revealed that SepL bound to Tir but 
not to any other secreted proteins and this binding was critical for switching 
the T3SS from translocon secretion to effector substrate secretion in EHEC 
O157. As a part of the SepL/SepD complex, SepD might also interact with 
other T3 effectors directly which would help to explain the SepL-SepD 
complex requirement for the NSS secretion. The aim of the following 
experiments was to screen for potential binding partner of SepD. 
 
A sepD mutant was cultured in a T3S permissive condition and the over-
secreted protein was precipitated by adding 10% TCA into the culture 
supernatant. This secreted protein sample was separated by SDS-PAGE and 
transferred onto a nitrocellulose membrane. This membrane was incubated 
with a K-12 lysate containing 6x Histidine-tagged SepD and a far-Western 
blot carried out using a penta-His antibody. Multiple bands were detected 
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Fig. 4.2 Interaction between SepL/SepD and hypersecreted effector 
proteins 
The supernatant samples were prepared from different strains and 
separated by 15% SDS PAGE (top panel right) as described in 
materials and methods. Far-western blot was carried out using BL21 
lysate containing 6x His tagged SepD (top panel middle) or SepL (top 
panel left). Multiple bands were detected (labelled * for SepL detection 
and # for SepD detection) in this far-Western analysis; the possible 
interacting proteins are listed in the table.  
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that bound SepD and the sizes of these molecules were equivalent to most of 
the over-secreted effector proteins but not Tir. Tir was proposed to be the 
first effector protein being delivered into host cells and also showed an 
interaction with SepL. As a control protein, SepL was found only binding to 
Tir but not any other effector proteins. This far-Western result suggested that 
SepD interacts with other over-secreted effector proteins but not Tir directly 
(Fig. 4.2).  
 
While I have shown that SepD is required for SepL membrane localization 
and that SepL complexed to Tir was proposed to act as a block for effector 
secretion, there is no further report on the function of SepD in controlling 
effector secretion. A key question is what does SepD do in the EHEC T3S 
process and why does SepD potentially bind to so many different effectors. 
So the potential of these SepD interactions were investigated further; the 
possible interaction of SepD and the NSS of NleA was tested using a GST 
pull-down assay. A GFP tag was fused to the C-terminal of Map and the first 
12aa of NleA. The coding sequences of SepL, SepD and CesT were also 
inserted into pGEX 4T-2 to generate the different GST fusions. GST-tagged 
and GFP-tagged fusion proteins were expressed in BL21 and GST pull-down 
assays carried out as described in Materials and Methods. As a positive 
control, interactions were investigated between GST-CesT and Map-GFP. 
As expected, there were no interactions detected between GST-SepL/Map-
GFP, GST-CesT/12aa NleA-GFP or GST-SepL/12aa NleA-GFP. 
Surprisingly, there was an interaction detected between GST-SepD/12aa 
NleA-GFP but not between GST-SepD/Map-GFP (Fig. 4.3). From the SepD 
far-Western result, it was known that SepD might be able to bind other over-
secreted effectors but not Tir. This detection indicates that the NSS of NleA 
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can bind to SepD directly. And the interaction between SepD and CesT was 
detected using the the same strategy (Fig. 4.3). The chaperone binding 
capacity of SepD implies that SepD may be involved in chaperone-mediated 
secretion. While this short section raises more questions than answers it does 
indicate further functions of the SepL/SepD complex and a model is 
discussed below. 
Fig. 4.3 SepD binding capacities
GST tagged SepL, SepD, EscD, EscF and CesT proteins were expressed 
in K12 strain-DH5. The fusion proteins was immobilized on the G-
Sephorase 4B (Amersham) columns and DH5 lysates containing different 
GFP (or Histidine) tagged proteins were put through these columns 
separately. The columns were washed 3 times with PBS following the flow 
through and GST tagged proteins were eluted by reduced Glutathione. 
Eluates were separated by 15% SDS PAGE and Western blots were 
carried out using a GFP (or penta-His) antibody as described in Materials 
and Methods. SepD was detected interacting with CesT (B and C) and the 










There are many T3S effector proteins identified in EHEC/EPEC/CR (Kenny 
et al., 1997b, McNamara and Donnenberg, 1998, Deng et al., 2004, Tobe et 
al., 2006). Unlike the structural proteins of the EHEC T3SS which are 
encoded by the genes on the LEE, effector proteins are encoded not only by 
the genes on the LEE but also on cryptic lambdoid prophages distributed 
throughout the EHEC genome (Deng et al., 2004, Tobe et al., 2006). These 
proteins are able to be delivered into host cells via the T3SS and are 
involved in modulating host cell functions. While the function of these 
effector proteins is the subject of extensive research,, it is also important to 
understand the mechanism and regulation of effector delivery.  As shown in 
EHEC/EPEC/CR, there is an ordered cascade of protein secretion (Deng et 
al., 2005) and Tir is proposed to be the first effector protein to be 
translocated into host cells (Mills et al., 2008, Thomas et al., 2007), 
consistent with my work in Chapter 3.  
 
Interestingly, the T3 secretion of effectors is enhanced when sepL or sepD 
are deleted (Deng et al., 2005). This over-secretion phenotype led initially to 
more than 8 novel effector proteins being identified from a sepL 
mutant(Deng et al., 2004) with further work extending this to 39 additional 
proteins (Tobe et al., 2006) and some of them were not even detected in the 
supernatant of wild type EHEC (Roe et al., 2007). In order to understand the 
regulation of effector secretion, two secretion pathways were tested in EHEC 
and sepL/sepD mutants. It was confirmed that there were two independent 
secretion pathways for T3 effectors in EHEC according to my observations.  
Further examination showed that the NSS of NleA cannot be secreted via 
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EHEC T3SS in the absence of theSepL-SepD complex.  However Tir 
without the NSS and therefore only with the CBD signal is behaving in the 
opposite way, being inhibited by the presence of the SepL-SepD complex. 
This evidence indicates that the SepL-SepD complex may be important for 
Box 1: two independent secretion pathways in EHEC
Although some information about two secretion pathways in EHEC were discovered by my 
work, further work is required to define how these secretion signals work for the export of the 
effector proteins. Here, I propose models of these two secretion pathways in EHEC based on 
our current research and previous reports. As shown above, the NSS of NleA is able to 
initiate the effector export in a wild type EHEC which required the SepL/SepD complex and 
the CBD region is responsible for the effector over-secretion in sepL/sepD mutants. The 
model for the NSS pathway therefore includes the SepL-SepD complex engaging at the T3 
basal structure: I, the SepL/SepD complex is localized to the T3 basal apparatus; II. Effectors 
are self-targeted to the T3SS by the NSS/SepD interaction; III. Effectors are exported by the 
T3SS. However, EHEC effectors actually could not be secreted in this manner due to the 
dominant CBD sequence which controls the injection, potentially in a more specific manner. 
With their CBD regions, effector secretion was mediated via their chaperones in T3SS 
(Thomas et al., 2007). The model for CBD –dependent secretion is more likely to be the main 
pathway used during EHEC infection. In this model, SepL-SepD are no longer complexed at 
the T3SS which could promote the CBD secretion pathway: I. SepL-SepD complex 
disassociates from the T3SS and effectors are chaperoned by CesT; II. CesT delivers 
effectors to the ATPase according to binding affinities; III. Ordered export of effectors.  
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switching between these two independent secretion pathways (proposed 
models see Box 1).  
 
To achieve regulation of effector secretion, SepL-SepD complex needs a 
mechanism to block the CBD signal and facilitate the use of the NSS. My 
study (Far Western analysis) demonstrates that SepD acts as a binding 
partner for many EHEC T3 effectors and the NSS of NleA was shown to 
interact with SepD directly using a GST pull down experiment. SepD also 
binds to a multi-functional chaperone protein CesT according to my study. 
Taken together, I suggest that SepD in the SepL-SepD complex works as a 
potential targeting site for this ‘original’ N-terminal secretion signal. 
However, I propose that the CBD pathway is a more efficient way for 
protein translocation to occur after the NSS targeting and so the CBD has 
surpassed the NSS as a secretion (as opposed to targeting) signal. The CBD 
secretion pathway might be inhibited by the SepL-SepD complex via the 
interaction between SepD and CesT in EHEC.  
 
CesT is a multifunctional chaperone which is required for stabilizing 
effectors and the over-secretion phenotype of sepL/sepD mutant (Thomas et 
al., 2005, Thomas et al., 2007). Previous research has already showed that 
CesT interacts with multiple effector proteins using a CesT affinity column 
in EPEC (Thomas et al., 2005). An escort mechanism for cycling of export 
chaperones during T3 flagellum assembly was reported previously (Evans et 
al., 2006). For chaperone cycling, normally there is a docking area for the 
accumulation of secreted proteins and chaperones. It was suggested that C 
ring protein acted as a docking sites for T3 effectors and chaperones 
(Gonzalez-Pedrajo et al., 2006, Spaeth et al., 2009). But a C-ring component 
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has not yet been identified in EHEC/EPEC/CR. Although SepD doesn’t 
share a significant sequence similarity with other C ring components 
according to a multiple sequence alignment (Pallen et al., 2005a), it remains 
a possibility that SepL-SepD complex interacting with a C-ring component. 
An escort mechanism for cycling of export chaperones in EHEC was 
supported by SepD binding to CesT and the NSS of NleA. 
 
When the assembly of T3SS injectisome is completed in EHEC, effectors 
need to be targeted to T3SS for secretion/translocation. They could be 
targeted to the T3 basal apparatus via the interaction between SepD and the 
NSS according to my data, or could be carried to ATPase (EscN) by a 
chaperone protein (Gauthier and Finlay, 2003).  As proposed in chapter 3, 
SepL may release Tir to initiate effector secretion after EspA filament 
completed. Therefore, the NSS secretion pathway which required SepL-
SepD complex cannot be mainly responsible for effector secretion as SepL-
SepD complex would sequester Tir secretion in EHEC. However, the NSS 
signal could act as a perfect T3SS targeting signal facilitating CesT mediated 
effector secretion which didn’t require SepL-SepD complex. Logically, 
CesT mediated secretion would be the major approach used injecting 
virulence factor during the infection.  
 
Although some evidence was obtained in my research to support two 
secretion signal pathways (1. The NSS targeting and 2. CBD/chaperone 
mediated export) facilitating effector secretion regulation in EHEC O157, it 
remains unclear whether this mechanism is applicable for all other T3SS. 
More and more published work suggested that the NSS is sufficient for 
effector targeting / secretion via T3SS and CBD/chaperone interaction 
 141
confer T3SS specificity (Cheng et al., 1997, Cheng and Schneewind, 2000a, 
Lloyd et al., 2001a, Lloyd et al., 2001b, Crawford and Kaper, 2002, Birtalan 
et al., 2002, Lloyd et al., 2002, Ramamurthi and Schneewind, 2003b, 
Ramamurthi and Schneewind, 2003a, Sorg et al., 2005, Higashide and Zhou, 
2006, Rodgers et al., 2008, Badea et al., 2009). Although as mentioned in 
Chapter 1, the phenotype discrepancy suggested SepL and its homologues 
(YopN-TyeA, SsaL, MxiC, PopN…) were behaving in slightly different 
ways, they were all responsible for translocon/effector substrate switching 
(Yang et al., 2007, Yu et al., 2010, Coombes et al., 2004, Torruellas et al., 
2005, Ferracci et al., 2005, Schubot et al., 2005, Younis et al., Kresse et al., 
2000, O'Connell et al., 2004, Pallen et al., 2005b, Deng et al., 2005, Pallen 
et al., 2005a). Previous studies in Salmonella suggested that a protein 
complex (SsaM-SsaL-SpiC) controlling effector secretion could be 
disassociated by pH change (Coombes et al., 2004, Yu et al., 2010). 
Moreover, recent studies identified homologues of this protein complex in 
other T3SS which suggested functional similarity among SsaM-SsaL-SpiC 
(Salmonella SPI-2), SycN-YopN-TyeA-YscB (Yersinia), and CesL(Mpc)-
SepL-SepD (EHEC/EPEC/CR) (Pallen et al., 2005a, Younis et al., 2010). 
However, the SpiC/SepD/YscB family proteins have shown phenotypic 
diversity. YscB is known as a chaperone protein for YopN and SpiC is a 
secreted virulence protein (Day and Plano, 1998, Jackson et al., 1998, Cheng 
et al., 2001, Uchiya et al., 1999, Freeman et al., 2002, Yu et al., 2002). 
Furthermore, according to previous and my research, SepD was only known 
as a membrane-associated protein involved in T3 secretion switching and 
SepL localisation (O'Connell et al., 2004, Deng et al., 2005, Wang et al., 
2008). It remains possible that the SepD/SpiC family of proteins act as a 
T3SS docking site for recruiting and recycling of effector/chaperone, 
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therefore my proposal suggests an intriguing area for future work on how 
T3SS is controlled by environmental signals.  
 
4.4 Future work 
4.4.1 The NSS signals of EHEC secreted proteins: 
mRNA or amino acids? 
From previous reports and our own studies, it is known that the NSS is 
located in the N terminal region of secreted proteins and capable directing 
effector protein to host cells (Anderson and Schneewind, 1997, Cheng et al., 
1997, Lloyd et al., 2001b, Ramamurthi and Schneewind, 2002). But it is still 
unclear whether it is an mRNA signal or amino acid signal for EHEC 
secreted proteins. So the next aim is to define the nature of the EHEC NSS. 
The NSS of Yersinia secreted proteins was studied by Wolf-Watz and 
Schneewind’s groups (Anderson and Schneewind, 1997, Cheng et al., 1997, 
Lloyd et al., 2001b, Ramamurthi and Schneewind, 2002). It was reported 
that YopE had two distinct secretion signals and the NSS signal is able to 
direct YopE to the T3 basal proteins (Cheng et al., 1997). But it is still 
debatable whether the NSS is an mRNA or a peptide signal. Originally, 
Wolf-Watz and his colleagues’ work suggested that YopE is targeted for 
T3S by N-terminal, not mRNA, signal (Schesser et al., 1996). However, a 
year later, Schneewind’ group published their research which revealed a 
signal led to T3S of Yop proteins is contained in their 5’ messenger RNA 
rather than the peptide sequence (Anderson and Schneewind, 1997). Similar 
studies were carried out in Salmonella enterica by Galán and his colleagues 
and their results also suggested possible secretion signals (Lee and Galan, 
2004). So far no study has reported investigating the secretion signals of 
EHEC secreted proteins in details. Our work showed that there were two 
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secretion pathways of EHEC secreted proteins and the NSS pathway 
requires the presence of SepL/SepD in EHEC. Moreover, our binding assay 
showed that the NSS of NleA was able to bind to SepD directly. Although it 
implied that the NSS of NleA was more likely to be a peptide signal rather 
than an mRNA signal, it is still possible that the NSS of NleA is encoded by 
an mRNA sequence. So, in the future, the frameshift and synonymous 
changes would be introduced into the NSS of EHEC secreted protein and the 
secretion abilities of those mutants would be tested in EHEC.    
 
4.4.2 SepD interactions 
My far-Western result suggested the possible interactions between SepD and 
many secreted proteins. The NSS of NleA was also shown to bind to SepD 
directly. Logically, the future work should be focused on identifying and 
confirming the potential SepD binding partners. The N-terminal secretion 
signals of various effector proteins would be tested for SepD direct binding 
capacity. As discussed above, SepL-SepD was proposed to interact with a C 
ring component of EHEC T3SS which might be SepQ (Pallen et al., 2005a) 
and serving as a docking site for secreted proteins and chaperones. This 
hypothesis would be further tested using GST pull-down or far-Western 
approach. Once SepL-SepD binding partners are identified, the domain 
within SepD required for these interaction could be mapped using truncated 









Materials and Methods 
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5.1 Bacterial strains, plasmids, oligonucleotides, 
media and antibodies   
The bacterial strains, media, antibodies and plasmids used in the study are 
described in Tables 5.1 & 5.2.  Table 5.3 lists the oligonucleotide primers 
used.  MEM-HEPES is minimal essential medium with 25 mM HEPES 
buffer (Sigma), containing additional glucose to a final concentration of 
0.2%. Luria-Bertani (LB) broth was also used (Oxoid).  Antibiotics were 
included when required at the following concentrations: chloramphenicol 
(cam) 12.5 µg ml-1, kanamycin (kan) 25 µg ml-1, ampicillin (Amp)  50 µg 
ml-1.  
 
5.2 Preparation of secreted proteins and bacterial 
fractions for protein analyses  
Bacteria were cultured in 50 ml MEM HEPES at 37°C (200 rpm) to an 
OD600 of 0.8 unless specifically stated. The bacterial cells were pelleted by 
centrifugation at 4,000 × g for 20 min, and supernatants were passed through 
filters (0.45 µm). Proteins were precipitated overnight with 10% TCA, and 
separated by centrifugation at 4,000 × g for 30 mins (4°C), the proteins were 
resuspended in 150 µl 1.5 M Tris (pH 8.8). The bacterial pellet was initially 
suspended in 150 µl of sonication buffer (10 mM Tris-HCl [pH 7.5], 0.5 mM 
PMSF and 0.5 µg/ml aprotinin) and sonicated (3 × 10 seconds) on ice. Cell 
envelopes and unbroken bacteria were removed by two rounds of 
centrifugation (5,000 × g for 10 mins at 4°C). The supernatant (whole cell 
fraction) was removed and the membranes pelleted by ultra-centrifugation of 
the samples for 1 hr at 50,000 × g, at 4°C. The supernatant containing 
cytoplasmic proteins was collected.  The membrane preparation was washed 
twice with sonication buffer and re-suspended in 150 µl SDS sample buffer 
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(63 mM Tris HCl [pH 6.8], 10% Glycerol, 2% SDS and 0.0025% 
Bromophenol Blue).  Proteins were separated by SDS-PAGE using standard 
methods and Western blotting performed as described previously (Sambrook 
et al., 1989) using the relevant antibodies listed in Table 5.2. Tir and EspD 
secretion levels were measured following enhanced chemi-luminescence 
(ECL)-detection from Western blots using Multi-analyst (Bio-Rad) software. 
 
5.3 DNA amplification and manipulation  
PCR amplification was performed as described previously (Sambrook et al., 
1989). Plasmid preparation and purification of PCR product according to 
manufacturer’s instructions (QIAprep spin miniprep kit, QIAquick Gel 
extraction kit, QIAquick PCR purification kit) (Appendix 1) 
 
5.4 Construction of various reporter tagged 
fusions  
For SepL/SepD co-localization study, a fusion construct to RFP (Sorensen et 
al., 2003) was made in pDW16. The pTac promoter was amplified from 
plasmid pGEX4T2 (Table 5.1) and cloned in front of rfp using primers 
ptac5’ and ptac3’ to create pDW17.  The sepD gene was then amplified from 
EHEC ZAP193 using primers sepD 5’r and sepD 3’r and cloned between the 
pTac promoter and rfp. Full length SepL and different carboxyl-terminal 
truncates of SepL (Fig. 3.1A) were fused to GFP in pAJR70 (Roe et al., 
2003b) using the primers described in Table 5.3. A 6 × His-tag was 
introduced at the carboxy end of SepL and three of the truncated SepL 
proteins (267aa, 290aa and 340aa) by PCR before cloning into pACYC184 
(Table 5.1). Different effectors were fused to a -lactamase or 6 × His-tag 
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using the primers described in Table 5.3. All constructs were confirmed by 
sequencing and listed in Table 5.1.   
 
5.5 Northern Analyses 
Bacteria were cultured in the relevant media and harvested at OD600 = 0.8 in 
MEM HEPES and OD600 = 1.5 in LB due to the difference of growth rates. 
Total RNA was extracted using a ‘ChargeSwitch Total RNA Cell Kit’ 
(Invitrogen) as per the manufacturer’s instructions (Appendix 1). Northern 
blotting was performed according to the NorthernMax® Kit Instruction 
Manual (Ambion) (Appendix 1). RNA was quantified using an Agilent 2100 
Bioanalyzer. Samples were hybridized with single-stranded DNA probes 
specific for either sepL or gfp.  The primers used to generate these probes are 
given in Table 5.3: for sepL the primers were sepL3-5’ & sepL4-3’; for egfp 
the primers were egfp5’P & egfp3’P. The probes were labeled with 
[32P]dCTP by incubating the mixture of  denatured DNA probe (25-50 ng) 
and [32P]dCTP (50 Ci) at 37 for 15 mins using Ready-To-Go DNA 
labelling beads (Amersham-Pharmacia Biotech). Following hybridization 
and washing steps, the 32P signal was detected with a PhosphorImager (Bio-
Rad GS-525), which allowed quantification using Multi-Analyst software 
(Bio-Rad). 
 
5.6 Construction of GST and 6 x His-tagged 
proteins and binding assays   
For the GST-SepL construct, sepL was amplified from EHEC O157 ZAP193 
by PCR using the primers sepL 5’g and sepL 3’g. The resulting PCR product 
was digested with BamHI and SmaI, and cloned into the BamHI and SmaI 
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sites of pGEX-4T-2. This creates a GST-SepL hybrid protein fusion (in 
pDW9) used in GST pull-down assays. A similar strategy was used to clone 
the 48aa carboxyl terminus of SepL, SepD and CesT using the primers 
described in Table 5.3. For His-tagged proteins, tir and sepD open reading 
frames were amplified by the primers listed in Table 5.3, digested with XbaI 
and XhoI, and cloned into the XbaI and XhoI sites of pET21d. For SepL and 
Tir domain analyses, the amplified fragments were cloned into pET28a via 
NdeI and XhoI to create N-terminal 6 × His-tags. All constructs were 
expressed in Escherichia coli BL21 (Table 5.2) following IPTG induction 
(0.1mM).  The GST fusions were expressed in AAEC 185 (an Escherichia 
coli K-12 derivative, Table 5.2) and the His-tag fusions in Escherichia coli 
BL21, both following IPTG (0.1mM) induction in LB at OD600 = 0.5.  For 
protein preparations, the bacteria were harvested at 4,000 × g (4°C) for 30 
mins 2 hours post IPTG inoculation. The bacterial pellet was suspended in 
Phosphate buffered saline (PBS) and sonicated. The supernatant was 
collected by centrifugation at 12,000 × g for 10 mins at 4°C. For the GST 
fusions, the supernatant was mixed with PBS balanced Glutathione-
Sepharose 4B beads for 30 mins at room temperature. The beads were 
separated by centrifugation at 500 × g for 5 mins. An aliquot of the 
supernatant was saved for analysis and rest of the supernatant discarded. The 
beads were washed three times using 10 volumes of PBS and separation by 
centrifugation at 500 × g for 5 mins. The beads were mixed gently in the 
same volume of Glutathione Elution Buffer (0.154 g of reduced glutathione 
dissolved in 50 ml of 50 mM Tris-HCl, pH 8.0) and incubated at room 
temperature for 10 mins. Supernatant was collected by centrifugation at 500 
× g for 5 mins. The elution and centrifugation step was repeated and the two 
eluates pooled.  Equal volumes of washes and eluates were loaded onto the 
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protein gels.  To check initial loading of columns, some eluates were stained 
with colloidal blue and/or Western blotted to confirm the presence of the 
expected GST fusion protein and His or GFP-tagged binding partners. 
  
For His-tagged proteins, these were expressed and purified as above except a 
Ni-NTA (Qiagen) column was used and elution was with the supplied 
Qiagen buffer.  For the in vitro binding assays, these were carried out on 
either glutathione or Ni-NTA columns on which the bait protein was first 
retained and then the protein being investigated was run through the column 
in a lysate prepared as above.  Following washes, elution was carried out as 
described above. Eluted samples were analysed by SDS-PAGE followed by 
colloidal blue staining and Western Blotting which were carried out 
essentially as described previously (Roe et al., 2003b, Karavolos et al., 2005) 
using the relevant antibodies listed in Table 5.2.  
 
5.7 Construction of sepL and sepD mutants   
The experiments were carried out essentially as described previously (Roe et 
al., 2003b, Emmerson et al., 2006) using allelic exchange methodology. 
Exchanging plasmid was transformed into appropriate strain background. 4-
8 single colonies were inoculated into 100 ml LB (Cam) medium and this 
culture was grown at 42°C (200 rpm) for 8-16 hrs. This step was repeated 3 
times by diluting (1:1000) into 100 ml fresh medium. After 4 rounds at 42°C, 
the culture was diluted into 100 ml LB medium with appropriate antibiotic 
(Kanamycin for sacB-kanaR cassette insertion, non-antibiotic added for 
knocking sacB-kanaR cassette out) and grown at 28°C (200 rpm) for 8-16 hrs. 
This step was repeated 3 times by diluting (1:1000) into 100 ml fresh 
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medium. After the final round of 28°C culturing, it was diluted to 10-6-10-7 
and put on LBK (for sacB-kanaR insertion) or LB (For sacB-kanaR knocking 
out) plate at 28°C. After 16-20 hours, single colonies should be visible and 
ready to be tested for antibiotic resistance and colony PCR screening. The 
respective primer sets used to amplify the sepL, sepD are described in Table 
5.3, the ler deletion was published previously (Low AS, 2006).  To generate 
plasmids for the sepL frameshift mutation, a fragment containing the sepL 
gene and flanking regions (Upstream 1kb+ downstream 1kb) was amplified 
from ZAP193 by PCR using sepL 5’allf and sepL 3’allf. It was digested with 
Kpn I and Xba I, and cloned into the Kpn I and Xba I sites of pIB307. 
Following the methodology in the Stratagene “Site-Directed Mutagensis” kit 
(Appendix 1), a single base pair was inserted at 345bp of sepL to generate a 
plasmid (pDW52) for allelic exchange. Final plasmid constructs (Table 5.1) 
were sequenced prior to the deletion exchange and each deletion confirmed 
by PCR analysis. The sepL and sepD mutants could be functionally 
complemented by pDW24 (SepL), pDW48 (SepL-His) pDW6 (SepL-GFP) 
and pDW20 (SepD-GFP) (Table 5.1) to restore translocon (EspD) secretion 
as determined by Western blotting (Fig. 4A, C and D).   
 
5.8 Far-Western Analysis 
Supernatant proteins were prepared from ZAP1143 (sepL) or ZAP1144 
(sepD) as described in the relevant section above. The secreted proteins 
were separated by SDS-PAGE using standard methods and then transferred 
to a Nitrocellulose membrane (150 volt for 90 mins) (Sambrook et al., 1989). 
The membrane was first blocked with 8% milk PBS overnight at 4°C and 
washed 3 times with PBS-Tween (0.5% v/v) before being incubated 
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overnight with saturated SepL-His or SepD-His in an Escherichia coli BL21 
lysate at 4°C.  After the incubation, the nitrocellulose membrane was washed 
3 times with PBS-Tween and the standard Western procedure for detecting 
the 6 x His-tags was carried out (Sambrook et al., 1989).  
 
5.9 RNA folding prediction 
The RNA secondary structures for different sepL fusions were predicted 
using RNADraw software, a program for RNA secondary structure 
calculation and analysis (Matzura and Wennborg, 1996). RNADRAW 
predicts RNA structures by identifying suboptimal structures using the free 
energy optimization methodology at a default temperature of 37°C. In this 
study, different length sepL coding regions with its 5’ UTR fused in frame to 
the full length gfp gene were used for RNA structure prediction. 
 
5.10 EspA filament staining 
Fixed bacteria were dried on slides and incubated with a 1:100 dilution of 
the anti-EspA serum (Table 5.2) (PBS/0.1% BSA) for 60-90 mins at room 
temperature. After 3 × washes (PBS/0.1% BSA), the bacterial samples were 
incubated with either FITC-conjugated (Green) or TRITC-conjugated (Red) 
goat anti-rabbit antibody (Dako, Table 5.2) (1:500, PBS/0.1% BSA) for 30-
60 mins and the slide was washed three times with PBS/0.1% BSA. The 
slide was then examined by fluorescence microscopy and the images were 




5.11 EBL cell binding assay 
Embryonic bovine lung (EBL) cells (German collection of cell cultures, No. 
ACC 192) were plated at a density of 1 × 105 in eight-chamber microscope 
slides (Becton and Dickinson). Cells were incubated at 37°C in 5% CO2 for 
24 hrs before bacterial co-culture. EHEC O157 strains were transformed 
with the appropriate GFP/RFP reporter plasmid (Table 5.1) using standard 
protocols. The resultant transformants were cultured overnight in LB 
medium with appropriate antibiotic at 37°C. For the binding assays, the 
bacteria were then inoculated into M9 cam medium (start OD600=0.05) until 
an OD600 = 0.6. Culture growth medium (MEM-Hepes) was removed from 
the chambers and the bacteria were added to each well of the multi-chamber 
slide (150 µl per chamber). The cells were then incubated at 37°C in 5% 
CO2 for 1 hr. The medium was then removed and replaced with fresh M9 
medium (Cam), removing any unattached bacteria. Cells were incubated for 
a further 1-3 hrs as required and then fixed with 200 l of 4% 
paraformaldehyde(in PBS).  In order to visualize EspA filaments on the 
surface of bacteria, EspA immuno-staining was carried out essentially as 
described above in section 5.10.   
 
5.12 Fluorescence imaging   
Fluorescence imaging was carried out using a Leica DM LB2 microscope 
and a 100 × objective lens.  Narrow bandwidth filters to excite and detect 
GFP/FITC were used (41017 Endow GFP, CHROMA).  Images were 
captured using a Hamamatsu ORCA-ER black and white CCD digital 
camera.  Images were analysed using OpenLab software (Improvision).  To 
measure levels of fluorescence in individual cells, transects were marked on 
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bacteria and the fluorescence levels determined using QFluor software 
(Leica).   
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Table 5.1 Plasmids used in the study (plasmids underlined were 
made by Dai Wang in this study) 
Plasmid Description 
pACYC184 Low copy number cloning vector from New England 
Biolabs 
pGEX-4T-2 Plasmid contained GST gene fusion system from 
Amersham Biosciences 
pET21d Plasmid contained 6 x His gene fusion system from 
Novagen 
pET28a Plasmid contained 6 x His gene fusion system from 
Novagen 
pTir-His pET21d digested with XbaI/XhoI; fragment contained full 
length tir gene amplified from ZAP193 and inserted 
p100Tir-His pET21d digested with XbaI/XhoI; fragment contained the 
first 100aa tir gene amplified from ZAP193 and inserted 
p200Tir-His pET21d digested with XbaI/XhoI; fragment contained the 
first 200aa tir gene amplified from ZAP193 and inserted 
p-200Tir-His pET28a digested with NdeI/XhoI; fragment contained the 
201-558aa tir gene amplified from ZAP193 and inserted 
p-382Tir-His pET28a digested with NdeI/XhoI; fragment contained the 
382-558aa tir gene amplified from ZAP193 and inserted 
pDG028 Low copy number vector containing sacB-kanaR cassette, 
laboratory stock. 
pIB307 pMAK705 based vector for allelic exchange; temperature 
sensitive replicon (Blomfield et al., 1991) 
pAJR70 pACYC184 digested with BamHI; gfp gene cloned 
BamHI/BglII (Roe et al., 2003b) 
pAJR104 pACYC184 containing bla gene (Karavolos et al., 2005) 
pAJR145 pACYC rpsM::gfp transcriptional fusion (Roe et al., 2004) 
pDW5 pAJR70 digested with BamHI/KpnI; map with its own 
promoter amplified from ZAP193, cloned in frame 5’ to gfp 
pDW6 pAJR70 digested with BamHI/KpnI; sepL with its own 
promoter amplified from ZAP193, cloned in frame 5’ to gfp 
pDW7 pIB307 digested with XbaI/HindIII; fragment contained 
1165 bp sepL downstream sequence amplified from 
ZAP193 and inserted 
pDW8 pDW7 digested with KpnI/BamHI; fragment contained 985 
bp sepL upstream sequence amplified from ZAP193 and 
inserted 
pDW9 pGEX-4T-2 digested with BamHI/SmaI; fragment 
contained full length sepL gene amplified from ZAP193 
and inserted 
pDW10 pIB307 cut with KpnI/BamHI; fragment contained 985 bp 
sepL upstream sequence amplified from ZAP193 and 
inserted 
pDW11 pDW8 digested with BamHI; sacB-kanaR cassette inserted 
pDW14  pDW8 digested with BamHI; fragment contained sepL-gfp 
sequence amplified from pDW6 and inserted 
pDW15 pGEX-4T-2 digested with BamHI/SmaI; fragment 
contained full length sepD gene amplified from ZAP193 
and inserted 
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pDW16 pACYC184 containing rfp gene (Roe et al., 2007) 
pDW17 pDW16: Artificial promoter ptac was inserted in front of rfp 
gene 
pDW18 pET21d digested with XbaI/XhoI; fragment contained full 
length sepD gene amplified from ZAP193 and inserted 
pDW20 pAJR70 digested with BamHI/KpnI; fragment contained full 
length sepD gene amplified from ZAP193, cloned in frame 
5’ to egfp 
pDW21 pDW307 digested with BamHI/SacI; fragment contained 
746 bp sepD upstream sequence amplified from ZAP193 
and inserted 
pDW22 pDW21 digested with BamHI/AseI; fragment contained 
805 bp sepD downstream sequence amplified from 
ZAP193 and inserted 
PDW23 pDW22 digested with BamHI; sacB-kanaR cassette 
inserted 
pDW24 pACYC184 digested with BamHI; Full length sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDW25 pDW17: sepD gene and its Shine-Dalgarno sequence was 
amplified from ZAP193 and fused to rfp gene in frame 
driven by ptac promoter 
pDW26 pACYC184 digested with BamHI/KpnI; 1-51bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDW27 pACYC184 digested with BamHI/KpnI; 1-210bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDW28 pACYC184 digested with BamHI/KpnI; 1-573bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDW29 pACYC184 digested with BamHI/KpnI; 1-870bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDW30 pACYC184 digested with BamHI/KpnI; 1-1020bp sepL 
gene with its own promoter amplified from ZAP193 and 
inserted 
pDW40 pGEX-4T-2 digested with BamHI/SmaI; fragment 
contained full length cesT gene amplified from ZAP193 
and inserted 
pDW42 pET21d digested with XbaI/XhoI; fragment contained full 
length sepL gene amplified from ZAP193 and inserted 
pDW45 pACYC184 digested with BamHI; 1-801bp sepL gene with 
its own promoter amplified from ZAP193 (6X His-tag was 
introduced into C-terminal by primer) and inserted 
pDW46 pACYC184 digested with BamHI; 1-870bp sepL gene with 
its own promoter amplified from ZAP193 (6X His-tag was 
introduced into C-terminal by primer) and inserted 
pDW47 pACYC184 digested with BamHI; 1-1020bp sepL gene 
with its own promoter amplified from ZAP193 (6X His-tag 
was introduced into C-terminal by primer) and inserted 
pDW48 pACYC184 digested with BamHI; Full length sepL gene 
with its own promoter amplified from ZAP193 (6X His-tag 
was introduced into C-terminal by primer) and inserted 
pDW50 pGEX-4T-2 digested with BamHI/SmaI; fragment 
contained caboxy-terminal 48aa residue of sepL gene 
amplified from ZAP193 and inserted 
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pDW51 pIB307 digested with KpnI/XbaI; fragment contained sepL 
gene and flanking regions (Upstream 1kb+ downstream 
1kb) amplified from ZAP193 and inserted 
pDW52 pDW51 was site-direct mutated by inserting a base pair at 
345bp of sepL ORF    
pDW53 pIB307 digested with BamHI/AseI; fragment contained 
csrA downstream sequence amplified from ZAP193 and 
inserted 
pDW54 pDW53 digested with BamHI/KpnI; fragment contained 
csrA upstream sequence amplified from ZAP193 and 
inserted 
pDW55 pDW54 digested with BamHI,  fragment contained sacB-
kanaR cassette inserted 
pDW61 pAJR70 digested with BamHI/KpnI; 1–81 bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDW62 pAJR70 digested with BamHI/KpnI; 1–84 bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDW63 pWSK29 digested with BamHI/EcoRI; hfq gene amplified 
from ZAP193 and inserted 
pDW66 pWSK29 digested with BamHI/EcoRI; csrA gene amplified 
from ZAP193 and inserted 
pDW64 pACYC177: sepL-gfp fragment restricted from pDW6 and 
inserted 
pDW65 pACYC177: 51bp sepL-gfp fragment restricted from 
pDW26 and inserted 
pDWNleA-
His 
pET21d digested with XbaI/XhoI; fragment contained full 
length nleA gene amplified from ZAP193 and inserted 
pDWHis-
NleA 
pET28a digested with NdeI/XhoI; fragment contained full 
length nleA gene amplified from ZAP193 and inserted 
pTD-8AT pAJR104 digested with BamHI/KpnI; full length nleA gene 
with its own promoter amplified from ZAP193 and inserted 
(Roe et al., 2007) 
pTD-9BT pAJR104 digested with BamHI/KpnI; nleB gene with its 
own 
promoter amplified from ZAP193 and inserted (Roe et al., 
2007) 
pTD-1A pAJR70 digested with BamHI/KpnI; 1–36 bp nleA gene 
with its own promoter amplified from ZAP193 and inserted 
(Roe et al., 2007) 
pDW-
12aaNleA 
pAJR104 digested with BamHI/KpnI; 1–36 bp nleA gene 
with its own promoter amplified from ZAP193 and inserted 
pDW37 pET21d digested with XbaI/XhoI; fragment contained full 
length cesT gene amplified from ZAP193 and inserted 
pDW38 pGEX-4T-2 digested with BamHI/SmaI; fragment 
contained full length escF gene amplified from ZAP193 
and inserted 
pDW39 pGEX-4T-2 digested with BamHI/SmaI; fragment 
contained full length escD gene amplified from ZAP193 
and inserted 
pDW6m-35 pDW6: a synonymous change was introduced into C-
terminal sepL using site-directed mutagenesis which 
altered its mRNA structure 
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pDW6m+1 pDW6: a single base change introduced at +1 site of sepL 
transcript using site-directed mutagenesis 
pDW6m pAJR70 digested with BamHI/KpnI; sepL gene amplified 
from ZAP193, cloned in frame 5’ to gfp 
pDW6m0 pDW6m: sepL/LEE4 promoter was amplified from ZAP193 
and inserted in front of sepL gene 
pDW6m1 pDW6m1: 5’UTR of GST was amplified from pGEX4T-2 
and inserted between LEE4 promoter and sepL gene 
pDWsepL3 pAJR70 digested with BamHI/KpnI; 1-3 bp sepL gene with 
its own promoter amplified from ZAP193 and inserted 
pDWsepL6 pAJR70 digested with BamHI/KpnI; 1-6 bp sepL gene with 
its own promoter amplified from ZAP193 and inserted 
pDWsepL9 pAJR70 digested with BamHI/KpnI; 1-9 bp sepL gene with 
its own promoter amplified from ZAP193 and inserted 
pDWsepL12 pAJR70 digested with BamHI/KpnI; 1-12 bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDWsepL15 pAJR70 digested with BamHI/KpnI; 1-15 bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDWsepL18 pAJR70 digested with BamHI/KpnI; 1-18 bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDWsepL21 pAJR70 digested with BamHI/KpnI; 1-21 bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDWsepL24 pAJR70 digested with BamHI/KpnI; 1-24 bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDWsepL27 pAJR70 digested with BamHI/KpnI; 1-27 bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDWsepL30 pAJR70 digested with BamHI/KpnI; 1-30 bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDWsepL33 pAJR70 digested with BamHI/KpnI; 1-33 bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDWsepL36 pAJR70 digested with BamHI/KpnI; 1-36 bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDWsepL39 pAJR70 digested with BamHI/KpnI; 1-39 bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDWsepL42 pAJR70 digested with BamHI/KpnI; 1-42 bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDWsepL45 pAJR70 digested with BamHI/KpnI; 1-45 bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDWsepL48 pAJR70 digested with BamHI/KpnI; 1-48 bp sepL gene 
with its own promoter amplified from ZAP193 and inserted 
pDW-tir pAJR70 digested with BamHI/KpnI; full length tir gene with 
its own promoter amplified from ZAP193 and inserted 
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Table 5.2 Bacterial strains and antibodies 
Strains Details 
AAEC185 Escherichia coli  K-12 strain 
BL21 (DE3) F– ompT hsdSB gal dcm (DE3) 
ZAP193 Escherichia coli O157:H7 stx-,  NCTC 
12900  
ZAP198 Escherichia coli O157:H7 (Naylor et al., 
2003) 
ZAP108 Escherichia coli O157:H7 (Roe et al., 
2003b) 
ZAP632 ZAP198: escRSTU replaced with 
kanamycin resistance gene 
ZAP984 ZAP198: LEE4 replaced with kanamycin 
resistance gene (Naylor et al., 2005) 
ZAP928 ZAP193: sepL replaced with sepL-gfp 
(full-length) 
ZAP1004 Escherichia coli O157 stx- Nalr Δler (Low 
et al., 2006) 
ZAP1143 Escherichia coli NCTC 12900; O157 stx- 
Nalr ΔsepL (total deletion) 
ZAP1144 Escherichia coli NCTC 12900; O157 stx- 
Nalr ΔsepD (total deletion) 
ZAP1211 Escherichia coli NCTC 12900; O157 stx 
Nalr ΔsepL (Frameshift mutation by 
insertion of an additional base at 
nucleotide position 345 of sepL) 
ZAP193escN Escherichia coli O157:H7 stx- escN,  
NCTC 12900 (Roe et al., 2007) 
EDL933 Escherichia coli O157:H7 sequenced 
strain (Perna et al., 2001) 
ZAP1205 EDL933: hfq replaced with 
chloramphenicol resistance gene 
CsrA ZAP193: csrA replaced with sacB-kanaR 
cassette 
SK ZAP193: sepL replaced with sacB-kanaR 
cassette 
M10 ZAP193:  the first 10 bases of sepL ORF 
replaced with GGTACC and 3 bases 
changed in espA ORF (279:T/C; 
336:G/A; 393:G/A) 
Media Details 
LB Luria-Bertani broth, Oxoid. (10 g Bacto 
tryptone, 5 g Bacto yeast, 10 g NaCl, add 
deionized H2O to 1 Liter, adjust pH to 7.0 
with NaOH, Sterilize by autoclaving) 
M9 M9 minimal medium was modified with a 
final glycerol concentration of 0.4%, 2 
mM MgSO4, 0.1 mM CaCl2, MEM Non-
Essential Amino acids Solution (Sigma), 
MEM Amino acids Solution (Sigma). 
MEM-HEPES Minimal essential medium with 25 mM 
HEPES buffer (Sigma), Glucose was 
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added to MEM-HEPES to give a final 
concentration of 0.2%. 
NYZ+ 10 g of NZ amine (casein hydrolysate); 5 
g of yeast extract; 5 g of NaCl; add 
deionized H2O to 1 Liter, adjust pH to 7.5 
with NaOH, Sterilize by autoclaving; Add 
the following filer-sterilized supplements 
(12.5 ml of 1 M MgCl2; 12.5 ml of 1 M 
MgSO4 and 10 ml of 2 M glucose) prior to 
use. 
Antibiotics Antibiotics were included when required 
at the following concentrations: 
chloramphenicol (Cam) 12.5  µg ml 1, 
kanamycin (Kan) 25 µg ml 1, Ampicillin 
(Amp) 50 µg ml 1 
Antibodies Details 
Anti GFP Mouse monoclonal (Clontech) 
Anti EspA Mouse monoclonal (gift from Prof. Trinad 
Chakraborty) 
Anti EspD  Mouse monoclonal (gift from Prof. Trinad 
Chakraborty) 
Anti Tir Mouse monoclonal (gift from Prof. Trinad 
Chakraborty) 
Anti OmpA  Rabbit polyclonal (gift from Prof. John 
Leong)  
Anti GroEL Rabbit polyclonal (Stressgen) 
Anti-His Mouse Penta-His antibody (Qiagen) 
Anti-Rabbit Igs Peroxidase-conjugated Swine Anti-
Rabbit Immunoglobulins, mainly IgG, 
HRP (DAKO) 
Anti-Mouse Igs Polyclonal Goat Anti-Mouse 




Goat Anti-Rabbit  IgG, FITC/TRITC 
(DAKO) 
Alexa Fluor Anti-Mouse 
IgG 
Alexa Fluor 488 goat anti-mouse 
(Green) ; Alexa Fluor 594 goat anti-
mouse (Red) (Invitrogen) 
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sepL 5’lhs pDW8, pDW10 CGGGGTACCTTTTTAAACTCTGATG
CCAG 
sepL 3’lhs pDW8, pDW10 CGCGGATCCTGGAAACTCACGTAAT
C 
sepL 5’rhs pDW7 TGCTCTAGATATTAATTACTCAATA
ATTTTTTTG 
sepL 3’rhs pDW7 CCAAGCTTAACAATTTTACTTTTTT
GTG 






sepL 3’g pDW9,50 CAACCCGGGTCAAATAATTTCCTCC
TTATAGTC 
sepL 3BamH pDW24 CGGGATCCTCAAATAATTTCCTCCT
TATAGTC 
sepD 5’lhs pDW21 GCGAGCTCCAGCGATCTCAGTTTCG
ATG 
sepD 3’lhs pDW21 GCCGGATCCCATACATATTACCCGT
CCTG 
sepD 5’rhs pDW22 GCGGATCCCCGCCAACACACTTGTT
TTC 
sepD 3’rhs pDW22 GCATTAATCGGTCTTTTACAACAAC
TGC 
sepD 5’g pDW15 CGGGATCCATGAACAATAATAATGG
CATAG 
sepD 3’g pDW15 CCCCGGGTTACACAATTCGTCCTAT
ATCAG 
sepD 5’ pDW20 CGGGATCCCTAAAGAAAGAGAAAAA
TGCG 
sepD 3’ pDW20 GGGGTACCTTACACAATTCGTCCTA
TATCAG 
cesT 5’g pDW40 CGGGATCCATGTCATCAAGATCTGA
ACTTTTA 
































































































































ptac 5’r pDW17 GGAAGATCTGGAAGCTGTGGTATGG
CTGT 
ptac 3’r pDW17 CGGGGTACCCATCCCGGGTGTTTCC
TGTG 
sepD 5’r pDW20 TCCCCCCGGGGTGTTGTTATCAAGT
CATCC 















For enterohaemorrhagic Escherichia coli, a fully functional T3SS is required for 
inducing typical attaching and effacing lesions on host cells which are crucial for 
pathogen colonization in either the human patient or natural host reservoir 
(McDaniel and Kaper, 1997, Naylor et al., 2005).  The colonization of EHEC 
O157 causes pathological changes to epithelial cells in the gastrointestinal tract 
which include rearrangement of the cytoskeleton and actin accumulation beneath 
the bacteria and eukaryotic membrane (Knutton et al., 1989b, Frankel et al., 
1998). In order to achieve those changes, bacterial need to transfer virulence 
factors into host cells via a T3SS channel (Kenny et al., 1997b, Abe et al., 1998, 
McNamara and Donnenberg, 1998, Tomson et al., 2005, Caron et al., 2006). 
Recent studies have demonstrated that effector proteins can have contradictory 
functions (Kenny et al., 2002, Tu et al., 2003, Berger et al., 2009), therefore, it 
is very important to get the effectors delivered to the right place and at the right 
time for optimal function. 
 
Several mechanisms have evolved to tackle this issue at the transcriptional, 
posttranscriptional and posttranslational levels in T3SS pathogens (Chilcott and 
Hughes, 2000, Karlinsey et al., 2000a, Urbanowski et al., 2005, Yahr and 
Wolfgang, 2006, Lee and Hughes, 2006, Urban and Vogel, 2007, Zarivach et al., 
2008, Riordan and Schneewind, 2008). As T3SS expression is the first step of 
virulence delivery, it has been shown that there are multiple layers of regulation 
involved in this early stage (McCaw et al., 2002, Urbanowski et al., 2005, 
Vakulskas et al., 2009, Karlinsey et al., 2000a).  Transcriptional activation of 
T3SS needs various environmental signal inputs which include temperature, 
calcium/magnesium/ferric/bicarbonate ion concentration changes and cell 
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contact (Kenny et al., 1997a, Beltrametti et al., 2000, Abe et al., 2002, 
Rosenshine et al., 1996a, Nisan et al., 1998).  In this process, EHEC senses the 
presence of target epithelial cells by detecting multiple host signals and then 
initiates T3SS expression (Kenny et al., 1997a). According to previous reports, 
T3SS signal sensor/receptors have been found in other pathogens (Aldon et al., 
2000), although the signal sensor(s) has not yet been identified in EHEC.  T3SS 
Fig. 6.1. Model for control of LEE4 expression by Ler, SepD and Hfq/CsrA pathways.  
SepD and Ler, the global regulator of T3SS, are required to fully activate LEE4 
transcription in EHEC O157 (A). Hfq and another regulator-CsrA were found to be 
important for posttranscriptional regulation of LEE4. The proposed Hfq/CsrA regulation 
model is shown in B.  LEE4 translation is activated when CsrA binds to LEE4 transcript 
and/or inhibits Hfq mediated CsrB sequestration via CsrA/CsrB binding (‘ON’). The large 
LEE4 (sepL-espADB) mRNA is cleaved by RNase E after SepL is translated and then 
EspADB translation is initiated. LEE4 expression is repressed when CsrB binds to LEE4 
transcript with its chaperone Hfq (‘OFF’). The Large LEE4 mRNA is sequestered and no 




activation is known to occur primarily through the global regulator Ler (Mellies 
et al., 1999, Friedberg et al., 1999, Sperandio et al., 2000, Bustamante et al., 
2001, Haack et al., 2003, Berdichevsky et al., 2005, Laaberki et al., 2006). 
Previously Ler was shown to regulate the transcription level of LEE1, LEE2, 
LEE3, LEE5 (tir) and LEE4 (esp) in EHEC and most of this control has been 
demonstrated to be through direct binding of Ler to the respective promoter 
regions (Sperandio et al., 2000, Berdichevsky et al., 2005, Haack et al., 2003). 
Although sepL is located adjacent to ORFs encoding EspADB within the LEE4 
operon, the transcriptional level of sepL and espADB were observed to be very 
different (Kresse et al., 2000, Roe et al., 2003b) and a later study suggested a 
posttranscriptional mechanism was important for expression of LEE4 (Roe et al., 
2003b, Roe et al., 2004, Lodato and Kaper, 2009). In my study, SepL expression 
was, for the first time, demonstrated to be heterogeneous and co-ordinated with 
EspA filament expression on the surface of the cell. My data also showed that 
SepL expression was also activated by Ler, probably at the transcriptional level.  
This result confirmed that Ler functions as a global regulator for T3SS in EHEC 
O157:H7. Apart from Ler regulation of SepL production, both SepD and 
EscRSTU were found to stimulate SepL expression in my work.  This could be 
the result of feedback mechanisms when mutations in the assembly or regulation 





6.1 Transcriptional regulation of LEE4 
It was known the expression of EHEC T3SS was mainly activated through Ler 
(Friedberg et al., 1999, Sperandio et al., 2000, Elliott et al., 2000). The level of 
T3 secretion was found to be variable in certain EHEC strains but not through 
differences in LEE1 (Ler) expression (Roe et al., 2003b). Although both LEE4 
promoter sequences and LEE4 transcription levels were found to be very similar, 
it was shown that espADB transcript levels were different in different EHEC 
strains (Roe et al., 2003b, Roe et al., 2004). Therefore, it was proposed that 
LEE4 expression was post-transcriptionally regulated. In my study, to 
investigate SepL expression, a GFP reporter was tagged to the SepL C-terminus 
with which SepL expression could be visualized and measured using 
fluorescence microscopy and fluorimetry. SepL heterogeneous expression was 
also visualised using this approach. Northern blotting analysis using both sepL 
and gfp probes suggested that there were two different LEE4 transcripts detected 
which might be associated with SepL heterogeneous expression. The minimal 
sequence requirement for SepL heterogeneity was mapped to the first 81bp of 
sepL ORF using both GFP fusion and RNA modelling. It was observed that the 
AUG start codon and the ribosome binding site of sepL can be present at the 
base of  harpin loops when modelled using RNA structure software.  
 
6.2 Posttranscriptional regulation of LEE4 
Although it was demonstrated that the LEE4 transcript is subject to post-
transcriptional processing and the mRNA structure is crucial for this regulation, 
the actual regulator(s) were not known (Roe et al., 2003b, Lodato and Kaper, 
2009, Bhatt et al., 2009). In my study, multiple regulators were tested and two 
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factors were identified. Hfq, a well described sRNA chaperone which is known 
to be involved in sRNA regulation, was shown to change SepL expression 
dramatically by >100 fold when Hfq was mutated and it also changed SepL 
heterogeneous expression. While my work was submitted for publication, two 
other reports were published which showed Hfq regulation of LEE expression 
via Ler but without further mechanism (Shakhnovich et al., 2009, Hansen and 
Kaper, 2009). From my study, it is clear that Ler can activate SepL expression 
by 12.5 fold. So, considering the impact of Ler regulation, my data implied other 
Hfq regulation over LEE4 which is not via Ler. Because Hfq is a sRNA 
chaperone, there are likely to be a sRNAs involved in LEE4/SepL expression via 
transcript processing/degradation. Another factor which was found to affect 
SepL expression dramatically in my study was CsrA, an RNA binding protein. It 
also affected SepL expression not only at the population level but also at the 
single cell level. A very recent report suggested that CsrA can regulate LEE4 
expression via direct binding to the LEE4 transcript (Bhatt et al., 2009). It is 
known that these two factors were involved in Csr RNA regulation according to 
previous studies (Romeo, 1996, Romeo, 1998, Babitzke and Romeo, 2007, 
Lucchetti-Miganeh et al., 2008). Therefore, Csr regulation of LEE4, which 
includes CsrABCD and Hfq, might be responsible for LEE4 post-transcription 
regulation with the detailed mechanism still unknown (Fig. 6.1.).  Potentially via 
this mechanism, the expression of the EHEC translocon can be coupled to T3SS 
assembly which has been indicated for the T3 flagella system (Chilcott and 
Hughes, 2000, Karlinsey et al., 2000a). 
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6.3 Posttranslational regulation of T3SS by SepL-
SepD complex 
 
6.3.1 SepL-SepD complex controls the substrate 
specificity of EHEC T3S 
So far, my work has shown regulation governing T3SS at two different levels. 
However, even after the translation of T3SS, there is a posttranslational 
mechanism employed by EHEC which controls the secretion of T3S proteins. It 
has been reported that YopN controls effector secretion in Yersinia T3SS 
(Forsberg et al., 1991, Day et al., 2003, Ferracci et al., 2004). YopN was 
proposed as a syringe plug which blocked the secretion channel of the T3SS. 
The sensing of low calcium levels triggers release of the T3SS blocker YopN 
and therefore opens a conduit for effector secretion (Ferracci et al., 2005, 
Schubot et al., 2005). SepL was previously demonstrated as a key protein for 
translocon and effector export in EHEC that has homology to YopN/TyeA in 
Yersinia spp. (Pallen et al., 2005a). Here, in my study, the function of SepL was 
analysed. It was discovered that the C-terminal of SepL is not required for 
translocon export or SepL membrane localization. Of note was the fact that 
membrane-associated SepL truncates were also found to have the capacity to 
interact with SepD, indicating  that the two phenotypes may be linked. However, 
the most significant result was that the C-terminus of SepL was shown to be 
required for effector secretion but not translocon secretion. Further investigation 
revealed that the C-terminus of SepL is capable of binding to Tir, considered to 
be the first effector protein translocated into host cells (Mills et al., 2008). A 
recent publication suggests that Tir secretion is required for the hypersecretion 
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phenotype in a sepD mutant (Thomas et al., 2007). Therefore, a secretion 
controlling mechanism is proposed as depicted in Fig.6.2. As LEE4 (espADB) 
and LEE5 (tir) are co-ordinately expressed, EspADB and Tir are present in the 
bacterial cytoplasm at the same time. In my model, effector secretion is held 
back via SepL-Tir sequestration while EspA filament assembly is ongoing. SepL 
is important for this model as it acts as a substrate switch which changes T3S 
from translocon export to effector translocation. Recently it was demonstrated 
that Ca2+ is involved in the regulation of type 3 secretion in EPEC/EHEC/CR 
(Ide et al., 2003, Deng et al., 2005), altering the ratio between secreted Esp 
proteins and Tir. This effector oversecretion phenotype was also observed in 
ΔsepL and ΔsepD strains. It has been shown that the calcium concentration is 
much lower in eukaryotic cytoplasm comparing with in bacterial cytoplasm, 
Therefore, the depletion of Ca2+ was considered as a host cell signal and also a 
symbol of T3 channel opening between the bacterium and the host cell and 
which somehow alters the SepL-SepD complex conformation and initiates an 
effector substrate specific secretion. Although the mechanism of how SepL 
releases Tir is still unknown, analysis of SepL homologue protein structures 
offers a possibility. MxiC, a structural homologue in Shigella, was shown to 
have a flexible C terminus and structural change could result in substantial 
domain re-arrangement, opening up one face of the molecule (Deane et al., 
2008).  Therefore, the same kind of structural change in SepL might be 
stimulated by changes in calcium concentration or pH levels on contact with the 
host cell leading to Tir release.  
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SepD, a binding partner protein of SepL, is also involved in this secretion 
controlling mechanism. SepD is encoded by a gene (rorf6) on the LEE2 operon 
and it was known that SepD is a membrane-associated protein which binds SepL 
forming a secretion switch complex (Deng et al., 2005). In my study, SepD was 
found important not only for binding SepL to form a SepL-SepD switch 
complex, but also for SepL expression. SepD was suggested as an expression 
regulator for NleI before (Li et al., 2006). It was also demonstrated that SepD is 
necessary for normal SepL transcription in my study. Although it was known 
that the SepL-SepD complex controls the substrate specificity of EHEC T3S, the 
role of SepD was unknown. In my study, it is implied that SepD binding to SepL 
was crucial for SepL membrane localization as mentioned above. A previous 
report, and my own data, indicated that translocon proteins can be exported at 
extremely low levels from a sepD mutant while they cannot be exported at all 
from a sepL mutant (Fig. 2.1 and Deng et al., 2004). It is suggested that SepL 
might play a more important role in translocon export and this phenotype might 
result from random membrane localised SepL without the help of SepD 
localisation to the T3SS.  
 
6.3.2 Two secretion signals and SepL-SepD are required 
for effector targeting and secretion regulation  
EHEC virulence proteins are delivered via the T3SS channel but the targeting 
mechanism to the T3 basal apparatus is not clear. For T3 effector proteins in 
Yersina, there were two secretion pathways mechanism proposed (Cheng et al., 
1997). Yersinia effectors have two different secretion signals, an N-terminal 
signal and a chaperone binding domain (CBD) signal. The N-terminal signal 
 173
could target itself to the T3 basal proteins in a chaperone independent way while 
CBD signal secretion requires a chaperone protein. It has been reported that N-
terminal 15aa Tir was sufficient for translocation into host cells via T3SS 
independent of its chaperone CesT (Crawford and Kaper, 2002). However, 
nothing was known about the CBD secretion pathway of Tir so far. In my study, 
these two secretion pathways were investigated and a model proposed for EHEC 
O157 (Chapter4, Box 1). Tir without its N-terminal 20aa was tested for CBD 
secretion pathway in my model. My data demonstrated that Tir had a CBD 
secretion pathway which is enhanced in a sepL or sepD mutant. NleA, another 
EHEC T3 effector, was also tested for the N-terminal secretion pathway in my 
work. It was obvious that the N-terminal 12aa of NleA as a fusion to B-
lactamase were able to be exported via T3SS in EHEC. Critically, this construct 
could not be secreted in a sepL or sepD mutant which normally results in an 
effector hypersecretion phenotype. As SepL-SepD complex is the controller for 
effector secretion in EHEC, it led to another hypothesis that the SepL-SepD 
complex is required for N-terminal signal targeting for secretion via direct 
interactions. Using GST pull down assays, N-terminal 12aa NleA was found to 
interact directly with SepD but not SepL. My subsequent Far-Western analysis 
suggested that SepD could bind most of the hypersecreted effectors but not Tir 
which interacted with SepL. My GST pull down and Far-Western results 
strongly suggest that SepL and SepD proteins act together as a T3 gating 
complex for effector secretion.  CesT, which is a key part of effector secretion 
pathway, is known to interact with T3SS ATPase ― EscN with or without Tir 
(Gauthier and Finlay, 2003), However it was found still membrane associated in 
an EscN mutant (Thomas et al., 2005) which suggested another T3 membrane 
 174
localised protein interacts with CesT. As the SepL-SepD complex is key to 
control of effector secretion and membrane-associated, they were both tested for 
their CesT binding capacity using GST pull downs in my study and CesT 
binding to SepD in vitro was demonstrated.  Therefore, taking all the 
information together, a model (Fig.6.2) is proposed for the role of SepL-SepD 
complex: 1) SepL localizes to the T3 basal apparatus in a SepD-dependent 
manner; 2) SepL holds up effector secretion via Tir binding while facilitating 
Fig. 6.2. Posttranslational regulation of T3 translocon assembly and effector 
secretion.  
A secretion control model is proposed based on my studies of the SepL-SepD 
complex. (1) SepL localises to T3 basal apparatus in a SepD dependent manner; 
(2) SepL holds back effector secretion via Tir interaction while facilitating EspA 
filament production; (3) effectors target to SepL-SepD complex via SepD binding; 
(4) after sensing host cells signals, SepL structure changes to release Tir and 
unblock T3 channel; (5) effector protein secretion via a chaperone cycling 
mechanism between the SepD-SepL complex and the ATPase, EscN. 
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EspA filament production; 3) effectors are targeted to the T3SS via the SepL-
SepD complex; 4) after sensing host cell signals, the SepL structure is altered to 
release Tir possibly via an interaction with EscD; 5) effector protein secretion 
then occurs via a chaperone cycling mechanism based on CesT.  
 
My study of the SepL-SepD complex reveals that EHEC T3SS requires multiple 
regulatory inputs to coordinate its expression, assembly and secretion. My work 
has made a contribution to our understanding of secretion control in EHEC and 
EPEC. The proposed expression and secretion regulation models also lead to 
some interesting hypotheses about EHEC/EPEC T3SS which should to be tested 
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A1.1 Plasmid DNA Purification Using the QIAprep 
Spin Miniprep Kit 
1. 1–5 ml overnight cultures of E. coli in LB medium were harvested by 
centrifugation at 13000xg for 5 mins. 
2. Resuspend pelleted bacterial cells in 250 μl Buffer P1 and transfer to a 
microcentrifuge tube. 
3. Add 250 μl Buffer P2 and mix thoroughly by inverting the tube 4–6 
times. 
4. Add 350 μl Buffer N3 and mix immediately and thoroughly by inverting 
the tube 4–6 times. 
5. Centrifuge for 10 min at 13,000 rpm (~17,900 x g) in a table-top 
microcentrifuge. 
6. Apply the supernatants from step 4 to the QIAprep spin column by 
decanting or pipetting. 
7. Centrifuge for 30–60 s. Discard the flow-through. 
8. Recommended: Wash the QIAprep spin column by adding 0.5 ml Buffer 
PB and centrifuging for 30–60 s. Discard the flow-through. 
9. Wash QIAprep spin column by adding 0.75 ml Buffer PE and 
centrifuging for 30–60 s. 
10. Discard the flow-through, and centrifuge for an additional 1 min to 
remove residual wash buffer. 
11. Place the QIAprep column in a clean 1.5 ml microcentrifuge tube. To 
elute DNA, add 50 μl Buffer EB (10 mM Tris·Cl, pH 8.5) or water to 
the center of each QIAprep spin column, let stand for 1 min, and 
centrifuge for 1 min. 
 
A1.2 QIAquick PCR Purification Kit Protocol using a 
microcentrifuge 
1. Add 5 volumes of Buffer PB to 1 volume of the PCR sample and mix. It 
is not necessary to remove mineral oil or kerosene. 
2. If pH indicator I has beein added to Buffer PB, check that the color of 
the mixture is yellow. 
3. Place a QIAquick spin column in a provided 2 ml collection tube. 
4. To bind DNA, apply the sample to the QIAquick column and centrifuge 
for 30–60 s. 
5. Discard flow-through. Place the QIAquick column back into the same 
tube. 
6. To wash, add 0.75 ml Buffer PE to the QIAquick column and centrifuge 
for 30–60 s. 
7. Discard flow-through and place the QIAquick column back in the same 
tube. Centrifuge the column for an additional 1 min. 
8. Place QIAquick column in a clean 1.5 ml microcentrifuge tube. 
9. To elute DNA, add 50 μl Buffer EB (10 mM Tris·Cl, pH 8.5) or water 
(pH 7.0–8.5) to the center of the QIAquick membrane and centrifuge the 
column for 1 min. Alternatively, for increased DNA concentration, add 
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30 μl elution buffer to the center of the QIAquick membrane, let the 
column stand for 1 min, and then centrifuge. 
10. If the purified DNA is to be analyzed on a gel, add 1 volume of Loading 
Dye to 5 volumes of purified DNA. Mix the solution by pipetting up and 
down before loading the gel. 
 
A1.3 QIAquick Gel Extraction Kit Protocol using a 
microcentrifuge 
1. Excise the DNA fragment from the agarose gel with a clean, sharp 
scalpel. 
2. Weigh the gel slice in a colorless tube. Add 3 volumes of Buffer QG to 
1 volume of gel (100 mg ~ 100 μl). 
3. Incubate at 50°C for 10 min (or until the gel slice has completely 
dissolved). To help dissolve gel, mix by vortexing the tube every 2–3 
min during the incubation. 
4. After the gel slice has dissolved completely, check that the color of the 
mixture is yellow (similar to Buffer QG without dissolved agarose). 
5. Add 1 gel volume of isopropanol to the sample and mix. 
6. Place a QIAquick spin column in a provided 2 ml collection tube. 
7. To bind DNA, apply the sample to the QIAquick column, and centrifuge 
for 1 min. 
8. Discard flow-through and place QIAquick column back in the same 
collection tube. 
9. Recommended: Add 0.5 ml of Buffer QG to QIAquick column and 
centrifuge for 1 min. 
10. To wash, add 0.75 ml of Buffer PE to QIAquick column and centrifuge 
for 1 min. 
11. Discard the flow-through and centrifuge the QIAquick column for an 
additional 1 min at 17,900 x g (13,000 rpm). 
12. Place QIAquick column into a clean 1.5 ml microcentrifuge tube. 
13. To elute DNA, add 50 μl of Buffer EB (10 mM Tris·Cl, pH 8.5) or water 
(pH 7.0–8.5) to the center of the QIAquick membrane and centrifuge the 
column for 1 min. Alternatively, for increased DNA concentration, add 
30 μl elution buffer to the center of the QIAquick membrane, let the 
column stand for 1 min, and then centrifuge for 1 min. 
14. If the purified DNA is to be analyzed on a gel, add 1 volume of Loading 
Dye to 5 volumes of purified DNA. Mix the solution by pipetting up and 
down before loading the gel. 
 
A1.4 Polymerase Chain Reaction (PCR) 
1. Setup a 50 l PCR reaction in a DNase free PCR tube in the following 
order: ①5 l 10x PCR reaction buffer(Containing Mg2+); ②2.5 l 
foreward primer (10 M); ③2.5 l reverse primer (10M); ④2 l 
dNTP mix (10 mM each); ⑤0.2 l  Taq polymerase (5unitsl); ⑥
32.8 l dH2O; ⑦1l DNA template (10ng-500ng). 
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2. Setup 3-steps thermal cycles as following example: 
①1 cycle: 95°C (denature) for 4 mins; 
②20-30 cycles: 95°C (denature) for 45 seconds; 55°C (anneling) for 45 
seconds; 72°C (extension) for several mins (1 minute/kb of product 
length). 
③72°C for 10 mins (final extension), then keep at 4°C. 
 
A1.5 Purification of total RNA (Invitrogen 
ChargeSwitch® Total RNA Cell Kits) 
  A1.5.1 Preparing Bacterial Lysates 
1. Harvest 1-10 ml bacterial culture by centrifugation. Completely remove 
the growth medium. 
2. Wash the cells with 1X PBS. Centrifuge the cells and completely 
remove the PBS from the cell pellet. 
3. Resuspend the cells in 500 μl Lysis Mix. Pipet up and down thoroughly 
(up to 15 times) until the pellet is broken up and the lysate is no longer 
viscous. 
4. Incubate at 60°C for 15 minutes. 
5. After incubation, vortex the lysate briefly to mix. Cool the samples for 1 
minute on ice. 
 
  A1.5.2 Binding RNA 
1. Thoroughly vortex the tube containing the ChargeSwitch® Magnetic 
Beads to fully resuspend the beads in the storage buffer. 
2. Add 100 μl of ChargeSwitch® Magnetic Beads to the lysate. 
3. Add 200 μl Binding Buffer (B9) to the samples and mix by pipetting up 
and down gently 5 times using a 1 ml adjustable pipette tip set to 700 μl 
to mix the sample without forming bubbles. 
4. Incubate at room temperature for 1 minute to allow the RNA to bind to 
the beads. 
5. Place the sample on the MagnaRack™ until the beads have formed a 
tight pellet and the supernatant is clear. 
6. Without removing the tube from the magnet, carefully aspirate and 
discard the supernatant without disturbing the pellet of beads by angling 
the pipette such that the tip is pointed away from the pellet. 
 
  A1.5.3 DNase I Treatment 
1. Remove the tube containing the pelleted magnetic beads from the 
magnet. There should be no supernatant in the tube. 
2. Add 500 μl Wash Buffer (W14) to the tube and pipet up and down 
gently 5 times to resuspend the magnetic beads using a 1 ml pipette tip 
set to 700 μl to mix the sample without forming bubbles. 
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3. Place the sample on the magnet until the beads have formed a tight 
pellet and the supernatant is clear. 
4. Without removing the tube from the magnet, carefully aspirate and 
discard the supernatant without disturbing the pellet by angling the 
pipette such that the tip is pointed away from the pellet. Remove the 
tube from the magnet. 
5. Add 250 μl of the prepared DNase I Mix. Resuspend the magnetic beads 
by pipeting up and down gently 5 times using a 1 ml pipette tip set to 
200 μl to mix the sample without forming bubbles or vortex at low 
speed to avoid any solution from collecting in the cap of the tube. 
6. Incubate at room temperature for 10 minutes. 
7. Add 80 μl Binding Buffer (B9) to the sample and pipet up and down 
gently 5 times using a 1 ml pipette tip set to 200 μl to mix the sample 
without forming bubbles or vortex at low speed to resuspend the 
magnetic beads. 
8. Incubate at room temperature for 1 minute. 
9. Place the sample on the magnet until the beads have formed a tight 
pellet and the supernatant is clear. 
10. Without removing the tube from the magnet, carefully aspirate and 
discard the supernatant without disturbing the pellet by angling the 
pipette such that the tip is pointed away from the pellet. 
 
  A1.5.4 Washing RNA 
1. Remove the tube containing the pelleted magnetic beads from the 
magnet. There should be no supernatant in the tube. 
2. Add 750 μl Wash Buffer (W13) to the tube. Resuspend the magnetic 
beads by pipeting up and down gently at least 5 times using a 1 ml 
pipette tip set to 700 μl to mix the sample without forming bubbles or 
vortex at low speed to avoid any solution from collecting in the tube cap. 
3. Place the sample on the magnet until the beads have formed a tight 
pellet and the supernatant is clear. 
4. Without removing the tube from the magnet, carefully aspirate and 
discard the supernatant without disturbing the pellet by angling the 
pipette such that the tip is pointed away from the pellet. Remove the 
tube from the magnet. 
5. Add 750 μl Wash Buffer (W14) or 500 μl. Resuspend the magnetic 
beads by pipeting up and down gently 3 times to using a 1 ml adjustable 
pipette tip set to 700 μl to mix the sample without forming bubbles or 
vortex at low speed. 
6. Place the sample on the magnet until the beads have formed a tight 
pellet and the supernatant is clear. 
7. Without removing the tube from the magnet, carefully aspirate and 
discard the supernatant without disturbing the pellet by angling the 
pipette such that the tip is pointed away from the pellet. 
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  A1.5.5 Eluting RNA 
1. Remove the tube containing the pelleted magnetic beads from the 
magnet. There should be no supernatant in the tube  
2. Add 150 μl Elution Buffer (E7) to the tube. Resuspend the magnetic 
beads by pipeting up and down gently 10 times using a pipette tip set to 
120 μl to mix the sample or vortex at low speed.  
3. Incubate at room temperature for 5 minutes.  
4. Place the sample on the magnet until the beads have formed a tight 
pellet and the supernatant is clear. Without removing the tube from the 
magnet, carefully transfer the supernatant containing the RNA to a 
sterile microcentrifuge tube without disturbing the pellet by angling the 
pipette such that the tip is pointed away from the pellet.  
5. Discard the used magnetic beads. Do not reuse the magnetic beads.  
6. Store the purified total RNA at -80°C or use the RNA for the desired 
downstream application. 
 
A1.6 NorthernMax® Kit Instruction Manual 
(Before Start, Use the RNaseZap® Solution provided with the kit to remove any 
contaminating.)  
  A1.6.1 Preparation of Gel 
1. Melt 1 g agarose in 90 mL RNase-free water for every 100 mL of gel.  
2. Add 10 mL 10X Denaturing Gel Buffer per 100 mL of gel.  
3. Pour the gel to about 0.6 cm in thickness and allow the gel to solidify at 
RT or at 4°C, remove the comb.  
4. Set up the electrophoresis chamber. 
 
  A1.6.2 Preparation of Sample RNA 
1. Mix sample RNA with 3 volumes Formaldehyde Load Dye and incubate 
the samples 15 min at 65°C.  
2. Load the RNA samples into the wells of the gel and Run the gel at ~5 
V/cm.  
3. (optional) Examine the gel with UV light, and photograph it.  
 
  A1.6.3 Transfer of RNA to the Membrane 
1. Prepare blotting materials and assemble the transfer materials as shown 
in Fig.A2.1.  
2. Transfer for 15–20 min per mm of gel thickness.  
3. Disassemble the transfer setup and crosslink the RNA (UV 290nm/60 s). 
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  A1.6.4 Prehybridization and Hybridization 
1. Preheat ULTRAhyb to 68°C and prehybridize ≥30 min at 42°C (10 mL 
preheated ULTRAhyb Buffer per 100 cm2 of membrane).  
2. Add a DNA probe to the prehybridized blot and hybridize 2 hr to 
overnight.  
 
  A1.6.5 Washing and Exposure to Film 
1. 2X 5 min, room temperature washes with Low Stringency Wash 
Solution1 (Agitation). 
2. 2X 15 min, 42°C washes with High Stringency Wash Solution 2 
(Agitation).  
3. Seal radiolabeled blots in plastic and expose X-ray film 
 
A1.7 QuikChange Site-Directed Mutagenesis 
(Stratagene) 
1. Synthesize two complimentary oligonucleotides containing the desired 
mutation, flanked by unmodified nucleotide sequence. Purify these 
oligonucleotide primers prior to use in the following steps. (Mutagenic 
primers can be designed using web-based QuikChange Primer Design 
Program available online at http://www.stratagene.com/qcprimerdesign) 
2. Set up reactions as suggested in User’s Manual (5 l of 10× reaction 
buffer; 2 l (20 ng) of dsDNA template; 2.5 l (125 ng) of each 
oligonucleotide primer; 1 l of dNTP mix; 36 l ddH2O)  and start 
thermal cycles as shown in table below. 
Fig. A1.1 Schematic diagram of Downward Transfer Assembly 
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Segment Cycles Temperature Time 
1 1 95°C 30 seconds 
95°C 30 seconds 
55°C 1 minutes 
2 16 
68°C 7 minutes 
 
3. Following temperature cycling, place the reaction on ice for 2 minutes 
to cool the reaction to ≤37°C. 
4. Add 1 l of the Dpn I restriction enzyme (10 U/l) directly to each 
amplification reaction and gently mix each reaction mixture by 
pipetting the solution up and down. Spin down the reaction mixtures in 
a microcentrifuge for 1 minute and immediately incubate each reaction 
at 37°C for 1 hour to digest the parental dsDNA. 
5. Transfer 1 l of the Dpn I-treated DNA from each sample reaction to 
separate aliquots of the XL1-Blue supercompetent cells. Heat shock the 
transformation reactions for 45 seconds at 42°C and then place the 
reactions on ice for 2 minutes. Add 0.5 ml of NZY+ broth preheated to 
42°C and incubate the transformation reactions at 37°C for 1 hour with 
shaking at 200 rpm. 
6. Plate 200 l of each transformation reaction on LB(chloramphenicol) 
agar plate and Incubate the transformation plates at 28°C for >16 hours.  
7. Pick 8 colonies and extract DNA plasmid using the QIAprep Spin 
Miniprep Kit. 
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Summary
Type III secretion (T3S) from enteric bacteria is a
co-ordinated process with a hierarchy of secreted pro-
teins. In enteropathogenic and enterohaemorrhagic
Escherichia coli, SepL and SepD are essential for
translocator but not effector protein export, but how
they function to control this differential secretion is
not known. This study has focused on the different
activities of SepL including membrane localization,
SepD binding, EspD export and Tir secretion regula-
tion. Analyses of SepL truncates demonstrated that
the different functions associated with SepL can be
separated. In particular, SepL with a deletion of 11
amino acids from the C-terminus was able to localize
to the bacterial membrane, export translocon proteins
but not regulate Tir or other effector protein secretion.
From the repertoire of effector proteins only Tir was
shown to bind directly to full-length SepL and the
C-terminal 48 amino acids of SepL was sufficient to
interact with Tir. By synchronizing induction of T3S, it
was evident that the Tir-binding capacity of SepL is
important to delay the release of effector proteins
while the EspADB translocon is secreted. The interac-
tion between Tir and SepL is therefore a critical step
that controls the timing of T3S in attaching and effac-
ing pathogens.
Introduction
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is
the main EHEC serotype associated with outbreaks of
gastrointestinal disease in North America, parts of
Europe and Japan. It is an important pathogen that can
be life-threatening particularly in the young and the
elderly. EHEC strains express a type III secretion (T3S)
system encoded on the locus of enterocyte effacement
(LEE) pathogenicity island (Jerse et al., 1990; McDaniel
et al., 1995). The main phenotype associated with EHEC
O157 T3S is the formation of attaching and effacing
(A/E) lesions (Knutton et al., 1989; 1998). A/E lesions
require the injection of the translocated intimin receptor
(Tir) into the enterocyte (Kenny et al., 1997; Deibel et al.,
1998) and the cytoskeleton rearrangements associated
with A/E lesions require Tir and EspFu/TccP (Campel-
lone et al., 2004; Garmendia et al., 2004) that act
through N-WASP activation of the Arp2/3 complex
leading to alpha-actinin polymerization (Garmendia
et al., 2005).
The T3S system is evident as a needle-like projection
on the surface of the bacterium. Its predicted structure is
considered to have the proteins EscD (Pas), R, S, T, U
and V in the inner membrane joined to an outer mem-
brane ring of EscC, with EscF forming a needle-like
structure at the base of the EspA filament (Daniell et al.,
2001; Yip et al., 2005). The export of Tir and other effec-
tor proteins occurs through the hollow filament, with the
timing and regulation of translocation potentially driven
by chaperone proteins (Wainwright and Kaper, 1998;
Elliott et al., 1999; Neves et al., 2003). The filament is
considered to link to a pore in the epithelial cell mem-
brane that is composed of the bacterial protein EspD,
and possibly EspB (Wachter et al., 1999). Export of
effector proteins into the host cell is therefore dependent
on the initial export and assembly of EspADB. The
conduit that these three proteins form has been referred
to as a ‘translocon’ and the proteins as ‘translocators’
(Deng et al., 2005).
The LEE pathogenicity island contains at least 41
genes in five main operons. espADB are expressed from
the LEE4 operon and are preceded in this operon by
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sepL. sepL encodes a protein composed of 351 amino
acids (aa) with a predicted molecular weight of 39.95 kDa
(Kresse et al., 2000). Like many genes in the LEE it is
highly conserved between EHEC and enteropathogenic
E. coli (EPEC) strains (93.7–94.3% identity). SepL is
central to a switch that occurs between the export of
EspADB and the export of effector proteins. Original
research by Kresse et al. (2000) indicated that SepL was
associated predominately with the bacterial membrane
and in particular the outer membrane. Research using
EPEC O127 has demonstrated that the majority of SepL is
either in the cytoplasm (O’Connell et al., 2004) or in both
the cytoplasm and the inner membrane (Deng et al.,
2005).
How SepL works to govern the switch between trans-
locon and effector protein secretion is not known, but both
yeast two-hybrid and in vitro studies have demonstrated
that SepL interacts directly with SepD, a protein encoded
on LEE2 (Creasey et al., 2003; O’Connell et al., 2004).
A deletion of sepD has a similar phenotype to a sepL
mutant, in that the export of translocators but not effectors
is prevented (Deng et al., 2004). In fact, deletion of either
sepL or sepD leads to an increase in the levels of
secreted Tir and other effector proteins and this increased
effector protein secretion is not considered to be con-
trolled at the transcriptional level (Deng et al., 2004;
2005). A recent hypothesis is that SepL and SepD act as
a gate to allow translocator export, but that this gate
dissociates or changes in response to a drop in calcium
levels following the opening of a conduit to the host cell,
allowing effectors to be exported (Deng et al., 2005).
However, there is no evidence that SepL or SepD inter-
acts directly with the translocon proteins EspA, D or B.
The majority of SepL (267 aa) shares some homology
with YopN and its carboxy terminus (83 aa) homology with
TyeA, both from Yersinia spp. (Pallen et al., 2005). As
TyeA controls the secretion of specific effector proteins in
Yersinia spp. (Cheng and Schneewind, 2000; Day et al.,
2003; Sundberg and Forsberg, 2003) it was decided to
investigate full-length and carboxy-terminal truncates of
SepL in terms of the known activities of SepL including
localization, SepD binding, translocon export and Tir
secretion control.
Results
SepL is homologous to a combination of YopN and TyeA
from Yersinia spp. (Pallen et al., 2005; Fig. 8). The
carboxy terminus of SepL (final 83 aa) is homologous with
TyeA and so carboxy-terminal truncates of SepL fused to
eGFP were tested to determine if these deletions can
separate the different functions of SepL. The functions
analysed were the capacity to: (i) localize to the bacterial
membrane, (ii) bind to SepD, (iii) restore EspD secretion
in sepL mutants and (iv) reduce Tir secretion in sepL
mutants. Five truncated proteins were initially constructed
as illustrated in Fig. 1A.
Membrane localization and the role of SepD
Previous research has demonstrated that SepL in EHEC
O157 can be membrane-associated and can also bind
to SepD (Kresse et al., 2000; Creasey et al., 2003;
O’Connell et al., 2004). The different-length fusion con-
structs were examined for their presence in bacterial
membrane-containing fractions. The full-length SepL–
eGFP construct was present in membrane-containing
preparations of bacteria prepared from T3S-permissive
conditions while this was not the case for eGFP alone,
which was only detectable in the cytoplasmic fraction
(Fig. 1B). Deletion of either 11 aa or 61 aa from the car-
boxyl end of SepL (creating 340 aa and 290 aa proteins
fused to eGFP) still allowed detection in the membrane-
containing fractions, although this distribution was pre-
vented by any further truncation with detection only in the
cytoplasmic fraction. As controls, the distributions of
OmpA and GroEL in the same samples were as expected
(OmpA > 90% in the membrane-containing fraction;
GroEL > 99% in the cytoplasmic fraction) (Fig. 1B). Direct
imaging of individual bacteria containing the full-length
SepL–eGFP clearly showed a higher concentration of
fluorescence localized to the periphery of the bacteria
(Fig. 1C). This was not the case for bacteria expressing
just eGFP (Fig. 1C). The biochemical and imaging data
indicated that SepL localizes to the bacterial membrane
and this association does not require the carboxy-terminal
61 aa of SepL.
We next wanted to determine what effect sepD deletion
would have on the localization of SepL. sepD was deleted
by allelic exchange and the construct confirmed by
complementation with sepD on a plasmid (pDW20, data
not shown). Localization of SepL–eGFP was examined
using a combination of Western blotting and single cell
imaging (Figs 2A and B and 1C). The proportion of the
full-length SepL–eGFP hybrid protein that was in the
membrane-containing fraction was reduced in a sepD
background (Fig. 2A). In addition, in this background, the
localization of SepL–eGFP was clearly different in the
bacteria. The distribution now appeared asymmetric
(Fig. 2B), unlike the distribution of eGFP alone, indicating
that in the absence of SepD, SepL may associate with
another cellular protein that exhibits this asymmetric
distribution. The different SepL truncates fused to eGFP
were then assessed for their capacity to bind to purified
GST–SepD attached to a glutathione-sepharose 4B
column. Full-length SepL as well as the 340 aa and
290 aa fusions bound to SepD but further truncation from
the carboxy terminus prevented the interaction (Fig. 3).
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The SepL truncates that localized to the membrane are
the same as those that bound to SepD. Given that dele-
tion of sepD also reduced membrane association of SepL
and altered its cellular distribution, it is evident that SepD
is probably required for SepL localization to the bacterial
membrane.
Complementation of translocon (EspD) export in
a sepL mutant
SepL is required for translocon but not effector protein
export and translocon export can be complemented in a
sepL mutant by supplying sepL in trans (Kresse et al.,
CB
A
Fig. 1. Analysis of SepL–eGFP localization.
A. Figure of the SepL truncates fused to eGFP that were used in the study. The full-length, 340 aa, 290 aa and 267 aa SepL regions were
also generated as carboxy-terminal 6¥ His-tagged constructs.
B. Membrane localization of SepL truncates fused to eGFP. Western blotting was used to detect eGFP as described in Experimental
procedures. Integrity of the fractions was confirmed with anti-GroEL and anti-OmpA antibodies.
C. Fluorescence and phase contrast image overlays demonstrating localization of eGFP and SepL–eGFP in a single bacterium. Fluorescence
levels were measured along a transect drawn through individual cells. The examples shown demonstrate the peripheral localization of
SepL–eGFP but not eGFP alone.
SepL function in EHEC O157 1501
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 69, 1499–1512
2000). This was also the case in this study in which the
full-length SepL–eGFP fusion could complement a com-
plete sepL deletion mutant for EspD secretion (Fig. 4A).
In our hands this complementation never achieved the
EspD secretion levels of the wild-type strain and this
was also the case for complementation with sepL alone,
pDW24 (data not shown). Analysis of the SepL truncates
in the sepL deletion strain indicated that only the full-
length protein and the 11 aa carboxy-terminal deletion
were able to export EspD. Deletion of 11 aa from SepL
partially complemented the sepL deletion for EspD
secretion (Fig. 4A). It was interesting to note that a dele-
tion of 61 aa (leaving a 290 aa SepL derivative) failed to
export EspD despite membrane localization and SepD
binding activity.
Our ongoing work indicates that the failure to com-
pletely complement a full sepL deletion is due to changes
in the LEE4 transcript (data not shown). To verify the
phenotypes of the SepL truncates in a sepL-mutated
background, a frameshift mutation was constructed in
sepL (ZAP1211) that will have less impact on the structure
of the LEE4 transcript. In this background, EspD secretion
could be complemented completely by sepL in trans
(Fig. 4D). The 11 aa carboxy-terminal deletion in this
background was still able to restore some EspD secretion,
although at markedly reduced levels compared with the
full-length complement (Fig. 4D).
Regulation of effector protein secretion
A sepL mutant is characterized by high levels of Tir secre-
tion (Kresse et al., 2000 and Fig. 4B) and of other effector
proteins including NleA (Deng et al., 2004). To investigate
the function of the different SepL truncate fusions in this
capacity, the levels of Tir secreted were determined by
Western blotting in the sepL mutants transformed with the
different SepL constructs. Of note was that only the full-
length SepL construct was able to lower Tir secretion
levels to those demonstrated for the wild-type strain
(Fig. 4B). To confirm this result and to rule out any impact
of eGFP on the phenotypes, four His-tagged SepL con-
structs were also tested. These were: (i) full-length SepL,
(ii) a protein with the first 340 aa of SepL but deleted for
the carboxy-terminal 11 aa, (iii) the first 290 aa of SepL
but deleted for the carboxy-terminal 61 aa and (iv) the first
267 aa of SepL but deleted for the carboxy-terminal
84 aa. These variants had exactly the same phenotypes
as the respective eGFP fusions in the sepL deletion
background. For example, analysis of the general secre-
tion profiles indicated that the 11 aa carboxy-terminal
SepL truncate failed to control secretion of Tir, whereas
A
B
Fig. 2. SepL–eGFP localization in different EHEC O157 genetic
backgrounds.
A. Western blot detection of eGFP in membrane and cytoplasmic
fractions of the described EHEC O157 strains expressing
SepL–eGFP (pDW6). Western blotting was carried out as
described in Experimental procedures.
B. Localization of SepL–eGFP in a sepD mutant. Fluorescence
intensities across a representative bacterium expressing the
SepL–eGFP fusion are shown. The asymmetric distribution of the
SepL–eGFP fusion in a sepD mutant background (ZAP1144) is
apparent when compared with the distribution in the wild-type
background (Fig. 1C).
Fig. 3. Capacity of SepL truncates to bind to SepD. Each of the
SepL–eGFP constructs was tested for the capacity to bind to
immobilized GST–SepD. Following elution, the SepL–eGFP
truncates were detected by Western blotting as described in
Experimental procedures.
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complementation with full-length SepL could (Fig. 4B and
C). Moreover, it was apparent that this regulation also
applied to other T3S effectors with sizes equivalent to
those of NleA and EspZ, as complementation with full-
length SepL restored normal secretion levels in a sepL
mutant but de-regulated effector protein secretion was still
apparent when the 11 aa carboxy-terminal SepL truncates
(or any of the other truncates) were transformed into this
background (Fig. 4C). This result was also confirmed in
the sepL frameshift mutant background (Fig. 4D).
Tir binds to the carboxy terminus of SepL
To determine if any of the effector proteins directly inter-
act with SepL, the secreted supernatant effector proteins
from a sepL mutant were separated by SDS-PAGE and a
Far-Western was carried out to examine their interaction
with 6¥ His-tagged SepL. Using this approach, SepL only
interacted clearly with one protein in the bacterial super-
natant and this protein was of a molecular weight equiva-
lent to Tir (Fig. 5A). This interaction was confirmed using
a GST–SepL construct that bound to 6¥ His-tagged Tir
(Fig. 5B). As a control, His-tagged Tir bound to GST–
CesT (and GST–SepL) but not to GST alone. As an 11 aa
deletion at the carboxy terminus of SepL failed to limit Tir
secretion, we hypothesized that the SepL interaction with
Tir that limits effector protein secretion requires the
carboxy terminus of SepL. This was confirmed as 6¥
His-tagged Tir was shown to bind to full-length SepL–
eGFP but not to any of the SepL truncates (Fig. 5C). We
next wanted to determine if the carboxy terminus of SepL
alone could bind to Tir. The final 48 aa of SepL was fused
to GST and immobilized on a glutathione-sepharose 4B
column. This region was selected based on a compara-
tive domain analysis with YopN/TyeA (Fig. 8). Tir-His was
able to bind to this hybrid protein but not GST alone
(Fig. 5D).
The Far-Western analysis indicated that only Tir was
interacting with SepL from the different secreted effector
proteins. However, this may be a result of conformation
or levels of the proteins present in this type of analysis.
To determine if SepL could interact with another hyper-
secreted effector protein, NleA was expressed with either
an amino- or carboxy-terminal 6¥ His-tag but neither con-
struct demonstrated any interaction with immobilized
GST–SepL (Fig. S1). Therefore, despite the fact that
SepL regulates the secretion of a combination of effector
proteins, the data presented here indicate that the inter-
action of SepL with effector proteins may be limited to Tir
and this interaction is prevented by removal of the final
11 aa of SepL and that the final 48 aa of SepL are suffi-
cient to bind to Tir.
Fig. 4. Analysis of protein secretion in E. coli
O157 (DsepL) expressing different SepL
truncates.
A. The first two panels show EspD levels in
the supernatant (SN) and whole-cell fractions
(WC) when the different SepL–eGFP
constructs were used to complement a sepL
mutant (ZAP1143).
B. The panel shows detection of secreted Tir
by Western blotting from the samples labelled
in (A).
C. Analysis of bacterial supernatants from
a sepL mutant complemented with the
His-tagged SepL constructs described in the
Fig. 1 and the text. The wild-type (ZAP193)
supernatant profile is also shown for
comparison. These experiments confirm the
results obtained with the SepL–eGFP
constructs in (A) and (B) and demonstrate
that the carboxy-terminal 11 aa of SepL are
required to limit the secretion of effector
proteins in addition to Tir.
D. Colloidal blue staining of secreted proteins
from E. coli O157 engineered to contain a
frameshift mutation in sepL (ZAP1211) and
then complemented with full-length SepL
(pDW48) and the C-terminal 11 aa deletion
of SepL (pDW47). Western blotting for EspD
and Tir for these strains is also shown.
Preparation of protein samples and detection
of Tir and EspD by Western blotting were as
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Analysis of Tir domains that interact with SepL
and CesT
Tir is stabilized by CesT that is also required for efficient
secretion of Tir (Abe et al., 1999; Elliott et al., 1999). CesT
is also the main chaperone for the other effector proteins
that are hyper-secreted in a sepL mutant (Thomas et al.,
2005). Prevention of Tir secretion may simply require SepL
binding to Tir but the impact of CesT in this interaction is
unknown. To determine where SepL and CesT bind to Tir,
different Tir constructs were expressed as His-tagged
fusions and interactions with immobilized GST–SepL,
GST–CesT and GST alone were analysed (Fig. 6). Previ-
ous research has shown that the N-terminal 233 aa of Tir
contains a CesT binding domain (Abe et al., 1999; Elliott
et al., 1999). Our results confirmed that the first 200 aa of
Tir bound to CesT (Fig. 6). However, another CesT binding
domain was mapped in Tir deleted for its first 200 aa. Even
deletion of the first 382 aa of Tir still produced a polypeptide
that could bind to CesT. By contrast, the first 200 aa of Tir
did not interact with SepL but the remainder of the protein
did bind to SepL as did the 382 amino-terminal truncate.
The data indicate that there are at least two regions in Tir
that can interact with CesT and that one of these could
compete with SepL–Tir binding.
The interaction of Tir with SepL controls the timing
of secretion
As an 11 aa deletion of SepL retains the capacity to export
translocon proteins but is unable to limit effector protein
secretion, it raised the possibility that effector protein
export was now occurring at the same time as translocon
export as the capacity of SepL to bind Tir potentially
sequesters Tir export and somehow limits the secretion of
other effector proteins during translocon assembly. To test




Fig. 5. SepL binds to Tir.
A. Detection of supernatant proteins that bind to SepL. Supernatant proteins from a sepL mutant (ZAP1143) were separated by SDS-PAGE,
transferred to a nitrocellulose membrane and then incubated with SepL-His (+) prepared from E. coli BL21. As a control (-), the incubation
with SepL-His was omitted. The Far-Western was developed following incubation with an anti-penta-His antibody as described in Experimental
procedures.
B. Detection of Tir binding by immobilized SepL. His-tagged Tir was prepared in E. coli BL21 and incubated with immobilized GST–SepL,
GST–CesT and GST alone. Following elution, Tir-His was detected by Western blotting.
C. The C-terminus of SepL is required for Tir binding. 6¥ His-tagged Tir was purified on nickel-NTA columns and E. coli K-12 (AAEC185)
lysates, containing the different indicated truncates of SepL fused to eGFP, were run through the columns. Following washes, proteins were
eluted and separated by PAGE. SepL constructs were then detected by Western blotting using an anti-GFP antibody.
D. The carboxy terminus of SepL is sufficient to bind to Tir. The C-terminal 48 aa of SepL was fused to GST and immobilized onto a column.
6¥ His-tagged Tir bound to the 48 aa C-terminal SepL construct and was detected in the eluate by Western blotting.
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the wild-type strain and a sepL mutant complemented
with either full-length sepL or the 11 aa carboxy-terminal
deletion. Bacteria were cultured initially in a medium
(Luria–Bertani, LB) that is not permissive for T3S and then
transferred to a medium (MEM-HEPES) that induces T3S.
Following the transition, samples were taken at regular
intervals and the levels of secreted Tir and EspD deter-
mined as described in Experimental procedures. For the
full-length SepL complement in the sepL deletion, EspD
secretion was detectable but not Tir at early time points
(Fig. 7A). This pattern was similar in the wild-type strain
(Fig. 7A) By contrast, in the sepL mutant complemented
with the C-terminal 11 aa deletion of SepL, Tir secretion
was detectable along with EspD secretion at early time
points (Fig. 7A) following the induction of T3S. While it is
appreciated that Tir secretion levels are higher in the
truncate-complemented background it is clear from analy-
sis of the EspD/Tir secretion ratios (Fig. 7B) that Tir
secretion is no longer delayed in the sepL mutant
complemented with the 11 aa truncate by comparison with
full-length sepL complementation or the wild type. Conse-
quently, secretion hierarchy is disrupted when the capac-
ity of SepL to bind Tir is removed.
Discussion
SepL and SepD are critical proteins controlling the
switch between translocon and effector protein secretion
in A/E E. coli. From the current study, we propose that
SepL directly contributes to the T3S hierarchy by binding
to Tir and through this sequestration prevents the secre-
tion of Tir and other effector proteins while the translo-
con components are exported. This activity requires the
carboxy terminus of SepL and can be separated from
other phenotypes associated with SepL, including its
membrane localization, SepD binding and translocon
export.
The C-terminus of SepL shares some homology with
TyeA and the remainder of SepL some homology with
YopN, both from Yersinia spp. (Pallen et al., 2005)
(Fig. 8). TyeA controls the export of specific effector pro-
teins so it was logical to investigate C-terminus deletions
Fig. 6. SepL and CesT binding domains of Tir. Different 6¥
His-tagged truncates of Tir were incubated with immobilized
GST–CesT, GST–SepL and GST alone. Following elution, 6¥
His-tagged Tir constructs were detected as described in the
Experimental procedures. 100aaTir-His and 200aaTir-His are
His-tagged constructs containing the first 100 and 200 aa of Tir
respectively. The first 200 aa of Tir is known to contain a CesT
binding region (Abe et al., 1999; Elliott et al., 1999). -200aaTir-His
and -382aaTir-His are His-tagged constructs containing Tir without
the first 200 and 382 aa respectively.
B
A
Fig. 7. Secretion timing is altered by deletion of the carboxy
terminus of SepL.
A. E. coli O157:H7 (ZAP193) (top panel) and the sepL deletion
(ZAP1143) (second panel) complemented by either full-length SepL
(pDW6) or SepL with a deletion of the final 11 aa (pDW30) were
cultured in LB that represses T3S and then transferred into
MEM-HEPES that induces T3S.
B. Samples were taken at defined optical densities and the levels
of secreted EspD and Tir determined as described in Experimental
procedures. The cultures were repeated in triplicate and the blots
shown represent the secretion patterns from one set from which
the ratio of secreted Tir to EspD is also shown. Wild type, ZAP193
(); DsepL, ZAP1143 complemented with full-length SepL (), or
with the C-terminal -11 aa truncate ().
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of SepL to see if these can separate the known activities
of SepL and this did prove to be the case. Membrane
localization was investigated by both imaging and bio-
chemical analysis of SepL–eGFP constructs. While some
cleavage of eGFP was detected from these heterologous
proteins it was evident that only the full-length SepL and
SepL constructs with deletions of either 11 aa or 61 aa
from the C-terminus were able to localize to membrane-
containing fractions. The same three SepL constructs
were also able to bind to SepD in vitro. In addition, a sepD
mutation reduced the levels of SepL–eGFP associated
with the membrane-containing fractions and led to its
asymmetric distribution in the bacterial cell. SepD is
expressed from LEE2 along with T3S basal apparatus
proteins and it is likely that the SepL interaction with SepD
is responsible for the membrane localization of SepL,
possibly to the T3S apparatus, although higher-resolution
imaging is required to investigate this. This work confirms
previous research that indicated that SepL can be
membrane-associated (Kresse et al., 2000; Deng et al.,
2005), although one report for EPEC concluded that it
was only cytoplasmic (O’Connell et al., 2004). This same
study also concluded that effector proteins were not
hyper-secreted in a sepL mutant, although this does not
agree with the current study and other published research
(Kresse et al., 2000; Deng et al., 2004; 2005). In our work
the ratios obtained for the SepL–eGFP fusion in the dif-
ferent fractions were variable, potentially indicating only a
weak association of SepL with the membrane, potentially
via SepD. Each membrane preparation may disassociate
this interaction to different levels and account for the
variation seen.
SepL-dependent translocator secretion was abolished
with a C-terminus deletion of 61 aa, even though this
construct could still bind SepD and localize to the
membrane. By contrast, only the full-length SepL protein
was able to restore normal levels of Tir and other effector
protein secretion in a sepL mutant. Therefore, the 11 aa
deletion still functioned to some extent to export translo-
con proteins but had lost effector protein secretion control.
As the final 11 aa of SepL were essential for controlling
effector protein secretion, we examined whether any of
these hyper-secreted proteins could actually bind to
SepL. Tir was shown to interact with SepL and this inter-
action required the carboxy-terminal 11 aa of SepL. In
addition, the C-terminal 48 aa of SepL, when combined
with GST, was capable of binding to Tir (Fig. 5D). When
the structure of the YopN76-293–TyeA complex (Schubot
et al., 2005) is overlaid with SepL, it is evident that the
final 48 aa of SepL map to the final two alpha helices of
TyeA and this domain is sufficient to interact with Tir. The
sequence divergence at the C-terminal 12 aa between
TyeA and SepL may relate to the recognition of different
proteins in the two organisms. Our work also demon-
strates that the region of SepL required for SepD binding
must lie within the YopN homologous region (Fig. 8).
There was no evidence from our work that any of the
other secreted effector proteins could bind directly to
BA
Fig. 8. Protein sequence and predicted structural comparisons between SepL and YopN/TyeA.
A. Amino acid alignment of SepL (gb|AAG58821) with YopN (gb|AAS58563) and TyeA (gb|AAS58564) of Yersinia pestis. Align X software
(Invitrogen) was used to align the first 268 aa of SepL with YopN (294 aa) and the remaining 84 aa of SepL with TyeA (93 aa). Identical aa are
shown by red text on a yellow background; blocks of similar amino acids are highlighted in green.
B. Structure of the YopN76-293–TyeA complex overlaid with SepL (red). YopN and TyeA are depicted in green and cyan respectively.
The alignment and mapping was performed using Swissmodel using the 1XL3 file from Schubot et al. (2005) as a model. PyMol
(http://pymol.sourceforge.net/) was used to generate the figure.
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SepL, although this cannot be discounted as they have
not all been tested individually. The Far-Western analysis
only identified one clear binding partner, Tir. While NleA
is known to be secreted at higher levels in a sepL
mutant, it did not bind to SepL in vitro using similar
approaches that were successful with Tir. Therefore, it
appears likely that the Tir–SepL interaction is critical in
limiting the secretion of effector proteins in general. This
finding fits well with recently published research (Thomas
et al., 2007) that demonstrated that Tir is required for
hyper-secretion of other effector proteins in a sepD
mutant background.
Our previous work has demonstrated that LEE4 and
LEE5 are co-ordinately expressed, indicating that Tir will
be produced in individual bacteria while the translocon is
being assembled (Roe et al., 2004). Therefore, we inves-
tigated the hypothesis that the binding of Tir by SepL
actually sequesters it and prevents its early release while
the translocon is being assembled. The timing of release
of Tir and the translocon protein EspD were investigated
using a shift in culture conditions from a non-permissive to
a permissive medium for T3S. Under these conditions, Tir
secretion was demonstrated to be delayed in the wild type
and a sepL deletion strain complemented by full-length
SepL. However, Tir secretion occurred at the same time
as EspD secretion when the strain was complemented
with SepL deleted for the C-terminal 11 aa. The data
support the proposition that the timing of Tir and effector
protein secretion is directly controlled by SepL binding to
Tir. The altered timing may also account for the higher
levels of secreted effector proteins found in bacterial
supernatants of sepL mutants as these can be exported
over a longer period by each cell. However, as the dele-
tion of the C-terminus of SepL will have other effects on
SepL function, we cannot rule out that another mecha-
nism may be responsible for limiting effector protein
export.
How Tir binding to SepL could prevent secretion of
other effector proteins is not understood but it must pre-
sumably stall a series of T3S apparatus interactions with
effector proteins prior to EscN/ATPase-driven export.
Another key question is how such a mechanism is then
switched once translocon export has finished, allowing
effector protein export. It has been suggested that
opening a conduit to the host cell via the translocon could
induce a change in local ion concentrations in particular
calcium, which may disassociate or alter the SepL/SepD
complex (Deng et al., 2005). Our current work has indi-
cated that the SepL–Tir interaction could also be a target
for such a trigger. Alternatively, SepL and/or SepD may
have limited stability so their activity is only for a defined
period. Another possibility is that SepL (like YopN) may be
secreted to initiate effector secretion (Pallen et al., 2005).
We have tested whether His-tagged fusions to SepL or
the SepL region homologous to YopN (the first 267 aa of
SepL) are exported into the bacterial supernatant. There
was no evidence for this even though both were
expressed inside the bacterial cell (data not shown). An
indication of a potential mechanism to release Tir from
SepL comes from previous research that has shown a
direct interaction between Tir and EscD (Pas) (Kresse
et al., 1998). EscD is considered to be a protein in the
inner membrane complex of the T3S (Ogino et al., 2006)
and when deleted prevents both translocon and effector
protein secretion. However, plasmid complementation of
escD led to high levels of Tir secretion (Ogino et al.,
2006), indicating that overexpression of EscD also leads
to loss of Tir secretion control. We have shown that SepL
binds directly to EscD (D. Wang and D. Gally, unpubl.
data) and this binding requires the same final 11 aa of
SepL that are required for SepL binding to Tir. It may be
that two different organizations of the SepL–SepD
complex are required to permit translocator and effector
protein export with different binding partners at the
C-terminus of SepL.
Normal levels of Tir secretion also require presenta-
tion by its chaperone, CesT, and will require the inter-
action of complexed Tir with the ATPase, EscN, which
then energizes the export of Tir (Gauthier and Finlay,
2003). Many other effector proteins utilize CesT, espe-
cially those known to be hypersecreted in a sepL mutant
(Thomas et al., 2005). Our in vitro data indicate that the
CesT binding domain shown in the amino-terminal third
of Tir is not the only region of Tir that interacts with
CesT. It remains possible that while the amino-terminal
domain is important for stability a further domain is nec-
essary for its export. Multiple chaperone binding sites in
Tir have been suggested by others (Elliott et al., 1999).
In the context of the current work, SepL and CesT were
shown to bind in the C-terminal half of Tir and prelimi-
nary data support competitive interactions between
SepL and CesT for Tir binding. CesT and Tir are both
expressed from the LEE5 transcript (Elliot et al., 1999)
and LEE4 and LEE5 are co-ordinately expressed (Roe
et al., 2004). As a consequence, Tir stabilized by CesT
will be present in the cell while EspA filaments are
assembled. CesT–Tir must interact with the T3S system
to allow Tir release from CesT and its subsequent
export. Therefore, we propose that the CesT–Tir
complex interacts with a SepD–SepL ‘filter’ but the inter-
action of Tir with SepL becomes the stalling point
for effector protein secretion. Once Tir export is triggered
by disassociation of this interaction, other effectors
can then be exported but these also have to pass
through the SepD–SepL ’filter’, perhaps requiring an
interaction of CesT and/or effectors with SepD. This
combination of possible interactions is the focus of
ongoing research.
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Logically, secretion of Tir and effector proteins
should be restricted until the translocon is assembled
so they can be secreted directly into the host cell. If
Tir is secreted prior to this it may interfere with translo-
con assembly and perhaps, more importantly, it may
bind to surface-expressed intimin and therefore block
the subsequent interaction of intimin with host
membrane-inserted Tir. A/E E. coli along with Citrobacter
rodentium are unique in having SepL and SepD proteins
and are the only bacterial pathogens to date known to
inject their own receptor. This may not be a coincidence
as tight control over the release of this receptor is
required.
Experimental procedures
Bacterial strains, plasmids, oligonucleotides,
media and antibodies
The bacterial strains, media, antibodies and plasmids used
in the study are described in Tables 1 and 2. Table 3 lists
the oligonucleotide primers used. MEM-HEPES is minimal
essential medium with HEPES buffer (Sigma), containing
additional glucose to a final concentration of 0.2%. LB
broth was also used (Oxoid). Antibiotics were included
when required at the following concentrations: chloram-
phenicol 12.5 mg ml-1, kanamycin 25 mg ml-1 and ampicillin
50 mg ml-1.
Table 1. Plasmids used in the study.
Plasmid Description
pACYC184 Low-copy-number cloning vector
pGEX-4T-2 Plasmid contained GST gene fusion system from Amersham Biosciences
pET21d Plasmid contained 6¥ His gene fusion system from Novagen
pTir-His pET21d digested with XbaI/XhoI; fragment contained full-length tir gene amplified from ZAP193 and inserted
p100Tir-His pET21d digested with XbaI/XhoI; fragment contained the first 100 aa tir gene amplified from ZAP193 and inserted
p200Tir-His pET21d digested with XbaI/XhoI; fragment contained the first 200 aa tir gene amplified from ZAP193 and inserted
p-200Tir-His pET28a digested with NdeI/XhoI; fragment contained the 201–558 aa tir gene amplified from ZAP193 and inserted
p-382Tir-His pET28a digested with NdeI/XhoI; fragment contained the 382–558 aa tir gene amplified from ZAP193 and inserted
pDG028 Low-copy-number vector containing sacB/kan cassette, laboratory stock
pIB307 pMAK705-based vector for allelic exchange; temperature-sensitive replicon (Blomfield et al., 1991)
pAJR70 pACYC184 digested with BamHI; egfp gene cloned BamHI/BglII (Roe et al., 2003)
pDW6 pAJR70 digested with BamHI/KpnI; sepL with its own promoter amplified from ZAP193, cloned in frame 5′ to egfp
pDW7 pIB307 digested with XbaI/HindIII; fragment contained 1165 bp sepL downstream sequence amplified from ZAP193
and inserted
pDW8 pDW7 digested with KpnI/BamHI; fragment contained 985 bp sepL upstream sequence amplified from ZAP193 and inserted
pDW9 pGEX-4T-2 digested with BamHI/SmaI; fragment contained full-length sepL gene amplified from ZAP193 and inserted
pDW10 pIB307 cut with KpnI/BamHI; fragment contained 985 bp sepL upstream sequence amplified from ZAP193 and inserted
pDW11 pDW8 digested with BamHI; sacB/kan cassette inserted
pDW15 pGEX-4T-2 digested with BamHI/SmaI; fragment contained full-length sepD gene amplified from ZAP193 and inserted
pDW20 pAJR70 digested with BamHI/KpnI; fragment contained full-length sepD gene amplified from ZAP193, cloned in frame
5′ to egfp
pDW21 pDW307 digested with BamHI/SacI; fragment contained 746 bp sepD upstream sequence amplified from ZAP193 and inserted
pDW22 pDW21 digested with BamHI/AseI; fragment contained 805 bp sepD downstream sequence amplified from ZAP193
and inserted
PDW23 pDW22 digested with BamHI; sacB/kan cassette inserted
pDW24 pACYC184 digested with BamHI; full-length sepL gene with its own promoter amplified from ZAP193 and inserted
pDW26 pACYC184 digested with BamHI/KpnI; 1–51 bp sepL gene with its own promoter amplified from ZAP193 and inserted
pDW27 pACYC184 digested with BamHI/KpnI; 1–210 bp sepL gene with its own promoter amplified from ZAP193 and inserted
pDW28 pACYC184 digested with BamHI/KpnI; 1–573 bp sepL gene with its own promoter amplified from ZAP193 and inserted
pDW29 pACYC184 digested with BamHI/KpnI; 1–870 bp sepL gene with its own promoter amplified from ZAP193 and inserted
pDW30 pACYC184 digested with BamHI/KpnI; 1–1020 bp sepL gene with its own promoter amplified from ZAP193 and inserted
pDW40 pGEX-4T-2 digested with BamHI/SmaI; fragment contained full-length cesT gene amplified from ZAP193 and inserted
pDW42 pET21d digested with XbaI/XhoI; fragment contained full-length sepL gene amplified from ZAP193 and inserted
pDW45 pACYC184 digested with BamHI; 1–801 bp sepL gene with its own promoter amplified from ZAP193 (6¥ His-tag
was introduced into C-terminus by primer) and inserted
pDW46 pACYC184 digested with BamHI; 1–870 bp sepL gene with its own promoter amplified from ZAP193 (6¥ His-tag
was introduced into C-terminus by primer) and inserted
pDW47 pACYC184 digested with BamHI; 1–1020 bp sepL gene with its own promoter amplified from ZAP193 (6¥ His-tag
was introduced into C-terminus by primer) and inserted
pDW48 pACYC184 digested with BamHI; full-length sepL gene with its own promoter amplified from ZAP193 (6¥ His-tag
was introduced into C-terminus by primer) and inserted
pDW50 pGEX-4T-2 digested with BamHI/SmaI; fragment contained caboxy-terminal 48 aa residue of sepL gene amplified
from ZAP193 and inserted
pDW51 pIB307 digested with KpnI/XbaI; fragment contained sepL gene and flanking regions (upstream 1 kb + downstream
1 kb) amplified from ZAP193 and inserted
pDW52 pDW51 was site-direct mutated by inserting a base pair at 345 bp of sepL orf
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Preparation of secreted proteins and bacterial fractions
for protein analyses
Bacteria were cultured in 50 ml of MEM-HEPES at 37°C
(200 r.p.m.) to an OD600 of 0.8 unless specifically stated. The
bacterial cells were pelleted by centrifugation at 4000 g
for 20 min, and supernatants were passed through filters
(0.45 mm). The proteins were precipitated overnight with 10%
TCA, and separated by centrifugation at 4000 g for 30 min
(4°C); the proteins were suspended in 150 ml of 1.5 M Tris
(pH 8.8). The bacterial pellet was initially suspended in 150 ml
of sonication buffer [10 mM Tris-HCl (pH 7.5), 0.5 mM PMSF,
aprotinin (0.5 mg ml-1)] and sonicated on ice. Cell envelopes
and unbroken bacteria were removed by two rounds of
centrifugation (5000 g for 10 min at 4°C). The supernatant
(whole-cell fraction) was removed and the membranes
pelleted by ultra-centrifugation of the samples for 1 h at
500 000 g at 4°C. The supernatant containing cytoplasmic
proteins was collected. The membrane preparation was
washed twice with sonication buffer and re-suspended in
150 ml of SDS sample buffer. Proteins were separated by
SDS-PAGE using standard methods and Western blotting
performed as described previously (Roe et al., 2003; Naylor
et al., 2005) using the relevant antibodies listed in Table 2.
Tir and EspD secretion levels were measured following
enhanced chemi-luminescence detection from Western blots
using Multi-analyst (Bio-Rad) software.
SepL analysis
Full-length SepL and different carboxy-terminal truncates of
SepL (Fig. 1) were fused to eGFP in pAJR70 (Roe et al.,
2003) using the primers described in Table 3. A 6¥ His-tag
was introduced at the carboxy end of SepL and three of the
truncated SepL proteins (267, 290 and 340 aa) by PCR
before cloning into pACYC184 (Table 1). All constructs were
confirmed by sequencing.
Construction of GST and 6¥ His-tagged proteins and
binding assays
For the GST–SepL construct, sepL was amplified from EHEC
O157 ZAP193 by PCR using the primers sepL 5′g and sepL
3′g. The resulting PCR product was digested with BamHI
and SmaI, and cloned into the BamHI and SmaI sites of
pGEX-4T-2. This creates a GST–SepL hybrid protein fusion
(in pDW9) used in GST pull-down assays. A similar stategy
was used to clone the 48 aa carboxy terminus of SepL, SepD
and CesT using the primers described in Table 3. For His-
tagged proteins, tir and sepD open reading frames were
amplified by the primers listed in Table 3, digested with XbaI
and XhoI and cloned into the XbaI and XhoI sites of pET21d.
For sepL and tir domain analyses, the amplified fragments
were cloned into pET28a via NdeI and XhoI to create
N-terminal 6¥ His-tags. All constructs were expressed in
E. coli BL21 (Table 2) following IPTG induction (0.1 mM). The
GST fusions were expressed in AAEC 185 (an E. coli K-12
derivative, Table 2) and the His-tag fusions in E. coli BL21,
both following IPTG induction in LB (0.1 mM) at OD600 = 0.5.
For protein preparations, the bacteria were harvested at
4000 r.p.m. (4°C) for 30 min. 2 h post IPTG inoculation. The
bacterial pellet was suspended in PBS and sonicated. The
supernatant was collected by centrifugation at 12 000 g for
10 min at 4°C. For the GST fusions, the supernatant was
Table 2. Bacterial strains and antibodies.
Strains Details
ZAP193 E. coli O157:H7 stx-, NCTC 12900
ZAP198 E. coli O157:H7 (Naylor et al., 2003)
ZAP1004 E. coli O157 stx Nalr Dler (Low et al., 2006)
ZAP1143 E. coli NCTC 12900; O157 stx Nalr DsepL (total deletion)
ZAP1144 E. coli NCTC 12900; O157 stx Nalr DsepD (total deletion)
ZAP1211 E. coli NCTC 12900; O157 stx Nalr DsepL (frameshift mutation by insertion of an additional base at nucleotide
position 345 of sepL)
Media Details
LB LB broth, Oxoid
M9 M9 minimal medium was modified with a final glycerol concentration of 0.4%, 2 mM MgSO4, 0.1 mM CaCl2, MEM
non-essential amino acids solution (Sigma), MEM amino acids solution (Sigma)
MEM-HEPES Minimal essential medium with HEPES buffer (Sigma), glucose was added to MEM-HEPES to give a final
concentration of 0.2%
Note Antibiotics were included when required at the following concentrations: chloramphenicol 12.5 mg ml-1, kanamycin
25 mg ml-1
Antibodies Details
Anti-GFP Mouse monoclonal (Clontech)
Anti-EspD Mouse monoclonal (gift from Prof. Trinad Chakraborty)
Anti-Tir Mouse monoclonal (gift from Prof. Trinad Chakraborty)
Anti-OmpA Rabbit polyclonal (gift from Prof. John Leong)
Anti-GroEL Rabbit polyclonal (Stressgen)
Anti-His Mouse Penta-His antibody (Qiagen)
Anti-Rabbit Igs Peroxidase-conjugated Swine anti-rabbit immunoglobulins, mainly IgG, HRP, DAKO
Anti-Mouse Igs Polyclonal goat anti-mouse immunoglobulins, mainly IgG, HRP, DAKO
Anti-Rabbit Igs,
FITC/TRITC conjugated
Goat anti-rabbit IgG, FITC/TRITC, DAKO
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mixed with PBS-balanced glutathione-sepharose 4B beads
for 30 min at room temperature. The beads were separated
by centrifugation at 500 g for 5 min. An aliquot of the super-
natant was saved for analysis and the rest of the supernatant
discarded. The beads were washed three times using 10 vols
of PBS and separation by centrifugation at 500 g for 5 min.
The beads were mixed gently in the same volume of Glu-
tathione Elution Buffer (0.154 g of reduced glutathione dis-
solved in 50 ml of 50 mM Tris-HCl, pH 8.0) and incubated at
room temperature for 10 min. Supernatant was collected by
centrifugation at 500 g for 5 min. The elution and centrifuga-
tion step was repeated and the two eluates pooled. Equal
volumes of washes and eluates were loaded onto the protein
gels. To check initial loading of columns, some eluates were
stained with colloidal blue and/or Western blotted to confirm
the presence of the expected GST fusion protein and His- or
GFP-tagged binding partners.
For His-tagged proteins, these were expressed and puri-
fied as above except a Ni-NTA column was used and elution
was with the supplied Qiagen buffer. For the in vitro binding
assays, these were carried out on either glutathione or
Ni-NTA columns on which the bait protein was first retained
and then the protein being investigated was run through the
column in a lysate prepared as above. Following washes,
elution was carried out as described above. Eluted samples
were analysed by SDS-PAGE followed by colloidal blue stain-
ing and Western Blotting.
Construction of sepL and sepD mutants
The experiments were carried out essentially as described
previously (Roe et al., 2003; Emmerson et al., 2006) using
allelic exchange methodology. The respective primer sets
Table 3. Oligonucleotides used in the study. The underlined letters highlight the restriction sites used in the relevant primers.
Primer name Application Sequence
sepLfull-5′ pDW6,24,26,27,28,29,30,45,46,47,48 CGGGATCCATGGCTAATGGTATTGAATTTAATCTTACCAGATGCTTGCTTTATTG
sepLfull-3′ pDW6 GGGGTACCAATAATTTCCTCCTTATAGTC
sepL 5′lhs pDW8, pDW10 CGGGGTACCTTTTTAAACTCTGATGCCAG
sepL 3′lhs pDW8, pDW10 CGCGGATCCTGGAAACTCACGTAATC
sepL 5′rhs pDW7 TGCTCTAGATATTAATTACTCAATAATTTTTTTG
sepL 3′rhs pDW7 CCAAGCTTAACAATTTTACTTTTTTGTG
sepL 5′g pDW9 CGGGATCCATGGCTAATGGTATTGAATTTAATC
C48aasepL 5′g pDW50 CGGGATCCGAAGATAAACATATTTATTATTTTC
sepL 3′g pDW9,50 CAACCCGGGTCAAATAATTTCCTCCTTATAGTC
sepL 3BamH pDW24 CGGGATCCTCAAATAATTTCCTCCTTATAGTC
sepD 5′lhs pDW21 GCGAGCTCCAGCGATCTCAGTTTCGATG
sepD 3′lhs pDW21 GCCGGATCCCATACATATTACCCGTCCTG
sepD 5′rhs pDW22 GCGGATCCCCGCCAACACACTTGTTTTC
sepD 3′rhs pDW22 GCATTAATCGGTCTTTTACAACAACTGC
sepD 5′g pDW15 CGGGATCCATGAACAATAATAATGGCATAG
sepD 3′g pDW15 CCCCGGGTTACACAATTCGTCCTATATCAG
sepD 5′ pDW20 CGGGATCCCTAAAGAAAGAGAAAAATGCG
sepD 3′ pDW20 GGGGTACCTTACACAATTCGTCCTATATCAG
cesT 5′g pDW40 CGGGATCCATGTCATCAAGATCTGAACTTTTA
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used to amplify the sepL, sepD are described in Table 3, the
ler deletion was published previously (Low et al., 2006). To
generate plasmids for the sepL frameshift mutation, a frag-
ment containing sepL gene and flanking regions (upstream
1 kb + downstream 1 kb) was amplified from ZAP193 by PCR
using sepL 5′allf and sepL 3′allf. It was digested with by KpnI
and XbaI, and cloned into the KpnI and XbaI sites of pIB307.
Following the methodology in the Stratagene ‘Site-Directed
Mutagensis’ kit, a single base pair was inserted at 345 bp of
sepL to generate a plasmid (pDW52) for allelic exchange.
Final plasmid constructs (Table 1) were sequenced prior to
the deletion exchange and each deletion confirmed by PCR
analysis. The sepL and sepD mutants could be functionally
complemented by pDW24 (sepL), pDW48 (sepL::6xhis),
pDW6 (sepL::egfp) and pDW20 (sepD::egfp) (Table 1) to
restore translocon (EspD) secretion as determined by
Western blotting (Fig. 4A, C and D and data not shown).
Fluorescence imaging
Fluorescence imaging was carried out using a Leica DM LB2
microscope and a 100¥ objective lens. Narrow-bandwidth
filters to excite and detect eGFP/FITC were used (41017
Endow GFP, CHROMA). Images were captured using
a Hamamatsu ORCA-ER black and white CCD digital
camera. Images were analysed using OpenLab software
(Improvision). To measure levels of fluorescence in individual
cells, transects were marked on bacteria and the fluores-
cence levels determined using QFluor software (Leica).
Far-Western analysis
Supernatant proteins were prepared from ZAP1143 (DsepL)
as described in the relevant section above. The secreted
proteins were separated by SDS-PAGE using standard
methods and then transfered to an enhanced chemi-
luminescence Nitrocellulose membrane. The membrane was
first blocked with 8% milk PBS overnight at 4°C and washed
three times with PBS-Tween (0.5% v/v) before being incu-
bated overnight with SepL-His in an E. coli BL21 lysate at
4°C. After the incubation, the nitrocellulose membrane was
washed three times with PBS-Tween and the standard
Western procedure for detecting the 6¥ His-tags was carried
out.
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